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Chair’s introduction – Mr John Tait | Te kupu whakataki a te manukura – 
ko John Tait 
Firstly, and most importantly, I would like to recognise the mothers and babies whose lives have been lost, 
and the families and whānau who bear the grief of losing their loved ones.  
 
It is therefore with the upmost respect and recognition to those mothers and babies that I present the 14th 
annual report of the Perinatal and Maternal Mortality Review Committee (the PMMRC). The information 
presented in this report does not begin to demonstrate the lifelong heartache experienced following each 
one of the deaths included.  
 
It is the aim and belief of the PMMRC that the production of this report will highlight and direct necessary, 
and urgent, service and system-level changes to reduce these deaths in Aotearoa/New Zealand. 
 
I would like to thank the members of the PMMRC and working groups for their ongoing valuable 
contribution and commitment to improving the outcomes of all mothers and babies here in Aotearoa/New 
Zealand. Equally, I would like to acknowledge the significant work of local coordinators both in collecting 
information on these deaths and supporting the families and whānau through this extrordinarily difficult 
time. Without the generous contribution of your time and expertise it would not have been possible to 
produce this report.   
 
I would also like to acknowledge that 2020 was International Year of the Midwife. It is also significant that 
August 2020 marks the 30th anniversary of the Nurses Amendment Act 1990, which reintroduced 
autonomous midwifery practice in Aotearoa/New Zealand. We acknowledge the commitment of midwives 
who are so deeply involved in supporting women, families and whānau through the loss of a child, while 
navigating their own professional and personal experience.  
 
Each year, the PMMRC report investigates the epidemiology of perinatal mortality, maternal mortality and 
neonatal encephalopathy, and this year also includes a supplementary document on maternal morbidity 
(Appendix A). This year’s report shows there has been a significant reduction in deaths overall (perinatal 
related deaths) in Aotearoa/New Zealand since 2007, as well as a significant reduction in fetal and early 
neonatal deaths. However, we must not be complacent.   
 
While this report shows a decrease in these deaths, it is unacceptable that, yet again, it is babies of Māori, 
Pacific and Indian women who are over-represented within the data in this report. Also, it is of great 
concern to the PMMRC that this inequity could further increase as a result of barriers to accessing care 
during the response to the COVID-19 pandemic. 
 
Wāhine Māori have statistically significant higher rates of maternal mortality than New Zealand European 
women. While there were no deaths by suicide in 2018, this remains the single largest cause of maternal 
death in Aotearoa/New Zealand, with suicide accounting for 44 percent of direct causes of maternal death 
since 2006.   
 
Therefore, this year we challenge, and call to action, all of us working within the health system, health 
organisations and health practitioners, to prioritise and implement the recommendations of the PMMRC to 
ensure quality and equitable maternal and perinatal care is provided. This is desperately needed.  
 




Chair, Perinatal and Maternal Mortality Review Committee 
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Parents, whānau, families and communities Ngā mātua, ngā whānau me 
ngā hapori  
E kī ana te kōrero, ahakoa he iti te matakahi, ka pakaru i a ia te tōtara, tihei mauri ora! - A little effort can 
achieve great things, I exhort the breath of life. 
 
E aku nui, e aku rahi tēnā koutou katoa – special greetings to you all. 
 
Ko wai au? I te taha o tōku māmā, he uri au no Aerana, County Antrim, Ballymena. I te taha o tōku pāpā, 
he uri au no Pare Hauraki ahau. Ko Pania (Lisa) Paraku tōku ingoa. Kia ora.   
 
Once again, I am humbled to stand on behalf of bereaved whānau and families as a member of the 
Perinatal and Maternal Mortality Review Committee (the PMMRC). My role is to offer whānau and family 
voice to spaces that are typically clinical and data driven. This is no small feat.  
 
My beautiful Jasmine Lee was born perfect and still in 2006, and she, along with her five siblings who did 
not enter the world of light, bring me to this mahi. My own experience has been heavy and varied within our 
health system and it is important that I stand with our PMMRC rōpū in pursuit of zero preventable deaths or 
harm for our pēpi and our māmā. 
 
To my fellow bereaved parents, whānau and families, can I offer the following mihi to you: Ko te tūmanako 
ka nui te aroha ki a koe, ki a kōrua, ki a koutou me ōu whānau hoki, my love to you and to your family.  
 
Ki ngā pēpi kua ngaro ki te pō, moe mai koutou. To our precious ones who have disappeared into the night, 
rest in peace. I acknowledge our precious babies, our grief and our journey. 
 
I acknowledge those that stand with me in this mahi. My whānau whānui, my whānau at Sands, our Māori 
māmā rōpū, and Dr Vicky Culling who remains fearless in the collective pursuit of national bereavement 
care which offers equitable outcomes for our community – ngā mihi nui ki a koutou. 
 
As a proud wāhine Māori standing with three mana wāhine, together with our ngākau Māori who make up 
the PMMRC, our wero, our challenge, has become louder, and more urgent. We can no longer ignore the 
fact that evidence-based recommendations of the PMMRC are not being prioritised and implemented, year 
after year after year. 
 
On behalf, I ask – Why? Is this kaupapa not important enough, the health and wellbeing of our precious 
babies, their mothers? Why are our babies and mothers dying, when in some cases this is preventable? 
Why are my people the ones most affected, when we hold the right to equitable outcomes under Te Tiriti? 
Why are our cousins in the Pacific, our young mothers and our friends from India also those most affected?   
 
I then ask – How? How can we engender a collective response that recognises shared space and shared 
value in order to implement the recommendations of the PMMRC, and where possible, ensure our most 
precious taonga, our babies and their mothers, can be in the world of light?   
 
How do we dismantel and decolonise our system, standing strong in anti-racism and begin to heal the 
mamae of historical trauma? The answers have been gifted to us, within the Hauora Report,2 within the 
Health and Disability System Review, in particular the alternate view,3 and within our humble 
recommendations from the PMMRC.   
 
 
2 Wai 2575 Tribunal Report 2019. HAUORA: Report on Stage One of the Health Services and Outcomes Kaupapa Inquiry. URL: 
https://forms.justice.govt.nz/search/Documents/WT/wt_DOC_152801817/Hauora%20W.pdf  
3 See pp 173–6: https://systemreview.health.govt.nz/assets/Uploads/hdsr/health-disability-system-review-final-report.pdf  
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My elders have asked me... ‘If not you, then who?’ And now I ask the same of you. I share this whakataukī 
or proverb ‒ Ma pango, ma whero ka oti te mahi – collectively the work will be done.   
 
E hoa mā, he kaupapa nui tēnei. My friends, this is such an important kaupapa for us all.  
 
To my fellow PMMRC whānau, e mihi maioha ki a koutou, many thanks for what you do. This is heavy mahi 
that must be done to achieve equitable outcomes, prevent our babies and mothers dying where we can, 
and to create a gentle path when our loved ones do die. You do this mahi with grace – I acknowledge you 
and on behalf, I thank you.  
 
To my fellow bereaved parents, whānau and families we stand with and for you. Our wero and our 
recommendations inform the system of how to be better. We can do this, and we must, in honour of our 
precious babies and mothers who have gone before and in service to us all. 
 
Ahakoa he mihi poto tēnei, he mihi aroha.   
 
Nō reira, tēnā koutou, tēnā koutou, tēnā tātou katoa. Although this greeting is short, it is from the heart with 
love. Therefore, greetings to you all, greetings to us all.  
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Key findings for the maternity sector from the PMMRC’s 14th annual 
report | Ngā kitenga matua e pā ana ki te rāngai whakawhānau i te 
pūrongo ā-tau 14 o te PMMRC  
To be inserted 
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Executive summary | Whakarāpopototanga matua 
This monitoring report outlines some of the trends in mortality in babies and mothers, and serious morbidity 
from neonatal encephalopathy. Deaths are usually multifactorial in nature – usually a death has more than 
one cause. The aim of this work is to monitor trends and look at systems issues that could be modified to 
prevent future deaths.  
Definitions used by the PMMRC – perinatal related and infant deaths 
Source: Adapted from New Zealand Health Information Service (2007) and Ministry of Health (2010).4 
Perinatal mortality 
Since 2007, when the Perinatal and Maternal Mortality Review Committee (PMMRC) began collecting data, 
deaths overall (perinatal related deaths) have reduced significantly. Perinatal mortalities (fetal and early 
neonatal deaths) decreased significantly among babies of New Zealand European mothers, but not for any 
other ethnic group. 
The decrease in the rate of stillbirths was largely driven by a reduction in stillbirths in babies of New 
Zealand European women. There was also a statistically significant decrease in stillbirths for babies of 
Middle Eastern, Latin American, or African (MELAA) women, but no significant change occurred in any 
other ethnic group.  
The rates of terminations of pregnancy and rates of neonatal mortality overall showed no statistically 
significant changes.  
Deaths due to congenital anomalies remain the leading cause of death overall. The rates of perinatal-
related mortality in the peripartum period due to hypoxia have decreased significantly since 2007.  
Our results show that certain groups are at higher risk of serious adverse outcomes. These include babies 
of Māori, Pacific and Indian mothers; and babies of mothers aged less than 20 years. Mortality also 
increased somewhat for babies of mothers aged 40 years and over.  
Mortality rates varied significantly by the level of socioeconomic deprivation in the areas where mothers 
lived, as measured by the New Zealand Index of Deprivation 2013 (NZDep2013). Those mothers living in 
the most deprived areas (quintile 5) were statistically significantly more likely to lose a baby from stillbirth, 
neonatal death and perinatal related death overall, compared with those living in any other quintile. This 
variation in mortality rates by deprivation was most marked for deaths due to spontaneous preterm labour 
or rupture of membranes.  
4 New Zealand Health Information Service. 2007. Fetal and Infant Deaths 2003 & 2004.Wellington: Ministry of Health. 
Ministry of Health. 2010. Fetal and Infant Deaths 2006. Wellington: Ministry of Health. 
Gestation Birth 7 days 28 days 1 year 

















Perinatal related deaths 
Neonatal deaths 
Infant deaths 
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Our data suggest that the National Maternity Collection (MAT) data set5 underestimates maternal body 
mass index (BMI). However, regardless of whether we use MAT or PMMRC data, the mortality rates from 
stillbirth, neonatal death and perinatal related death overall increase with increasing maternal BMI. 
Rates of mortality from stillbirth, neonatal death and perinatal related death overall were higher for babies 
of women who were smoking at the time of registration with a lead maternity carer (LMC) compared with 
those who were not. Smoking is a significant and modifiable risk factor of perinatal loss. When women are 
appropriately supported to quit, outcomes clearly improve in relation to some risk factors for mortality, such 
as spontaneous preterm birth and small for gestational age. Effective smoking cessation programmes do 
exist, and investment in appropriate programmes designed to reduce this modifiable risk factor should be 
supported.   
Mortality rates were higher for small for gestational age babies than those who were appropriate or large for 
gestational age. In particular, babies with a birthweight in the 5th customised centile group or below have 
substantially higher mortality rates than the other centile groups. 
Overall, around 41% of babies who died had optimal investigation into the cause(s) of their death, meaning 
that their death was investigated through post-mortem, karyotype confirming chromosomal abnormality or 
clinical examination or investigation confirming the diagnosis. Around half of terminations of pregnancy had 
‘optimal’ investigation, whereas under 40% of stillbirths and neonatal deaths did. There were some 
variations between prioritised ethnic groups in both the rate of offering of post-mortem and the rate of 
uptake if offered. 
Local review of cases showed that a number of deaths had potentially avoidable aspects. Review findings 
indicated contributory factors were present in just under one quarter of perinatal related deaths. Barriers to 
access and/or barriers to engagement with care were the most common type of contributory factor; others 
that the reviews considered were organisational and/or management factors, and personnel factors. 
Neonatal encephalopathy 
Neonatal encephalopathy (NE) is a clinically defined syndrome of disturbed neurological function within the 
first week after birth in an infant born from 35 weeks’ gestation, manifested by difficulty in initiating and 
maintaining respiration, depression of tone and reflexes, subnormal level of consciousness and often 
seizures.6  
The rate of NE cases per 1,000 term births fluctuated from year to year, with a high of 1.38 per 1,000 live 
births in 2012 and a low of 1.00 in 2014. Between the years 2010 and 2018, the rate has not shown a 
statistically significant trend up or down.  
Babies of primiparous women had the highest rates of NE, and those rates were statistically significantly 
higher than for babies of multiparous women regardless of parity. The rates of NE varied by gestational age 
at birth, with higher rates for those at the extreme ends of term pregnancies. Babies with lower birthweight 
had higher rates of NE; those under 2,500g had the highest rate. 
Overall, 77% of babies had cooling therapy, with the proportion slightly higher for babies with moderate NE. 
The rates of cooling were the same for babies of Māori mothers as for those with New Zealand European 
mothers.  
Mortality was much higher in babies with severe NE, among whom 60% died, compared with 2% of babies 
with moderate NE. 
5 The MAT data set is the primary source of information for publicly funded maternity care in Aotearoa/New Zealand. 
6 Nelson KB, Leviton A. 1991. How much of neonatal encephalopathy is due to birth asphyxia? American Journal of Diseases of 
Children 145(11): 1325–31. 
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Maternal mortality 
Maternal death is the death of a woman while pregnant or within 42 days of termination of pregnancy 
(miscarriage, termination7 or birth), irrespective of the duration and site of the pregnancy, from any cause 
related to or aggravated by the pregnancy or its management, but not from accidental or incidental causes. 
The PMMRC collected information on a total of 126 maternal deaths during pregnancy or within 42 days 
postpartum over the period 2006–2018, as well as on another 28 coincidental maternal deaths. The 
number of maternal deaths has fluctuated substantially over this time. Although the trend is not statistically 
significant, the total number of maternal deaths followed a general downward pattern over the study period. 
The incidence of maternal death increased with age, with the highest rates among those aged 40 years 
and over (39.2 per 100,000 maternities). In our analysis of the incidence of maternal deaths by prioritised 
ethnic group, wāhine Māori had statistically significantly higher rates than New Zealand European women. 
There was a general pattern of increasing mortality with increasing deprivation, when measured by 
NZDep2013. However, this pattern was not statistically significant (p=0.11).  
There were 68 direct8 and 50 indirect9 maternal deaths10 over the study period 2006–2018 inclusive. The 
single largest cause of maternal death in Aotearoa/New Zealand was suicide, which accounted for 30 
deaths during this time (44% of direct causes). The next leading cause was amniotic fluid embolism (AFE), 
which caused 14 deaths (11.1%). 
Suicide continues to be the leading cause of maternal death in Aotearoa/New Zealand and particularly 
affects wāhine Māori. PMMRC strongly recommends making targeted investment in maternal mental health 
a key priority for funding by the Ministry of Health. Maternal wellbeing, the development of culturally 
appropriate maternal screening tools and treatment for women and their babies continue to be areas in 
urgent need of investment, alongside addressing the wider societal drivers of suicide. Investment should 
prioritise populations who would benefit the most, such as ngā māma Māori, and be informed by research 
findings about when women most need that support.   
The COVID-19 outbreak in 2020 has impacted on maternity care in a number of ways. Supply of 
contraceptives has been and continues to be unreliable.11 Whānau were not able to attend hospital births 
and the maternity sector was challenged with the need to care for people giving birth while following 
recommendations to stay out of hospital as much as possible. We will take these conditions into account 
when examining 2020 data and reporting on them in 2022. 
7 Termination of pregnancy is the interruption of an ongoing pregnancy (whether the baby was stillborn or live born). This report 
includes only termination of pregnancy from 20 weeks’ gestation in the perinatal section. For maternal mortality, a maternal death 
following termination of pregnancy at any gestational age is included. 
8 Direct maternal deaths are those that result from obstetric complications of the pregnant state (pregnancy, labour or puerperium) 
from interventions, omissions or incorrect treatment or from a chain of events resulting from the above.  
9 Indirect maternal deaths are those that result from previous existing disease or disease that developed during pregnancy and was 
not due to direct obstetric causes but that was aggravated by the physiologic effects of pregnancy.  
10 For another eight maternal deaths, the cause is as yet unknown. 
11 PHARMAC. 2020. Oral contraceptives: Supply updates. Wellington: PHARMAC Te Pātaka Whaioranga. URL: 
https://www.pharmac.govt.nz/information-for/enquiries/oral-contraceptives-supply-updates/ (accessed 18 August 2020). 
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1 Challenge | Wero 
Year after year, the Perinatal and Maternal Mortality Review Committee (PMMRC) reports show inequity 
continues and no significant progress is being made to reduce mortality and morbidity for whānau Māori, 
Pasifika families, Indian families and those living in areas of high deprivation. Now the COVID-19 pandemic 
and its response are likely to amplify those shortcomings. 
 
While PMMRC acknowledges the hard work and determination of the sector and its contribution to a 
significant reduction in perinatal death overall, the inequities that remain are significant and unacceptable.  
 
Therefore, this year, our wero, our challenge to you – the decision-makers and leaders of the health 
system, and all health organisations and practitioners – is to give priority to implementing the 
recommendations of the PMMRC.  
Urgent action, centred in equity, is required to help reduce the loss and grief that families and whānau are 
experiencing as a result of preventable death in Aotearoa/New Zealand.  
 
Since 2007, the PMMRC has made numerous recommendations to drive service- and system-level 
change. Yet, despite the health sector’s commitment to it, the data show that this change has only 
benefited some groups and remains elusive for many who have greater need.  
 
We all have a responsibility to the women and their babies, families and whānau whose lives and deaths 
are represented in the PMMRC data to promptly implement recommendations to reduce the perinatal and 
maternal deaths that are preventable and avoidable. In 2018 alone, reviews identified preventable 
contributory factors that impacted on 79 perinatal related deaths.  
Strengthening your focus and prioritisation  
Of utmost concern to the PMMRC are the frequent barriers to accessing care, differential quality of 
maternity of care, stagnant rates of perinatal death and alarmingly higher rates of maternal suicide that 
Māori whānau are experiencing. We ask and challenge you all to prioritise recommendations that create a 
Tiriti-compliant system where it is safe for Māori women to give birth in Aotearoa/New Zealand.    
 
 
We absolutely should be better supporting these parents and whānau, as they are bearing the grief of 
the death of their baby […] ~ Dr Vicki Culling, perinatal and infant loss educator 
Implementation of the PMMRC recommendations remains critical to achieving high-quality, 
equitable maternal and perinatal care and outcomes.  
 
Achieving such care and outcomes will require you to: 
• meaningfully honour the health sector’s responsibilities to Te Tiriti o Waitangi 
• strengthen your focus and prioritisation to accelerate the implementation of PMMRC 
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Monitoring by ethnicity for improvement analysis 
To meet this challenge, district health boards (DHBs) must invest resource into monitoring key maternity 
indicators for Māori and other ethnic groups to identify variations between them, and then identify areas for 
quality improvement based on this analysis. Quality improvement projects must be co-developed so that 
models of care meet the needs of these populations.  
National consensus in the care of preterm births 
It is important that DHBs follow the national consensus statement specifically on the care of mother and 
baby(ies) at periviable gestations12 published in 2019.  
 
Preterm birth continues to be the leading cause of neonatal death, and Māori babies are over-represented 
in these deaths. Care for these babies needs to occur in one of Aotearoa/New Zealand’s six tertiary 
neonatal centres, meaning more than one third of families will need to access care away from home. The 
sector must support whānau and families to access this care, including with transport and accommodation 
for whānau from outside the tertiary neonatal centres. 
Cultural safety in practice 
All health organisations must require staff to practise cultural safety standards. Action is needed to address 
the lack of consideration of cultures and religions outside of western and Christian norms. 
Calling on the Ministry of Health 
The Ministry of Health plays a critical role in making resources available to support health practitioners, 
health organisations and district health boards to implement these recommendations.  
 
In upholding its responsibilities under Te Tiriti o Waitangi, the Ministry of Health needs to ensure that Māori 
have an equal voice in decision-making and the development of health policy, process and practice in order 
to achieve equitable health outcomes. The Ministry also has a significant role to play in working with, and 
influencing, other government agencies to do the same, and in this way accelerate progress across the 
wider determinants of health. 
 
The PMMRC calls on the Ministry of Health to prioritise: 
• the need for investment in maternal and infant mental health  
• the development of a high-quality, appropriate and equitable national perinatal bereavement pathway  
• aligning ethnicity data collected and included in all data sets with the Health Information Standards 




12 New Zealand Child and Youth Clinical Networks. 2019. National Consensus Statement on the care of mother and baby(ies) at 
periviable gestations. URL: https://www.starship.org.nz/guidelines/new-zealand-consensus-statement-on-the-care-of-mother-and-
baby-ies-at/ (accessed 24 November 2020). 
13 Ministry of Health. 2017. HISO 10001:2017 Ethnicity Data Protocols. Wellington: Ministry of Health. 
It would be misleading to conclude that failures in the health system are the reason for all the disparities. 
Sub-standard housing, poor education, unemployment, low incomes, cultural alienation, alienation from 
land, and frank discrimination have all contributed to the problem. In that respect, a whole-of-society 
remedy must be sought ~ Sir Mason Durie 
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Working together to make change 
To support the implementation of the recommendations of the PMMRC, Appendices B–F list 
recommendations that are yet to be fully implemented.    
 
Approximately half of the recommendations made over the past 13 years are yet to be fully implemented. 
Much work remains to be done. 
 
The recommendations have been grouped into five key areas: health practitioners, DHBs, colleges and 
regulatory bodies, government and research recommendations. Our aim in taking this approach is to make 
it easier for you to understand where you can make an impact.  
 
We hope that this information also enables you to support the work of your colleagues and organisations 
and that, in owning these responsibilities together, we can make the greatest and most valuable impact 
towards changing the outcomes of women and their babies, families and whānau. 
 
Ngā mihi nui ki a koutou katoa. 
 
 
Mr John Tait 
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2 Methods | Ngā tikanga mahi 
See Methods and definitions for Perinatal and Maternal Mortality Review Committee (PMMRC) reporting 
document, available at: www.hqsc.govt.nz/our-programmes/mrc/pmmrc/publications-and-
resources/publication/4210.  
Definitions used by the PMMRC 
Fetal death is the death of a fetus at 20 weeks’ gestation or beyond (≥20 weeks) or weighing at least 
400g if gestation is unknown. Fetal death includes stillbirth and termination of pregnancy. 
Termination of pregnancy is the interruption of an ongoing pregnancy (whether the baby was 
stillborn or live born). This report only includes termination of pregnancy from 20 weeks’ gestation. 
Neonatal death is the death of any baby showing signs of life at 20 weeks’ gestation or beyond or 
weighing at least 400g if gestation is unknown that occurs up until midnight of the 27th day of life. 
Early neonatal death is a death that occurs up until midnight on the sixth day of life. Late neonatal 
death is a death that occurs between the seventh day and midnight of the 27th day of life. 
Perinatal mortality is fetal and early neonatal death from 20 weeks’ gestation (or weighing at least 
400g if gestation is unknown) until midnight of the sixth day of life. 
Perinatal related mortality is fetal deaths (including terminations of pregnancy and stillbirths) and 
neonatal deaths (up to midnight of the 27th day of life) per 1,000 total babies born at 20 weeks’ 
gestation or beyond, and weighing at least 400g if gestation was unknown. 
A maternal death is the death of a woman while pregnant or within 42 days of termination of 
pregnancy (miscarriage, termination or birth), irrespective of the duration and site of the pregnancy, 
from any cause related to or aggravated by the pregnancy or its management. It does not include 
accidental or incidental causes of death of a pregnant woman (coincidental deaths). 
Maternities are all live births and all fetal deaths at 20 weeks’ gestation or beyond or weighing at 
least 400g if gestation is unknown. The maternal mortality ratio is calculated per 100,000 maternities. 
Neonatal encephalopathy (NE) is a clinically defined syndrome of disturbed neurological function 
within the first week of life, manifested by difficulty in initiating and maintaining respiration, depression 
of tone and reflexes, subnormal level of consciousness and often seizures. 
Ethnic comparisons 
Throughout the report, we make comparisons between prioritised ethnic groups. At times, we compare 
outcomes for babies of Māori women with outcomes for babies of New Zealand European women. Te Tiriti 
o Waitangi underlies the health sector’s obligations to Māori, and upholds Māori rights to monitor the Crown 
to ensure that it meets these responsibilities and that Māori have equitable outcomes in the health sector. 
Adding to the Tiriti-based Māori rights are the broader rights of women and children to equitable outcomes 
regardless of their ethnicity. In presenting comparisons between different ethnic groups, we are not 
commenting on the deficits of any particular ethnic group, but rather are highlighting the deficits of a society 
that creates, maintains and tolerates these differences. 
Comparison between mother and baby ethnicity 
The ethnicity of both mother and baby is important for reporting on mortality. As many of the determinants 
of health for a baby relate to their mother, in many instances it is appropriate to examine maternal ethnicity 
so that we can explore areas for improvement and intervention. In addition, to understand the burden of 
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Table 2.1 and Table 2.2 show how the numbers in individual ethnic groups can differ depending on the data 
sources. ‘PMMRC’ data are those that the PMMRC collects directly through our Rapid Reporting Forms, 
following the death of a baby so they relate only to babies who have died (numerator). ‘MAT’ data are those 
data that are in the National Maternity Collection, which contains data on pregnancy, delivery and babies. 
This source includes data on most babies born in Aotearoa/New Zealand (denominator population). Table 
2.1 shows that for maternal ethnicity, there are no substantial differences between the two data sources. In 
contrast, Table 2.2 shows that for baby ethnicity, substantial amounts of data are missing from MAT, with 
the overall effect of producing a large proportion (51%) of missing cases. This unfortunately makes the 
baby ethnicity data in MAT too unreliable to use. 
Table 2.1: Prioritised maternal ethnic group by PMMRC and MAT data sources for perinatal related deaths 
2007–2018 
2007–2018 PMMRC MAT 
Prioritised maternal ethnic group   
Māori 2,056 2,059 
Pacific peoples 1,037 1,072 
Indian 479 409 
Other Asian 599 566 
MELAA 150 173 
NZ European 3,012 2,648 
Other European 466 605 
Other <3 - 
Unknown <3 6 
Total 7,802 7,538 
MELAA = Middle Eastern, Latin American, or African. 
Sources: Numerator: PMMRC’s perinatal data extract 2007–2018; Denominator: MAT data 2007–2018. 
Table 2.2: Prioritised baby ethnic group by PMMRC and MAT data sources for perinatal related deaths 
2007–2018 
2007–2018 PMMRC MAT 
Prioritised baby ethnic group   
Māori 2,444 1,084 
Pacific peoples 1,058 531 
Indian 494 256 
Other Asian 592 282 
MELAA 155 80 
NZ European 2,799 1,306 
Other European 251 218 
Other - - 
Unknown 9 3,781 
Total 7,802 7,538 
MELAA = Middle Eastern, Latin American, or African. 
Sources: Numerator: PMMRC’s perinatal data extract 2007–2018; Denominator: MAT data 2007–2018. 
National Maternity Collection (MAT) 
MAT is based on two sources:  
• primary maternity services provided under section 88 of the New Zealand Public Health and Disability 
Act 2000, which is sourced from lead maternity carer (LMC) claims for payment 
• the National Minimum Dataset (NMDS), which contains information on inpatient and day patient health 
events during pregnancy, birth and the postnatal period for the mother and baby. 
While MAT should have a record of most births that occur in New Zealand, either through the NMDS for 
those who give birth in hospital or through LMC claims, antenatal data have not routinely been uploaded for 
women who are receiving care from providers other than LMC midwives, general practitioners (GPs) or 
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obstetricians. In particular, women who receive antenatal care through their DHB may not have their 
antenatal data entered into MAT. Some DHBs, such as Counties Manukau, routinely provide antenatal 
care. Due to a technical issue, antenatal data from DHBs may not be uploaded into MAT, even when the 
DHB provides them. The Ministry has developed the Health Information Organisation (HISO) Maternity 
Care Summary Standard in conjunction with stakeholders for the purpose of gaining consistent information 
from maternity service providers. These providers include DHBs, which have been advised to update 
unsupported maternity software as a matter of urgency in order to improve the consistency and availability 
of these data. In our 13th report, we presented an approximation of the effect of this approach on data 
reported: using the examples of smoking status and body mass index, we showed substantial differences 
between those women whose antenatal records are in MAT and those whose records are not.14 
Perinatal Society of Australia and New Zealand death classifications 
All perinatal deaths are classified in accordance with either the Perinatal Society of Australia and 
New Zealand (PSANZ) Perinatal Death Classification (PDC) or the PSANZ Neonatal Death Classification 
(NDC). In 2017, PSANZ revised these death classification systems to include new subcategories,15 which 
were subsequently implemented in New Zealand in 2018.  
We have classified the deaths presented in this report using the revised 2017 version of PSANZ death 
classification systems. This includes deaths from 1 January 2018. Deaths prior to 2018, which were 
originally classified using the 2007 version, have been reclassified according to the 2017 revision.  
 
 
14 PMMRC. 2019. Te Pūrongo ā-Tau Tekau mā Toru o te Komiti Arotake Mate Pēpi, Mate Whaea Hoki | Thirteenth Annual Report 
of the Perinatal and Maternal Mortality Review Committee: Te tuku pūrongo mō te mate me te whakamate 2017 | Reporting 
mortality and morbidity 2017. Wellington: Health Quality & Safety Commission. URL: 
https://www.hqsc.govt.nz/assets/PMMRC/Publications/13thPMMRCreport/13thPMMRCAnnualReportWebFINAL.pdf (accessed 18 
September 2020). p 16.   
15 For a comparison of the PSANZ death classification systems, see the Stillbirth and Neonatal Death Alliance (PSANZ-SANDA) 
website. URL: https://sanda.psanz.com.au/assets/Uploads/Appendix-U-Changes-in-this-version-of-the-classifications.pdf (accessed 
13 May 2020). 
 
 
Fourteenth Annual Report of the Perinatal and Maternal Mortality Review Committee   22 
3 Perinatal mortality | Te mate pēpi 
Aotearoa/New Zealand overview and key findings 
Since 2007, when the PMMRC started collecting data, there is some evidence of a statistically significant 
decrease in deaths overall (perinatal related mortality), and in the rates of perinatal (fetal and early 
neonatal) mortalities. Overall, there has been a statistically significant decrease in the rate of stillbirths16 but 
no reduction in neonatal mortality (Figure 3.1). Table 3.1 presents the rates of perinatal death for the period 
2009–2018. 
To examine the population groups that benefited from the improvements that occurred, we undertook 
further analyses by prioritised ethnic group. The main reason why perinatal related mortalities and perinatal 
mortalities fell over the period 2007–2018 was that mortality in babies of New Zealand European mothers 
fell by a statistically significant rate. Other ethnic groups had no statistically significant change in rates of 
perinatal related mortalities and in perinatal mortalities. 
Over the period 2007–2018, stillbirths in babies of both New Zealand European and Middle Eastern, Latin 
American, or African (MELAA) mothers decreased by a statistically significant rate, but the rate of stillbirths 
did not change in other groups. Similarly, there was a statistically significant decrease in fetal deaths for 
New Zealand European mothers, but not for any other ethnic groups. 
Between the years 2007 and 2018, there were no significant changes in terminations of pregnancy or in 
neonatal deaths for any of the ethnic groups. 
The mortality rates for babies of women of Māori, Pacific, Indian or Other European groups did not change 
to a statistically significant level in any of the above categories. 
Figure 3.1: Perinatal related mortality rates (per 1,000 births) using New Zealand definitions by year 2007–
2018 
 
* In this report, ‘Termination of pregnancy’ refers to the interruption of an ongoing pregnancy from 20 weeks’ gestation onwards. 
Sources: Numerator: PMMRC’s perinatal data extract 2007–2018; Denominator: MAT births 2007–2018. 
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2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 
Total births 65,203 65,449 63,243 63,286 60,137 60,080 59,783 60,606 60,478 59,258 
Fetal deaths (terminations of pregnancy and stillbirths)* 547 498 503 492 447 477 412 458 421 450 
Terminations of pregnancy 138 151 171 172 141 150 107 148 133 135 
Stillbirths 409 347 332 320 306 327 305 310 288 315 
Early neonatal deaths <7 days 137 165 139 142 122 150 131 123 137 116 
Late neonatal deaths 7–27 days 46 45 25 36 31 32 35 31 35 38 
Neonatal deaths <28 days# 183 210 164 178 153 182 166 154 172 154 
Perinatal mortalities+ 684 663 642 634 569 627 543 581 558 566 
Perinatal related mortalities^ 730 708 667 670 600 659 578 612 593 604 
Perinatal mortalities excluding lethal and terminated fetal abnormalities• 513 463 443 440 414 447 397 413 404 414 
Perinatal related mortalities excluding lethal and terminated  
fetal abnormalities• 
544 494 459 462 432 466 415 434 429 440 
  
Rate 
2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 
Total births                     
Fetal deaths (terminations of pregnancy and stillbirths)* 8.39 7.61 7.95 7.77 7.43 7.94 6.89 7.56 6.96 7.59 
Terminations of pregnancy 2.12 2.31 2.70 2.72 2.34 2.50 1.79 2.44 2.20 2.28 
Stillbirths 6.27 5.30 5.25 5.06 5.09 5.44 5.10 5.12 4.76 5.32 
Early neonatal deaths <7 days                     
Late neonatal deaths 7–27 days                     
Neonatal deaths <28 days# 2.83 3.23 2.61 2.83 2.56 3.05 2.80 2.56 2.86 2.62 
Perinatal mortalities+ 10.49 10.13 10.15 10.02 9.46 10.44 9.08 9.59 9.23 9.55 
Perinatal related mortalities^ 11.20 10.82 10.55 10.59 9.98 10.97 9.67 10.10 9.81 10.19 
Perinatal mortalities excluding lethal and terminated fetal abnormalities• 7.87 7.07 7.00 6.95 6.88 7.44 6.64 6.81 6.68 6.99 
Perinatal related mortalities excluding lethal and terminated  
fetal abnormalities• 
8.34 7.55 7.26 7.30 7.18 7.76 6.94 7.16 7.09 7.43 
* Fetal death rate per 1,000 babies born (includes terminations and stillbirths). 
# Neonatal death rate per 1,000 live born babies. 
+ Fetal deaths and early neonatal deaths per 1,000 babies born. 
^ Fetal deaths and early and late neonatal deaths per 1,000 babies born. 
• Lethal and terminated fetal abnormalities are all perinatal related deaths with Perinatal Society of Australia and New Zealand Perinatal Death Classification (PSANZ-PDC) of congenital anomaly, and neonatal deaths 
with PSANZ Neonatal Death Classification (PSANZ-NDC) of congenital anomaly. 
Sources: Numerator: PMMRC’s perinatal data extract 2009–2018; Denominator: MAT births 2009–2018. 
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Using international definitions, there is strong evidence of a statistically significant decrease in fetal deaths, stillbirths, perinatal mortalities and perinatal related 
mortalities over the period 2007–2018 (Figure 3.2). Table 3.2 presents the mortality rates using international definitions for the period 2009–2018. 




2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 
Total births 64,630 64,886 62,695 62,723 59,604 59,514 59,322 60,094 59,951 58,726 
Fetal deaths (terminations of pregnancy and stillbirths)* 231 199 191 166 155 162 164 171 158 151 
Terminations of pregnancy 9 17 24 13 12 13 7 15 16 7 
Stillbirths 222 182 167 153 143 149 157 156 142 144 
Early neonatal deaths <7 days 59 68 65 54 45 59 57 53 46 40 
Late neonatal deaths 7–27 days 30 31 18 24 24 23 28 23 22 20 
Neonatal deaths <28 days# 89 99 83 78 69 82 85 76 68 60 
Perinatal mortalities+ 290 267 256 220 200 221 221 224 204 191 
Perinatal related mortalities^ 320 298 274 244 224 244 249 247 226 211 
Perinatal mortalities excluding lethal and terminated fetal abnormalities• 237 202 179 166 156 167 174 167 156 149 
Perinatal related mortalities excluding lethal and terminated fetal 
abnormalities• 
253 219 188 176 167 177 185 180 169 157 
  Rate 
  2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 
Total births                     
Fetal deaths (terminations of pregnancy and stillbirths)* 3.57 3.07 3.05 2.65 2.60 2.72 2.76 2.85 2.64 2.57 
Terminations of pregnancy 0.14 0.26 0.38 0.21 0.20 0.22 0.12 0.25 0.27 0.12 
Stillbirths 3.43 2.80 2.66 2.44 2.40 2.50 2.65 2.60 2.37 2.45 
Early neonatal deaths <7 days                     
Late neonatal deaths 7–27 days                     
Neonatal deaths <28 days# 1.38 1.53 1.33 1.25 1.16 1.38 1.44 1.27 1.14 1.02 
Perinatal mortalities+ 4.49 4.11 4.08 3.51 3.36 3.71 3.73 3.73 3.40 3.25 
Perinatal related mortalities^ 4.95 4.59 4.37 3.89 3.76 4.10 4.20 4.11 3.77 3.59 
Perinatal mortalities excluding lethal and terminated fetal abnormalities• 3.67 3.11 2.86 2.65 2.62 2.81 2.93 2.78 2.60 2.54 
Perinatal related mortalities excluding lethal and terminated fetal 
abnormalities• 
3.91 3.38 3.00 2.81 2.80 2.97 3.12 3.00 2.82 2.67 
* Fetal death rate per 1,000 babies born (includes terminations and stillbirths). 
# Neonatal death rate per 1,000 live born babies. 
+ Fetal deaths and early neonatal deaths per 1,000 babies born. 
^ Fetal deaths and early and late neonatal deaths per 1,000 babies born. 
• Lethal and terminated fetal abnormalities are all perinatal related deaths with PSANZ-PDC of congenital anomaly, and neonatal deaths with PSANZ-NDC of congenital anomaly. 
Sources: Numerator: PMMRC’s perinatal data extract using the international definition (≥1,000g or ≥28 weeks if birthweight unknown) 2009–2018; Denominator: MAT births using the international definition (≥1,000g or 
≥28 weeks if birthweight unknown) 2009–2018. 
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Figure 3.2: Perinatal related mortality annual rates (per 1,000 births) using international definitions* by year 
2007–2018 
 
* Rates of fetal death, neonatal death, perinatal mortality and perinatal related mortality of babies weighing ≥1,000g, or ≥28 weeks if 
birthweight is unknown, per 1,000 total births of babies weighing ≥1,000g, or ≥28 weeks if birthweight is unknown. Babies without 
birthweight or gestation are included if they have been registered. 
Sources: Numerator: PMMRC’s perinatal data extract using the international definition (≥1,000g or ≥28 weeks if birthweight 
unknown) 2007–2018; Denominator: MAT births using the international definition (≥1,000g or ≥28 weeks if birthweight unknown) 
2007–2018. 
All perinatal deaths are classified in accordance with either the Perinatal Society of Australia and 
New Zealand (PSANZ) Perinatal Death Classification (PDC) or the PSANZ Neonatal Death Classification 
(NDC). We classified the deaths presented here using the 2017 revision of these death classification 
systems.17 
In 2018, from 20 weeks’ gestation onwards, 70% of terminations of pregnancy were classified as PSANZ-
PDC congenital anomaly, with 8.1% classified as PSANZ-PDC for maternal conditions. Nearly a quarter of 
stillbirths were classified as PSANZ-PDC unexplained antepartum fetal death (for unknown reasons). The 
rates of unexplained stillbirth between Māori and New Zealand European women showed statistically 
significant differences: rates for Māori were 1.6 times18 higher than those for New Zealand European 
women over the period 2007–2018 (data not shown).  
Of the known causes in 2018, 16% of stillbirths were due to placental dysfunction or causative placental 
pathology, and 12% due to spontaneous preterm labour or rupture of membranes. The leading PSANZ-
PDC category of neonatal death was spontaneous preterm birth (33.8%), followed by congenital anomaly 
(22.1%) and antepartum haemorrhage (15.6%) (Table 3.3). 
 
17 For a comparison of the PSANZ death classification systems, go to the Stillbirth and Neonatal Death Alliance (PSANZ-SANDA) 
website. URL: https://sanda.psanz.com.au/assets/Uploads/Appendix-U-Changes-in-this-version-of-the-classifications.pdf (accessed 
13 May 2020). 
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Table 3.3: Perinatal related deaths by perinatal death classification (PSANZ-PDC) 2018 











n % n % n % n % 
Congenital anomaly 94 69.6 34 10.8 34 22.1 162 26.8 
Perinatal infection <3 x 12 3.8 9 5.8 22 3.6 
Hypertension 6 4.4 10 3.2 3 1.9 19 3.1 
Antepartum haemorrhage 6 4.4 29 9.2 24 15.6 59 9.8 
Maternal conditions 11 8.1 23 7.3 8 5.2 42 7.0 
Complications of multiple pregnancy 3 2.2 23 7.3 5 3.2 31 5.1 
Specific perinatal conditions 4 3.0 18 5.7 6 3.9 28 4.6 
Hypoxic peripartum death - - <3 x 5 3.2 6 1.0 
Placental dysfunction or causative placental pathology <3 x 49 15.6 6 3.9 56 9.3 
Spontaneous preterm labour or rupture of membranes  
(<37 weeks’ gestation) 
9 6.7 39 12.4 52 33.8 100 16.6 
Unexplained antepartum fetal death - - 77 24.4 - - 77 12.7 
Neonatal death without obstetric antecedent - - - - <3 x <3 x 
‘x’ indicates percentage suppressed due to small numbers. 
Source: PMMRC’s perinatal data extract 2018. 
During the period 2007–2018, congenital anomalies were the most frequent cause of death. Table 3.4 
presents the causes of perinatal death for the period 2009–2018. 
Our data show strong evidence that perinatal deaths due to hypoxic peripartum death have statistically 
significantly reduced over the period 2007–2018 (p<0.001). The main reason for this decline was a 
statistically significant reduction in hypoxic peripartum deaths among babies of New Zealand European 
mothers.  
There is some evidence of a reduction in the rate of death from maternal hypertension, maternal conditions 
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Table 3.4: Perinatal death classification (PSANZ-PDC) specific perinatal related mortality rates (per 1,000 births) using New Zealand definition by year 2009–
2018  
Perinatal death classification 
(PSANZ-PDC) 
2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 
N=65,203 N=65,449 N=63,243 N=63,286 N=60,137 N=60,080 N=59,783 N=60,606 N=60,478 N=59,258 
n Rate n Rate n Rate n Rate n Rate n Rate n Rate n Rate n Rate n Rate 
Congenital anomaly 184 2.82 214 3.27 206 3.26 206 3.26 164 2.73 191 3.18 163 2.73 177 2.92 163 2.70 162 2.73 
Perinatal infection 25 0.38 28 0.43 21 0.33 19 0.30 20 0.33 24 0.40 22 0.37 26 0.43 28 0.46 22 0.37 
Hypertension 29 0.44 27 0.41 21 0.33 19 0.30 13 0.22 13 0.22 21 0.35 9 0.15 13 0.21 19 0.32 
Antepartum haemorrhage 79 1.21 78 1.19 78 1.23 60 0.95 75 1.25 69 1.15 79 1.32 72 1.19 78 1.29 59 1.00 
Maternal conditions 38 0.58 32 0.49 26 0.41 36 0.57 34 0.57 39 0.65 29 0.49 37 0.61 29 0.48 42 0.71 
Complications of multiple pregnancy 32 0.49 22 0.34 23 0.36 25 0.40 26 0.43 25 0.42 10 0.17 21 0.35 21 0.35 31 0.52 
Specific perinatal conditions 33 0.51 37 0.57 38 0.60 27 0.43 25 0.42 27 0.45 33 0.55 32 0.53 31 0.51 28 0.47 
Hypoxic peripartum death 29 0.44 20 0.31 20 0.32 21 0.33 11 0.18 17 0.28 17 0.28 13 0.21 13 0.21 6 0.10 
Placental dysfunction or causative placental 
pathology 
54 0.83 50 0.76 56 0.89 57 0.90 57 0.95 45 0.75 43 0.72 53 0.87 54 0.89 56 0.95 
Spontaneous preterm labour or rupture of 
membranes (<37 weeks’ gestation) 
119 1.83 120 1.83 94 1.49 115 1.82 88 1.46 122 2.03 77 1.29 87 1.44 84 1.39 100 1.69 
Unexplained antepartum fetal death 101 1.55 70 1.07 80 1.26 76 1.20 81 1.35 80 1.33 77 1.29 79 1.30 71 1.17 77 1.30 
Neonatal death without obstetric antecedent 7 0.11 10 0.15 4 0.06 9 0.14 6 0.10 7 0.12 7 0.12 6 0.10 8 0.13 <3 s 
‘s’ indicates rate suppressed due to small numbers. 
Sources: Numerator: PMMRC’s perinatal data extract 2009–2018; Denominator: MAT births 2009–2018. 
Using the international definition for perinatal related mortality of birthweight greater than or equal to 1,000g or gestational age 28 weeks or greater (Table 
3.5), we found some evidence of a statistically significant reduction in deaths due to antepartum haemorrhage, unexplained antepartum fetal death and 
neonatal death without obstetric antecedent during the study period 2007–2018.19 There was strong evidence of a statistically significant decrease in the rate 
of deaths due to hypoxic peripartum death.20  
 
19 Chi-squared tests for trend p=0.035, 0.043 and 0.027 respectively. 
20 Chi-squared test for trend p<0.0001. 
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Table 3.5: Perinatal death classification (PSANZ-PDC) specific perinatal related mortality rates (per 1,000 births) using international definition (≥1,000g or  
≥28 weeks if birthweight unknown) by year 2009–2018 
Perinatal death classification 
(PSANZ-PDC) 
2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 
N=64,630 N=64,886 N=62,695 N=62,723 N=59,604 N=59,514 N=59,322 N=60,094 N=59,951 N=58,726 
n Rate n Rate n Rate n Rate n Rate n Rate n Rate n Rate n Rate n Rate 
Congenital anomaly 65 1.01 79 1.22 86 1.37 67 1.07 54 0.91 65 1.09 64 1.08 66 1.10 56 0.93 52 0.89 
Perinatal infection 15 0.23 13 0.20 12 0.19 9 0.14 9 0.15 12 0.20 12 0.20 17 0.28 16 0.27 14 0.24 
Hypertension 14 0.22 11 0.17 9 0.14 3 0.05 5 0.08 6 0.10 10 0.17 6 0.10 6 0.10 6 0.10 
Antepartum haemorrhage 24 0.37 23 0.35 17 0.27 13 0.21 18 0.30 11 0.18 17 0.29 12 0.20 19 0.32 15 0.26 
Maternal conditions 20 0.31 19 0.29 7 0.11 17 0.27 22 0.37 14 0.24 15 0.25 16 0.27 8 0.13 17 0.29 
Complications of multiple pregnancy 8 0.12 <3 s 3 0.05 3 0.05 5 0.08 4 0.07 3 0.05 <3 s 3 0.05 4 0.07 
Specific perinatal conditions 23 0.36 27 0.42 28 0.45 15 0.24 16 0.27 20 0.34 26 0.44 22 0.37 18 0.30 19 0.32 
Hypoxic peripartum death 29 0.45 20 0.31 20 0.32 21 0.33 11 0.18 17 0.29 17 0.29 13 0.22 13 0.22 6 0.10 
Placental dysfunction or causative placental 
pathology 
33 0.51 31 0.48 29 0.46 32 0.51 22 0.37 30 0.50 24 0.40 24 0.40 19 0.32 34 0.58 
Spontaneous preterm labour or rupture of 
membranes (<37 weeks’ gestation) 
10 0.15 19 0.29 9 0.14 10 0.16 5 0.08 9 0.15 14 0.24 8 0.13 9 0.15 3 0.05 
Unexplained antepartum fetal death 72 1.11 45 0.69 50 0.80 45 0.72 51 0.86 49 0.82 40 0.67 55 0.92 51 0.85 39 0.66 
Neonatal death without obstetric antecedent 7 0.11 10 0.15 4 0.06 9 0.14 6 0.10 7 0.12 7 0.12 6 0.10 8 0.13 <3 s 
‘s’ indicates rate suppressed due to small numbers. 
Sources: Numerator: PMMRC’s perinatal data extract using the international definition (≥1,000g or ≥28 weeks if birthweight unknown) 2009–2018; Denominator: MAT births using the international definition (≥1,000g or 
≥28 weeks if birthweight unknown) 2009–2018. 
For stillbirths, there was strong evidence of a statistically significant reduction in hypoxic peripartum deaths between the years 2007 and 2018.21 There was 
some evidence of a reduction in the rate of stillbirths due to spontaneous preterm labour or rupture of membranes22 and antepartum haemorrhage.23 For this 
period, the largest category of death for stillbirth was unexplained antepartum fetal death (Table 3.6). 
 
21 Chi-squared test for trend p<0.0001. 
22 Chi-squared test for trend p=0.023. 
23 Chi-squared test for trend p=0.046. 
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Table 3.6: Perinatal death classification (PSANZ-PDC) specific stillbirth rates (per 1,000 births) by year 2009–2018 
Perinatal death classification 
(PSANZ-PDC) 
2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 
N=65,203 N=65,449 N=63,243 N=63,286 N=60,137 N=60,080 N=59,783 N=60,606 N=60,478 N=59,258 
n Rate n Rate n Rate n Rate n Rate n Rate n Rate n Rate n Rate n Rate 
Congenital anomaly 32 0.49 39 0.60 28 0.44 38 0.60 24 0.40 35 0.58 30 0.50 31 0.51 29 0.48 34 0.57 
Perinatal infection 16 0.25 17 0.26 10 0.16 9 0.14 10 0.17 12 0.20 12 0.20 10 0.17 17 0.28 12 0.20 
Hypertension 24 0.37 18 0.28 12 0.19 9 0.14 8 0.13 9 0.15 16 0.27 8 0.13 10 0.17 10 0.17 
Antepartum haemorrhage 53 0.81 46 0.70 48 0.76 31 0.49 44 0.73 33 0.55 46 0.77 38 0.63 37 0.61 29 0.49 
Maternal conditions 26 0.40 23 0.35 13 0.21 19 0.30 22 0.37 21 0.35 22 0.37 17 0.28 12 0.20 23 0.39 
Complications of multiple pregnancy 22 0.34 11 0.17 16 0.25 15 0.24 21 0.35 12 0.20 7 0.12 18 0.30 16 0.26 23 0.39 
Specific perinatal conditions 28 0.43 31 0.47 31 0.49 21 0.33 12 0.20 23 0.38 25 0.42 29 0.48 25 0.41 18 0.30 
Hypoxic peripartum death 11 0.17 7 0.11 9 0.14 11 0.17 3 0.05 7 0.12 9 0.15 4 0.07 4 0.07 <3 s 
Placental dysfunction or causative placental 
pathology 
46 0.71 43 0.66 51 0.81 54 0.85 53 0.88 44 0.73 39 0.65 47 0.78 48 0.79 49 0.83 
Spontaneous preterm labour or rupture of 
membranes (<37 weeks’ gestation) 
50 0.77 44 0.67 36 0.57 40 0.63 28 0.47 52 0.87 24 0.40 31 0.51 21 0.35 39 0.66 
Unexplained antepartum fetal death 101 1.55 68 1.04 78 1.23 73 1.15 81 1.35 79 1.31 75 1.25 77 1.27 69 1.14 77 1.30 
Neonatal death without obstetric antecedent - - - - - - - - - - - - - - - - - - - - 
s’ indicates rate suppressed due to small numbers. 
Sources: Numerator: PMMRC’s perinatal data extract, stillbirths only, 2009–2018; Denominator: MAT births 2009–2018. 
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Neonatal death 
For babies aged 20–27 weeks’ gestation, extreme prematurity was the leading cause of neonatal death during the period 2007–2018. 
For babies aged 28 weeks’ gestation and over, congenital anomalies were the leading cause of neonatal death, followed by neurological conditions. For this 
gestational group, neonatal deaths from neurological conditions decreased by a statistically significant rate over the study period 2007–2018 (data not shown). 
Table 3.7 presents the causes of neonatal death for the period 2009–2018. 




2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 
n Rate n Rate n Rate n Rate n Rate n Rate n Rate n Rate n Rate n Rate 
Gestation <28 weeks N=286 N=291 N=242 N=256 N=257 N=274 N=255 N=251 N=282 N=238 
Congenital anomaly <3 s - - <3 s <3 s <3 s <3 s 3 11.76 <3 s 4 14.18 <3 s 
Extreme prematurity 57 199.30 84 288.66 54 223.14 67 261.72 63 245.14 69 251.82 51 200.00  55   219.12  70 248.23 63 264.71 
Cardio-respiratory disorders 11 38.46 16 54.98 7 28.93 10 39.06 5 19.46 12 43.80 10 39.22 6 23.90 9 31.91 10 42.02 
Infection 5 17.48 7 24.05 7 28.93 10 39.06 5 19.46 7 25.55 <3 s 4 15.94 8 28.37 7 29.41 
Neurological 11 38.46 <3 s 8 33.06 6 23.44 8 31.13 12 43.80 11 43.14 8 31.87 8 28.37 3 12.61 
Gastrointestinal 5 17.48 4 13.75 <3 s <3 s <3 s <3 s <3 s 3 11.95 4 14.18 6 25.21 
Other 3 10.49 - - - - <3 s <3 s <3 s 4 15.69 <3 s <3 s - - 
Gestation ≥28 weeks N=63,787 N=64,109 N=61,997 N=61,625 N=59,106 N=58,945 N=58,748 N=59,489 N=59,269 N=57,196 
Congenital anomaly 41 0.64 46 0.72 48 0.77 36 0.58 31 0.52 43 0.73 42 0.71 33 0.55 28 0.47 34 0.59 
Extreme prematurity - - - - - - - - - - - - - - - - - - - - 
Cardio-respiratory disorders - - <3 s 4 0.06 4 0.06 <3 s 4 0.07 6 0.10 5 0.08 7 0.12 4 0.07 
Infection 7 0.11 12 0.19 8 0.13 7 0.11 7 0.12 8 0.14 5 0.09 10 0.17 7 0.12 5 0.09 
Neurological 30 0.47 26 0.41 15 0.24 19 0.31 17 0.29 12 0.20 20 0.34 16 0.27 14 0.24 13 0.23 
Gastrointestinal 3 0.05 <3 s - - <3 s - - <3 s <3 s <3 s - - 3 0.05 
Other 8 0.13 10 0.16 9 0.15 13 0.21 13 0.22 9 0.15 10 0.17 8 0.13 12 0.20 4 0.07 
‘s’ indicates rate suppressed due to small numbers. 
Sources: Numerator: PMMRC’s perinatal data extract, neonatal deaths only, 2009–2018; Denominator: MAT births excluding fetal deaths 2009–2018. 
 
 
Fourteenth Annual Report of the Perinatal and Maternal Mortality Review Committee   31 
Figure 3.3 presents the neonatal mortality rate by prioritised ethnic group (excluding congenital anomalies). 
This shows that the burden of mortality for all ethnic groups is in babies born before they reach 25 weeks’ 
gestation. By prioritised ethnic group, neonatal mortality rates are statistically significantly higher in babies 
born to mothers of Indian, Pacific and Māori ethnicities, compared with babies with New Zealand European 
mothers.  
Figure 3.3: Neonatal death risk (per 1,000 ongoing pregnancies) by gestational age at birth and maternal 
ethnicity excluding death with congenital anomalies 2009–2018* 
 
* Unknown/Other ethnicity not represented. 
MELAA = Middle Eastern, Latin American, or African. 
‘s’ indicates rate suppressed due to small numbers. 
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Maternal age 
Perinatal related mortality rates have a U-shaped trend by maternal age, with the highest rates at the 
extremes of childbearing age. This is particularly evident for stillbirths, where rates are highest for mothers 
aged under 20 years and aged 40 years and over. Neonatal deaths were highest in babies of mothers who 
were under 20 years of age (Figure 3.4 and Table 3.8). 
Figure 3.4: Perinatal related mortality rates (per 1,000 births, with 95% confidence intervals (CIs)) by 
maternal age 2014–2018 
 
Sources: Numerator: PMMRC’s perinatal data extract 2014–2018; Denominator: MAT births 2014–2018. 








deaths (total) Termination of 
pregnancy 
Stillbirths 
N=300,205 n=673 n=1,545 n=828 n=3,046 
N % n % Rate n % Rate n % Rate n % Rate 
<20 12,856 4.3 39 5.8 3.03 105 6.8 8.17 76 9.2 5.98 220 7.2 17.11 
20–24 48,728 16.2 76 11.3 1.56 286 18.5 5.87 177 21.4 3.66 539 17.7 11.06 
25–29 82,405 27.4 177 26.3 2.15 391 25.3 4.74 202 24.4 2.47 770 25.3 9.34 
30–34 93,168 31.0 196 29.1 2.10 417 27.0 4.48 219 26.4 2.37 832 27.3 8.93 
35–39 50,461 16.8 140 20.8 2.77 260 16.8 5.15 116 14.0 2.32 516 16.9 10.23 
≥40 12,499 4.2 45 6.7 3.60 84 5.4 6.72 38 4.6 3.07 167 5.5 13.36 
Unknown 88 0.0 - - - <3 x - - - - <3 x - 
‘x’ indicates percentage suppressed due to small numbers. 
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Figure 3.5: Perinatal related mortality rates (per 1,000 births, with 95% CIs) by maternal age and prioritised ethnic group 2014–2018 
 
MELAA = Middle Eastern, Latin American, or African. 
‘s’ indicates rate not calculated due to small numbers. 
Sources: Numerator: PMMRC's perinatal data extract 2014–2018; Denominator: MAT births 2014–2018. 
The study period 2007–2018 saw little change in perinatal related mortality rates by maternal age group. Some evidence indicates an increase in deaths of 
babies born to mothers younger than 20 years, but no evidence suggests any substantial change in any other age group (data not shown). Table 3.9 presents 
the rates of perinatal related deaths by maternal age for the period 2009–2018. 
Figure 3.5 shows the perinatal related mortality rates by maternal age for each prioritised ethnic group. The U-shaped trend by maternal age was evident for 
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2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 
n N n N n N n N n N n N n N n N n N n N 
<20 80 4,910 57 4,625 65 4,128 63 3,967 65 3,382 51 3,047 45 2,828 54 2,491 32 2,328 38 2,162 
20–24 142 12,085 164 12,259 116 11,940 126 11,697 115 11,011 116 10,477 86 10,139 125 9,779 104 9,497 108 8,836 
25–29 169 16,005 162 16,307 147 15,866 149 16,267 139 15,598 165 16,016 150 15,992 143 16,893 153 16,946 159 16,558 
30–34 169 17,840 149 18,104 160 17,608 163 17,855 147 17,129 175 17,983 158 18,296 169 18,746 174 19,038 156 19,105 
35–39 138 11,765 136 11,395 145 11,028 119 10,676 89 10,318 111 9,940 107 9,977 90 10,202 100 10,103 108 10,239 
≥40 32 2,569 40 2,731 34 2,648 50 2,805 45 2,678 40 2,596 32 2,531 30 2,481 30 2,546 35 2,345 
Unknown - 29 - 28 - 25 - 19 - 21 <3 21 - 20 <3 14 - 20 - 13 
 
2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 
Rate Rate Rate Rate Rate Rate Rate Rate Rate Rate 
<20 16.3 12.3 15.7 15.9 19.2 16.7 15.9 21.7 13.7 17.6 
20–24 11.8 13.4 9.7 10.8 10.4 11.1 8.5 12.8 11.0 12.2 
25–29 10.6 9.9 9.3 9.2 8.9 10.3 9.4 8.5 9.0 9.6 
30–34 9.5 8.2 9.1 9.1 8.6 9.7 8.6 9.0 9.1 8.2 
35–39 11.7 11.9 13.1 11.1 8.6 11.2 10.7 8.8 9.9 10.5 
≥40 12.5 14.6 12.8 17.8 16.8 15.4 12.6 12.1 11.8 14.9 
Unknown - - - - - - - - - - 
Sources: Numerator: PMMRC’s perinatal data extract 2009–2018; Denominator: MAT births 2009–2018. 
The leading cause of perinatal related death for all maternal age groups was spontaneous preterm labour or rupture of membranes (ROM). The highest rate of 
mortality due to spontaneous preterm labour/ROM was seen in babies born to mothers under 20 years of age. The relationship between spontaneous preterm 
labour/ROM and the demographic characteristics of the mother (such as maternal age, ethnicity and/or deprivation) should be the subject of future research.  
For women aged 20–24 years, antepartum haemorrhage and unexplained antepartum fetal death were the next most frequent causes after spontaneous 
preterm labour/ROM. In mothers aged 25–34 years, spontaneous preterm labour/ROM and unexplained antepartum death accounted for nearly 40% of 
perinatal related deaths. However, the rates for both categories were lower than the rates for women aged 24 years and younger, reflecting the overall lower 
perinatal related mortality rate in the age group of 25–34 years. Maternal conditions and placental dysfunction or causative placental pathology particularly 
affected mothers under 20 years of age, whereas hypertension was an uncommon cause of perinatal related death in this age group.   
The rate of placental dysfunction or causative placental pathology was highest in mothers under 20 years of age, and reduced with age until 40 years and 
over. Deaths due to hypertension or to specific perinatal conditions tended to increase with age (Table 3.10 and Figure 3.6). See Table 3.11 for further 
information on women under 20 years of age who were pregnant, and Table 3.12 for information about perinatal related deaths in this age group. 
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Table 3.10: Perinatal death classification (PSANZ-PDC) specific perinatal related mortality rates (excluding congenital anomalies) by maternal age* 2014‒
2018 
Perinatal death classification (PSANZ-PDC) 
Maternal age (years) 
<20 20–24 25–34 35–39 ≥40 
N=12,856 N=48,728 N=175,573 N=50,461 N=12,499 
n % Rate n % Rate n % Rate n % Rate n % Rate 
Perinatal infection 14 8.2 1.09 28 6.6 0.57 66 5.7 0.38 13 3.8 0.26 <3 x s 
Hypertension <3 x s 16 3.8 0.33 43 3.7 0.24 10 2.9 0.20 5 5.6 0.40 
Antepartum haemorrhage 26 15.2 2.02 69 16.2 1.42 201 17.4 1.14 45 13.3 0.89 16 17.8 1.28 
Maternal conditions 22 12.9 1.71 34 8.0 0.70 82 7.1 0.47 21 6.2 0.42 11 12.2 0.88 
Complications of multiple pregnancy <3 x s 19 4.5 0.39 57 4.9 0.32 23 6.8 0.46 7 7.8 0.56 
Specific perinatal conditions 4 2.3 0.31 28 6.6 0.57 82 7.1 0.47 29 8.6 0.57 8 8.9 0.64 
Hypoxic peripartum death 4 2.3 0.31 11 2.6 0.23 35 3.0 0.20 14 4.1 0.28 <3 x s 
Placental dysfunction or causative placental pathology 22 12.9 1.71 54 12.7 1.11 127 11.0 0.72 41 12.1 0.81 7 7.8 0.56 
Spontaneous preterm labour or rupture of membranes 
(<37 weeks’ gestation) 
53 31.0 4.12 93 21.9 1.91 229 19.8 1.30 77 22.7 1.53 17 18.9 1.36 
Unexplained antepartum fetal death 21 12.3 1.63 64 15.1 1.31 220 19.0 1.25 63 18.6 1.25 15 16.7 1.20 
Neonatal death without obstetric antecedent <3 x s 9 2.1 0.18 15 1.3 0.09 3 0.9 0.06 <3 x s 
* Excludes two babies where maternal age was unknown. 
‘x’ indicates percentage not calculated due to small numbers. 
‘s’ indicates rate not calculated due to small numbers. 
Sources: Numerator: PMMRC’s perinatal data extract (excluding congenital anomalies) 2014–2018; Denominator: MAT births 2014–2018. 
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Figure 3.6: Perinatal death classification (PSANZ-PDC) specific perinatal related mortality rates (excluding 
congenital anomalies, with 95% CIs) by maternal age 2014–2018 
 
‘s’ indicates rate suppressed due to small numbers. 
Sources: Numerator: PMMRC’s perinatal data extract (excluding congenital anomalies) 2014–2018; Denominator: MAT births 
2014–2018. 
Mothers under 20 years of age 
Of mothers under 20 years of age who experienced a perinatal related death, over 40% were 19 years of 
age. Relatively few women in this age group were living in the least deprived areas; the highest proportion 
lived in quintile 5 on the New Zealand Index of Deprivation 2013 (NZDep2013) (Table 3.11). 
Of mothers under 20 years of age who experienced a perinatal related death, 59% were Māori, and overall 
65% did not smoke. Half of the mothers had a body mass index (BMI) in the normal range. Ninety-nine 
percent of the mothers registered with an LMC during their pregnancy. Of the mothers under 20 years of 
age who were recorded as having registered with an LMC during their pregnancy (between 2009 and 
2018), 47% did so in their first trimester. However, because the data set is limited to mothers who 
registered with a midwife, obstetrician or GP LMC, the actual percentage of women who registered within 
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Table 3.11: Demographic and other characteristics of all mothers under 20 years of age by time period 
(2009–2013 and 2014–2018) 
Mothers aged under 20 years 
2009–2013 2014–2018  2009–2018 (Total) 
N=21,012 N=12,856  N=33,868 
N % N %  N % 
Age (years)        
<16 653 3.1 436 3.4  1,089 3.2 
16 1,767 8.4 980 7.6  2,747 8.1 
17 3,736 17.8 2,069 16.1  5,805 17.1 
18 6,124 29.1 3,696 28.7  9,820 29.0 
19 8,732 41.6 5,675 44.1  14,407 42.5 
Deprivation quintile        
1 (least deprived) 1,096 5.2 587 4.6  1,683 5.0 
2 1,668 7.9 1,002 7.8  2,670 7.9 
3 2,948 14.0 1,526 11.9  4,474 13.2 
4 5,301 25.2 3,026 23.5  8,327 24.6 
5  (most deprived) 9,769 46.5 6,612 51.4  16,381 48.4 
Missing 230 1.1 103 0.8  333 1.0 
Prioritised ethnic group        
Māori 12,143 57.8 7,930 61.7  20,073 59.3 
Pacific peoples 2,809 13.4 1,811 14.1  4,620 13.6 
Asian 321 1.5 191 1.5  512 1.5 
Indian 96 0.5 54 0.4  150 0.4 
Other Asian 225 1.1 137 1.1  362 1.1 
MELAA 163 0.8 106 0.8  269 0.8 
European 5,567 26.5 2,817 21.9  8,384 24.8 
NZ European 5,037 24.0 2,552 19.9  7,589 22.4 
Other European 530 2.5 265 2.1  795 2.3 
Unknown 9 0.0 <3 x  10 0.0 
Limited to LMC* N=16,982 N=11,416  N=28,398 
Smoking at registration with LMC        
Yes 6,129 36.1 3,868 33.9  9,997 35.2 
No 10,853 63.9 7,548 66.1  18,401 64.8 
Missing - - - -  - - 
BMI at registration        
<18.5 687 4.0 399 3.5  1,086 3.8 
18.5–24.9 8,824 52.0 5,253 46.0  14,077 49.6 
25.0–29.9 4,625 27.2 3,236 28.3  7,861 27.7 
30.0–34.9 1,961 11.5 1,654 14.5  3,615 12.7 
35.0–39.9 610 3.6 622 5.4  1,232 4.3 
≥40.0 228 1.3 235 2.1  463 1.6 
Unknown 47 0.3 17 0.1  64 0.2 
First registration with LMC        
First   7,292 42.9 5,954 52.2  13,246 46.6 
Second 8,314 49.0 4,594 40.2  12,908 45.5 
Third 1,284 7.6 768 6.7  2,052 7.2 
Postpartum 91 0.5 100 0.9  191 0.7 
Missing <3 x - -  <3 x 
* All data limited to mothers who were registered for care with an LMC (a midwife, obstetrician or GP) claiming from the Section 88 
Primary Maternity Services Notice. 
MELAA = Middle Eastern, Latin American, or African. 
LMC = lead maternity carer. 
BMI = body mass index. 
‘x’ indicates percentage not calculated due to small numbers. 
Source: MAT births of babies of mothers <20 years of age 2009–2018. 
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The stillbirth rate for babies of mothers under 20 years of age (7.15 per 1,000 births) was approximately 1.5 
times higher than for mothers aged 20 years and over (4.93 per 1,000 births), and the neonatal mortality 
rate was two times higher (5.46 per 1,000 births compared with 2.61 per 1,000 live births). The rate for 
termination of pregnancy was similar between the two groups (Table 3.12). In our 13th report, we 
highlighted that it is important for cohesive primary maternity services to be responsive to and appropriate 
for mothers aged under 20 years.24 
Table 3.12: Perinatal death classification (PSANZ-PDC) among babies of mothers <20 years of age and 
those ≥20 years of age 2009–2018 
Perinatal death classification 
(PSANZ-PDC) 
2009–2018 
Women <20 years Women ≥20 years 
N=33,868 N=583,445 
n Rate n Rate 
Termination of pregnancy (per 1,000 births) 97 2.86 1,296 2.22 
Stillbirth (per 1,000 births) 242 7.15 2,874 4.93 
Neonatal death (per 1,000 live births) 183 5.46 1,511 2.61 
Perinatal death classification (PSANZ-PDC)     
Congenital anomaly 124 3.66 1,661 2.85 
Perinatal infection 26 0.77 201 0.34 
Hypertension <3 s 179 0.31 
Antepartum haemorrhage 62 1.83 645 1.11 
Maternal conditions 34 1.00 267 0.46 
Specific perinatal conditions 15 0.44 217 0.37 
Hypoxic peripartum death 14 0.41 293 0.50 
Fetal growth restriction 12 0.35 151 0.26 
Spontaneous preterm birth 42 1.24 469 0.80 
Unexplained antepartum death 126 3.72 844 1.45 
No obstetric antecedent 55 1.62 701 1.20 
‘s’ indicates rate suppressed due to small numbers. 
Sources: Numerator: PMMRC's perinatal data extract, where matched to MAT data 2009–2018; Denominator: MAT births 
2009-2018. 
 
24 PMMRC. 2019. Te Pūrongo ā-Tau Tekau mā Toru o te Komiti Arotake Mate Pēpi, Mate Whaea Hoki | Thirteenth Annual Report 
of the Perinatal and Maternal Mortality Review Committee: Te tuku pūrongo mō te mate me te whakamate 2017 | Reporting 
mortality and morbidity 2017. Wellington: Health Quality & Safety Commission. URL: 
https://www.hqsc.govt.nz/assets/PMMRC/Publications/13thPMMRCreport/13thPMMRCAnnualReportWebFINAL.pdf (accessed 
6 May 2020).   
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Perinatal related mortality by prioritised ethnic group 
There were significant differences in perinatal related mortality by prioritised ethnic group of both mother 
(Figure 3.7 and Table 3.13) and baby (Figure 3.8 and Table 3.14). These patterns were the same, 
regardless of whether our analysis used the mother’s or baby’s prioritised ethnic group. 
Figure 3.7: Perinatal related mortality rates (per 1,000 births, with 95% CIs) by maternal prioritised ethnic 
group 2014–2018 
 
MELAA = Middle Eastern, Latin American, or African. 
Sources: Numerator: PMMRC’s perinatal data extract 2014–2018; Denominator: MAT births 2014–2018. 









deaths (total) Termination of 
pregnancy 
Stillbirths 
N=300,205* n=673 n=1,545 n=828 n=3,046 
N % n % Rate n % Rate n % Rate n % Rate 
Māori 75,506 25.2 117 17.4 1.55 415 26.9 5.50 278 33.6 3.71 810 26.6 10.73 
Pacific peoples 30,651 10.2 47 7.0 1.53 210 13.6 6.85 125 15.1 4.11 382 12.5 12.46 
Asian 50,763 16.9 141 21.0 2.78 246 15.9 4.85 127 15.3 2.52 514 16.9 10.13 
Indian 17,455 5.8 54 8.0 3.09 129 8.3 7.39 62 7.5 3.59 245 8.0 14.04 
Other Asian 33,308 11.1 87 12.9 2.61 117 7.6 3.51 65 7.9 1.96 269 8.8 8.08 
MELAA 7,078 2.4 20 3.0 2.83 29 1.9 4.10 16 1.9 2.28 65 2.1 9.18 
European 136,089 45.3 348 51.7 2.56 643 41.6 4.72 282 34.1 2.09 1,273 41.8 9.35 
NZ European 106,721 35.5 289 42.9 2.71 550 35.6 5.15 255 30.8 2.41 1,094 35.9 10.25 
Other European 29,368 9.8 59 8.8 2.01 93 6.0 3.17 27 3.3 0.92 179 5.9 6.10 
* Includes 118 unknown maternal ethnicity among total births and 2 unknown maternal ethnicity perinatal related deaths (total). 
MELAA = Middle Eastern, Latin American, or African. 
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Figure 3.8: Perinatal related mortality rates (per 1,000 births, with 95% CIs) by baby’s prioritised ethnic 
group 2014–2018 
 
MELAA = Middle Eastern, Latin American, or African. 
Sources: Numerator: PMMRC’s perinatal data extract 2014–2018; Denominator: MAT births 2014–2018. 








deaths (total) Termination of 
pregnancy 
Stillbirths 
N=300,205* n=673 n=1,545 n=828 n=3,046 
N % n % Rate n % Rate n % Rate n % Rate 
Māori 84,523 28.2 149 22.1 1.76 465 30.1 5.50 312 37.7 3.72 926 30.4 10.96 
Pacific peoples 30,055 10.0 46 6.8 1.53 214 13.9 7.12 133 16.1 4.46 393 12.9 13.08 
Asian 51,327 17.1 138 20.5 2.69 256 16.6 4.99 128 15.5 2.51 522 17.1 10.17 
Indian 18,415 6.1 57 8.5 3.10 137 8.9 7.44 63 7.6 3.46 257 8.4 13.96 
Other Asian 32,912 11.0 81 12.0 2.46 119 7.7 3.62 65 7.9 1.99 265 8.7 8.05 
MELAA 6,871 2.3 17 2.5 2.47 30 1.9 4.37 18 2.2 2.64 65 2.1 9.46 
European 123,408 41.1 321 47.7 2.60 578 37.4 4.68 236 28.5 1.93 1,135 37.3 9.20 
NZ European 97,776 32.6 296 44.0 3.03 518 33.5 5.30 220 26.6 2.27 1,034 33.9 10.58 
Other European 25,632 8.5 25 3.7 0.98 60 3.9 2.34 16 1.9 0.63 101 3.3 3.94 
* Includes 4,021 unknown baby’s ethnicity total births and 5 unknown baby’s ethnicity perinatal related deaths (total). 
MELAA = Middle Eastern, Latin American, or African. 
Sources: Numerator: PMMRC’s perinatal data extract 2014–2018; Denominator: MAT births 2014–2018. 
There was significant variation in the classification of perinatal related mortality by prioritised ethnic group 
(Figure 3.9). For deaths due to spontaneous preterm delivery, mortality rates were statistically significantly 
higher in Indian, Pacific and Māori women, compared with ‘All others’ (‘Other Asian’, MELAA and all 
European groups). For antepartum haemorrhage, rates were statistically significantly higher in babies of 
Indian and Pacific mothers than those of ‘All other’ mothers. Deaths due to placental dysfunction were 
statistically significantly higher in babies of Indian women than babies of ‘All other’ mothers. Deaths due to 
maternal conditions and perinatal infection were statistically significantly higher in babies of Pacific and 
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conditions were statistically significantly lower than for ‘All other’ mothers, and statistically significantly 
higher for hypertension.  
No significant differences in mortality rates by prioritised ethnic category were evident for deaths due to 
hypoxic peripartum death, complications of multiple pregnancy, unexplained antepartum death, and deaths 
where no obstetric antecedent was identified (Figure 3.9). 
While the rate of perinatal related mortality varies from year to year, few changes have occurred for most 
ethnic groups over the study period 2007–2018. There was some evidence that mortality rates have 
decreased in babies of New Zealand European mothers. However, the rates did not change for other ethnic 
groups. Table 3.15 presents the rates of perinatal related mortality by maternal ethnicity over time for the 
period 2009–2018.  
Mortality rates alone do not provide a complete picture of the burden of mortality in specific communities. 
For communities with high fertility rates, such as Pacific and Māori communities,25 the burden of perinatal 
deaths is greater than in communities with lower fertility rates. Therefore, these deaths have a greater 
impact in the community. 
Figure 3.9: Perinatal death classification (PSANZ-PDC) specific perinatal related mortality rates (per 1,000 
births, with 95% CIs) (excluding congenital anomalies) by maternal prioritised ethnic category 2014–2018 
 
* ‘All other’ includes Other Asian, Middle Eastern, Latin American, or African (MELAA), Other European, New Zealand European, 
Unknown/Other. 
‘s’ indicates rate suppressed due to small numbers. 




25 Statistics New Zealand. 2016. National ethnic population projections. URL: 
http://archive.stats.govt.nz/browse_for_stats/population/estimates_and_projections/projections-overview/nat-ethnic-pop-proj.aspx. 
(accessed 26 November 2020). 
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Table 3.15: Perinatal related mortality rates (per 1,000 births) by maternal prioritised ethnic group* and year 2009–2018 
Maternal prioritised 
ethnic group 
2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 
n N n N n N n N n N n N n N n N n N n N 
Māori 209 17,224 193 17,102 176 16,518 163 16,391 156 15,241 166 14,881 143 15,116 182 15,367 153 15,244 166 14,898 
Pacific peoples 106 7,563 107 7,651 79 7,276 94 7,087 84 6,539 83 6,304 71 6,186 73 5,973 82 6,098 73 6,090 
Asian 75 6,416 90 7,030 86 7,244 100 8,586 83 8,229 95 9,344 96 9,324 107 10,667 121 10,702 95 10,726 
Indian 33 1,931 36 2,081 35 2,153 38 2,368 37 2,445 45 2,760 43 3,116 53 3,500 58 3,862 46 4,217 
Other Asian 42 4,485 54 4,949 51 5,091 62 6,218 46 5,784 50 6,584 53 6,208 54 7,167 63 6,840 49 6,509 
MELAA 12 1,216 5 1,322 13 1,313 16 1,274 10 1,319 15 1,311 15 1,361 8 1,401 17 1,567 10 1,438 
European 328 32,739 312 32,301 313 30,838 297 29,906 267 28,771 299 28,199 253 27,772 241 27,175 220 26,850 260 26,093 
NZ European 292 26,541 271 26,105 263 24,820 250 24,040 230 22,895 262 22,304 224 21,900 207 21,379 183 20,929 218 20,209 
Other European 36 6,198 41 6,196 50 6,018 47 5,866 37 5,876 37 5,895 29 5,872 34 5,796 37 5,921 42 5,884 
 
2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 
Rate Rate Rate Rate Rate Rate Rate Rate Rate Rate 
Māori 12.13 11.29 10.66 9.94 10.24 11.16 9.46 11.84 10.04 11.14 
Pacific peoples 14.02 13.99 10.86 13.26 12.85 13.17 11.48 12.22 13.45 11.99 
Asian 11.69 12.80 11.87 11.65 10.09 10.17 10.30 10.03 11.31 8.86 
Indian 17.09 17.30 16.26 16.05 15.13 16.30 13.80 15.14 15.02 10.91 
Other Asian 9.36 10.91 10.02 9.97 7.95 7.59 8.54 7.53 9.21 7.53 
MELAA 9.87 3.78 9.90 12.56 7.58 11.44 11.02 5.71 10.85 6.95 
European 10.02 9.66 10.15 9.93 9.28 10.60 9.11 8.87 8.19 9.96 
NZ European 11.00 10.38 10.60 10.40 10.05 11.75 10.23 9.68 8.74 10.79 
Other European 5.81 6.62 8.31 8.01 6.30 6.28 4.94 5.87 6.25 7.14 
* Excludes 430 unknown maternal ethnicity total births and 2 unknown maternal ethnicity perinatal related deaths (total). 
MELAA = Middle Eastern, Latin American, or African. 
Sources: Numerator: PMMRC’s perinatal data extract 2009–2018; Denominator: MAT births 2009–2018. 
Spontaneous preterm labour or rupture of membranes was the leading classification of death for babies of Māori, Pacific, Indian and New Zealand European 
mothers. However, other leading causes varied by ethnic group. Unexplained antepartum death was a leading classification of death for babies of mothers in 
the Other Asian and Other European prioritised ethnic groups. For babies of Indian and Other Asian mothers, antepartum haemorrhage was a frequent cause 
of death. For babies of mothers in the MELAA prioritised ethnic group, antepartum haemorrhage was a leading cause of death (Table 3.16). 
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Table 3.16: Perinatal death classification (PSANZ-PDC) specific perinatal related mortality rates (excluding congenital anomalies) by maternal prioritised 
ethnic group* 2014–2018 
Perinatal death classification 
(PSANZ-PDC)  
Māori Pacific peoples 
Asian 
Indian Other Asian Total Asian 
N=75,506 N=30,651 N=17,455 N=33,308 N=50,763 
n % Rate n % Rate n % Rate n % Rate n % Rate 
Perinatal infection 45 6.9 0.60 22 7.3 0.72 9 4.9 0.52 8 4.9 0.24 17 4.9 0.33 
Hypertension 29 4.5 0.38 12 4.0 0.39 3 1.6 0.17 5 3.0 0.15 8 2.3 0.16 
Antepartum haemorrhage 102 15.7 1.35 51 16.9 1.66 37 20.0 2.12 35 21.3 1.05 72 20.6 1.42 
Maternal conditions 55 8.5 0.73 38 12.6 1.24 14 7.6 0.80 9 5.5 0.27 23 6.6 0.45 
Complications of multiple pregnancy 30 4.6 0.40 13 4.3 0.42 4 2.2 0.23 10 6.1 0.30 14 4.0 0.28 
Specific perinatal conditions 17 2.6 0.23 16 5.3 0.52 13 7.0 0.74 10 6.1 0.30 23 6.6 0.45 
Hypoxic peripartum death 24 3.7 0.32 3 1.0 0.10 <3 x s <3 x s 4 1.1 0.08 
Placental dysfunction or causative placental pathology 54 8.3 0.72 27 9.0 0.88 32 17.3 1.83 20 12.2 0.60 52 14.9 1.02 
Spontaneous preterm labour or rupture of membranes  
(<37 weeks’ gestation) 
170 26.2 2.25 63 20.9 2.06 41 22.2 2.35 25 15.2 0.75 66 18.9 1.30 
Unexplained antepartum fetal death 110 16.9 1.46 51 16.9 1.66 28 15.1 1.60 37 22.6 1.11 65 18.6 1.28 
Neonatal death without obstetric antecedent 13 2.0 0.17 5 1.7 0.16 <3 x s 3 1.8 0.09 5 1.4 0.10 
 
MELAA 
European    
NZ European Other European Total European    
N=7,078 N=106,721 N=29,368 N=136,089    
n % Rate n % Rate n % Rate n % Rate    
Perinatal infection <3 x s 30 4.1 0.28 6 5.8 0.20 36 4.3 0.26    
Hypertension <3 x s 21 2.8 0.20 3 2.9 0.10 24 2.8 0.18    
Antepartum haemorrhage 7 17.5 0.99 111 15.0 1.04 14 13.5 0.48 125 14.8 0.92    
Maternal conditions 3 7.5 0.42 45 6.1 0.42 6 5.8 0.20 51 6.0 0.37    
Complications of multiple pregnancy <3 x s 44 6.0 0.41 6 5.8 0.20 50 5.9 0.37    
Specific perinatal conditions <3 x s 74 10.0 0.69 10 9.6 0.34 84 10.0 0.62    
Hypoxic peripartum death <3 x s 32 4.3 0.30 <3 x s 33 3.9 0.24    
Placental dysfunction or causative placental pathology <3 x s 105 14.2 0.98 12 11.5 0.41 117 13.9 0.86    
Spontaneous preterm labour or rupture of membranes  
(<37 weeks’ gestation) 
6 15.0 0.85 145 19.6 1.36 19 18.3 0.65 164 19.5 1.21 
   
Unexplained antepartum fetal death 5 12.5 0.71 125 16.9 1.17 27 26.0 0.92 152 18.0 1.12    
Neonatal death without obstetric antecedent - - - 7 0.9 0.07 - - - 7 0.8 0.05    
* Excludes 134 unknown maternal ethnicity among total births (denominator) and 2 unknown maternal ethnicity perinatal related deaths (total) (numerator). 
‘x’ indicates percentage suppressed due to small numbers. 
‘s’ indicates rate suppressed due to small numbers. 
MELAA = Middle Eastern, Latin American, or African. 
Sources: Numerator: PMMRC’s perinatal data extract (excluding congenital anomalies) 2014–2018; Denominator: MAT births 2014–2018. 
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Socioeconomic deprivation 
Perinatal related mortality varied significantly by NZDep2013 quintile. Babies of mothers living in quintile 5 
(most deprived areas) had statistically significantly higher mortality rates than those in all other quintiles for 
all types of perinatal related mortality except termination of pregnancy (Figure 3.10 and Table 3.17). 
Although women living in NZDep2013 quintile 5 had a statistically significantly lower rate of termination of 
pregnancy than those in quintile 1, their rates for both stillbirth and neonatal death were significantly higher.  
Figure 3.10: Perinatal related mortality rates (per 1,000 births, with 95% CIs) by NZDep2013 quintile  
2014–2018 
 
Sources: Numerator: PMMRC’s perinatal data extract 2014–2018; Denominator: MAT births 2014–2018. 







deaths (total) Termination of 
pregnancy 
Stillbirths 
N=300,205 n=673 n=1,545 n=828 n=3,046 
N % n % Rate n % Rate n % Rate n % Rate 
1 (least deprived) 43,338 14.4 117 17.4 2.70 175 11.3 4.04 86 10.4 2.00 378 12.4 8.72 
2 47,844 15.9 120 17.8 2.51 218 14.1 4.56 87 10.5 1.83 425 14.0 8.88 
3 53,671 17.9 126 18.7 2.35 244 15.8 4.55 139 16.8 2.61 509 16.7 9.48 
4 66,956 22.3 147 21.8 2.20 343 22.2 5.12 183 22.1 2.75 673 22.1 10.05 
5 (most deprived) 85,907 28.6 161 23.9 1.87 557 36.1 6.48 325 39.3 3.82 1,043 34.2 12.14 
Unknown 2,489 0.8 <3 x s 8 0.5 - 8 1.0 - 18 0.6 - 
‘x’ indicates percentage not calculated due to small numbers. 
‘s’ indicates rate suppressed due to small numbers. 
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This variation in mortality rates by deprivation was most marked for deaths due to spontaneous preterm 
delivery, for which mortality rates generally increased with increasing deprivation. Other causes of death 
had little significant variation by deprivation (Figure 3.11 and Table 3.18). This pattern has been stable over 
time, with no significant changes in mortality rates by deprivation over the period 2007–2018. Table 3.19 
presents the rates of perinatal related death by deprivation over time for the period 2009–2018. 
Figure 3.11: Perinatal death classification (PSANZ-PDC) specific perinatal related mortality rates (per  
1,000 births, with 95% CIs) (excluding congenital anomalies) by NZDep2013 quintile* 2014–2018 
 
* Excludes 13 babies with unknown NZDep2013 quintile. 
‘s’ indicates rate suppressed due to small numbers. 
























Complications of multiple pregnancy
Specific perinatal conditions
Hypoxic peripartum death
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Table 3.18: Perinatal death classification (PSANZ-PDC) specific perinatal related mortality rates (per 1,000 births) (excluding congenital anomalies) by 
NZDep2013 quintile* 2014–2018 




Quintile 2 Quintile 3 Quintile 4 
Quintile 5 
(most deprived) 
N=43,338 N=47,844 N=53,671 N=66,956 N=85,907 
n % Rate n % Rate n % Rate n % Rate n % Rate 
Perinatal infection 14 5.6 0.32 12 4.2 0.25 15 4.1 0.28 20 4.1 0.30 61 7.8 0.71 
Hypertension 6 2.4 0.14 9 3.2 0.19 10 2.7 0.19 12 2.5 0.18 38 4.8 0.44 
Antepartum haemorrhage 42 16.8 0.97 46 16.2 0.96 48 13.2 0.89 86 17.7 1.28 130 16.5 1.51 
Maternal conditions 17 6.8 0.39 20 7.0 0.42 18 4.9 0.34 32 6.6 0.48 82 10.4 0.95 
Complications of multiple pregnancy 20 8.0 0.46 19 6.7 0.40 17 4.7 0.32 19 3.9 0.28 31 3.9 0.36 
Specific perinatal conditions 18 7.2 0.42 33 11.6 0.69 22 6.0 0.41 36 7.4 0.54 41 5.2 0.48 
Hypoxic peripartum death 9 3.6 0.21 7 2.5 0.15 14 3.8 0.26 15 3.1 0.22 21 2.7 0.24 
Placental dysfunction or causative placental 
pathology 
31 12.4 0.72 36 12.7 0.75 40 11.0 0.75 74 15.3 1.11 70 8.9 0.81 
Spontaneous preterm labour or rupture of 
membranes (<37 weeks’ gestation) 
43 17.2 0.99 43 15.1 0.90 96 26.3 1.79 112 23.1 1.67 173 22.0 2.01 
Unexplained antepartum fetal death 44 17.6 1.02 58 20.4 1.21 80 21.9 1.49 72 14.8 1.08 129 16.4 1.50 
Neonatal death without obstetric antecedent 6 2.4 0.14 <3 x s 5 1.4 0.09 7 1.4 0.10 11 1.4 0.13 
* Excludes 13 babies with unknown NZDep2013 quintile. 
‘x’ indicates percentage suppressed due to small numbers. 
‘s’ indicates rate suppressed due to small numbers. 
Sources: Numerator: PMMRC’s perinatal data extract (excluding congenital anomalies) 2014–2018; Denominator: MAT births 2014–2018. 
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Table 3.19: Perinatal related mortality rates (per 1,000 births) by NZDep quintile and year 2009–2018 
Deprivation 
quintile 
2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 
n N n N n N n N n N n N n N n N n N n N 
1 (least 
deprived) 
76 9,103 80 9,028 103 8,828 80 8,969 59 8,316 93 8,602 74 8,373 69 8,816 70 8,922 72 8,625 
2 106 9,539 104 9,782 99 9,551 89 9,545 78 9,378 77 9,321 83 9,478 91 9,797 93 9,763 81 9,485 
3 120 12,101 117 12,161 116 11,684 106 11,772 126 10,791 118 10,703 90 10,732 99 10,857 104 10,874 98 10,505 
4 178 15,189 155 15,206 152 14,788 140 14,715 114 13,566 138 13,469 138 13,436 127 13,471 118 13,364 152 13,216 
5 (most 
deprived) 
249 18,586 251 18,638 195 17,774 254 17,750 220 17,571 229 17,435 189 17,252 224 17,177 205 17,112 196 16,931 
Unknown <3 685 <3 634 <3 618 <3 535 3 515 4 550 4 512 <3 488 3 443 5 496 
 
2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 
Rate Rate Rate Rate Rate Rate Rate Rate Rate Rate 
1 (least 
deprived) 
8.35 8.86 11.67 8.92 7.09 10.81 8.84 7.83 7.85 8.35 
2 11.11 10.63 10.37 9.32 8.32 8.26 8.76 9.29 9.53 8.54 
3 9.92 9.62 9.93 9.00 11.68 11.02 8.39 9.12 9.56 9.33 
4 11.72 10.19 10.28 9.51 8.40 10.25 10.27 9.43 8.83 11.50 
5 (most 
deprived) 
13.40 13.47 10.97 14.31 12.52 13.13 10.96 13.04 11.98 11.58 
Unknown - - - - - - - - - - 
Sources: Numerator: PMMRC’s perinatal data extract 2009–2018; Denominator: MAT births 2009–2018. 
When examining the effect of deprivation on Māori and New Zealand Europeans, it is important to consider how deprivation levels are distributed in these two 
groups. Figure 3.12 shows the distribution of all infants born in Aotearoa/New Zealand by residential NZDep2013 decile over the period 2009–2018. 
Deprivation deciles, as the name implies, divide the population of Aotearoa/New Zealand into 10 groups (deciles), with 10% of the population in each one. For 
babies of New Zealand European mothers, approximately 10% of the population lives in each decile, with the exception of decile 10, in which 5% of this group 
lives. In contrast, very few Māori babies are born into NZDep2013 deciles 1 to 5, while nearly half (47%) are born into deciles 9 and 10, compared with 15% of 
babies born to New Zealand European mothers for these two deciles combined. Clearly the distribution of deprivation between babies of Māori and New 
Zealand European mothers is unequal. 
In this context, Figure 3.13 shows the perinatal related mortality rate by NZDep2013 decile. Overall, mortality rates increase with increasing deprivation for 
babies of both Māori and New Zealand European mothers. Those in decile 10 have the highest mortality rates. 
Because Māori mortality rates are highest in babies in decile 10 areas, and the proportion of Māori babies born into decile 10 areas is high, Māori are 
disproportionately affected by perinatal related mortality. Figure 3.14 presents the number of deaths by NZDep2013 decile, and shows that Māori communities 
living in decile 10 areas experience the burden of perinatal related mortality, with nearly twice as many deaths in this group as in any other. 
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Figure 3.12: All births by NZDep decile, Māori and New Zealand European 2009–2018 
 
Source: MAT births 2009–2018. 
Figure 3.13: Perinatal related mortality rates (per 1,000 births, with 95% CIs) by NZDep decile, Māori and 
New Zealand European 2009–2018 
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Figure 3.14: Perinatal related mortality (number of deaths) by NZDep decile, Māori and New Zealand 
European 2009–2018 
 
Source: PMMRC’s perinatal data extract 2009–2018. 
Poverty 
It is a consistent and enduring finding in this report series that living in the most deprived areas of Aotearoa/New 
Zealand is associated with increased mortality in babies. Area deprivation, as measured by NZDep2013, can only 
provide information on the area that people live in, rather than on their individual circumstances. However, the finding 
is clear and consistent that mortality increases with increasing area-level deprivation.  
 
To hypothesise about how living in a deprived area might contribute to poor health outcomes, we have considered the 
literature on poverty. While we are not measuring individual-level poverty in this report, there is likely to be a strong 
correlation between a higher prevalence of poverty and living in a high-deprivation area.  
 
Research on the relationship between individual and area-level poverty in Aotearoa/New Zealand is rare. However, 
one study, which looked only at a single area, found that while household-level socioeconomic status (as measured by 
an occupation-based index) did vary, the majority of households in high-deprivation areas were also considered to 
have low socioeconomic status.26  
 
About 682,500 people, or one in seven households, live in poverty in Aotearoa/New Zealand, including around 
220,000 children.27 Poverty is not just limited to those receiving benefits, although it is common in this group. Plum et 
al28 found that in households where at least one adult identified as being of Māori ethnicity (prioritised), 8.6% 
 
26 Jamieson LM, Thomson WM. 2006. Adult oral health inequalities described using area-based and household-based 
socioeconomic status measures. Journal of Public Health Dentistry 66(2): 104–9. 
27 New Zealand Council of Christian Social Services. nd. Facts about poverty in New Zealand. URL: 
https://nzccss.org.nz/work/poverty/facts-about-
poverty/#:~:text=There%20is%20poverty%20amidst%20prosperity,households%2C%20including%20around%20220%2C000%20c
hildren (accessed 26 June 2020). 
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experienced in-work poverty, compared with 5.9% of New Zealand Europeans. Other ethnic groups with higher rates 
of in-work poverty than New Zealand Europeans were Pacific peoples (9.5%), Asians (9.4%) and MELAA (9.5%).  
 
Poverty can impact on health directly, in that people are unable to afford primary care, unable to pay for prescription 
medicines and less likely to have health insurance. Indirect ways in which poverty can contribute to poor health 
outcomes include food insecurity,29 less access to transport and the stress of living with inadequate resources.30,31 
Lowly paid jobs are also less likely to allow employees the flexibility to have time off work to attend appointments. For 
those living in rural areas, poverty is compounded by difficulties of geographical access to health care.32 The stress of 
living in poverty can affect all facets of life, reducing the control individuals have over their lives. Acting through a 
number of different pathways, poverty is associated with certain adverse perinatal outcomes, such as pre-eclampsia 
and preterm birth.33  
Body mass index (BMI) 
This report uses BMI as a proxy indicator of risk to the health of both the mother and baby. Higher BMI also 
has implications for the provision of care, as we discussed in our 13th report.34 
Our analysis of data from both MAT (Table 3.20 and Figure 3.15) and the PMMRC (Table 3.21) shows that 
mortality from stillbirths, neonatal deaths and perinatal related deaths overall increased with increasing 
maternal BMI. Due to incomplete matching between the two data sets, some individuals who were in the 
PMMRC data set were not in MAT, and in other situations individuals in MAT could not be matched to the 
PMMRC records. Using PMMRC data for maternal BMI (numerator) had the net effect of reducing the 
number of women in BMI category 30.0–34.9 and increasing the numbers of women in BMI categories 
35.0–39.9 and ≥40.0. This suggests that MAT records underestimate true maternal BMI. 
 
29 Smith C, Parnell WR, Brown RC, et al. 2012. Balancing diet and the budget: food purchasing practices of food-insecure families 
in New Zealand. Nutrition & Dietetics 70: 278–85. 
30 Saunders P. 1998. Poverty and health: exploring the links between financial stress and emotional stress in Australia. Australian 
and New Zealand Journal of Public Health 22(1):11–6. 
31 Carter KN, Kruse K, Blakely T, et al. 2011. The association of food security with psychological distress in New Zealand and any 
gender differences. Social Science & Medicine 72(9): 1463–71. 
32 Pearce J, Witten K, Hiscock R, et al. 2008. Regional and urban–rural variations in the association of neighbourhood deprivation 
with community resource access: a national study. Environment and Planning 40: 2469–89. 
33 Nagahawatte NT, Goldenberg RL. 2008. Poverty, maternal health, and adverse pregnancy outcomes. Annals of the New York 
Academy of Sciences 1136: 80–5. 
34 PMMRC. 2019. Te Pūrongo ā-Tau Tekau mā Toru o te Komiti Arotake Mate Pēpi, Mate Whaea Hoki | Thirteenth Annual Report 
of the Perinatal and Maternal Mortality Review Committee: Te tuku pūrongo mō te mate me te whakamate 2017 | Reporting 
mortality and morbidity 2017. Wellington: Health Quality & Safety Commission. URL: 
https://www.hqsc.govt.nz/assets/PMMRC/Publications/13thPMMRCreport/13thPMMRCAnnualReportWebFINAL.pdf (accessed 18 
September 2020). 
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Table 3.20: Perinatal related mortality rates (per 1,000 births) by maternal BMI at registration with maternity 







deaths (total) Termination of 
pregnancy 
Stillbirths 
N=275,887 n=550 n=1,260 n=655 n=2,465 
N % n % Rate n % Rate n % Rate n % Rate 
<18.5 7,475 2.7 11 2.0 1.47 20 1.6 2.68 14 2.1 1.88 45 1.8 6.02 
18.5–24.9 129,585 47.0 282 51.3 2.18 484 38.4 3.74 254 38.8 1.97 1,020 41.4 7.87 
25.0–29.9 71,857 26.0 140 25.5 1.95 363 28.8 5.05 175 26.7 2.45 678 27.5 9.44 
30.0–34.9 37,975 13.8 77 14.0 2.03 193 15.3 5.08 117 17.9 3.10 387 15.7 10.19 
35.0–39.9 17,965 6.5 25 4.5 1.39 116 9.2 6.46 54 8.2 3.03 195 7.9 10.85 
≥40.0 10,520 3.8 14 2.5 1.33 80 6.3 7.60 40 6.1 3.84 134 5.4 12.74 
Unknown 510 0.2 <3 x - 4 0.3 - <3 x - 6 0.2 - 
Data not supplied to MAT 14   5   -3   16   
* All data limited to mothers who were registered for care with an LMC (a midwife, obstetrician or GP) claiming from the Section 88 
Primary Maternity Services Notice.  
BMI = body mass index. 
‘x’ indicates percentage suppressed due to small numbers. 
Sources: Numerator: PMMRC’s perinatal data extract where matched to MAT data, 2014–2018; Denominator: MAT births  
2014‒2018. 
Table 3.21: Perinatal related mortality rates (per 1,000 births) by maternal BMI at registration with maternity 







deaths Termination of 
pregnancy 
Stillbirths 
N=275,887 n=564 n=1,265 n=652 n=2,481 
N % n % Rate n % Rate n % Rate n % Rate 
<18.5 7,475 2.7 11 2.0 1.47 22 1.7 2.94 11 1.7 1.48 44 1.8 5.89 
18.5–24.9 129,585 47.0 283 50.2 2.18 479 37.9 3.70 261 40.0 2.03 1,023 41.2 7.89 
25.0–29.9 71,857 26.0 147 26.1 2.05 354 28.0 4.93 171 26.2 2.40 672 27.1 9.35 
30.0–34.9 37,975 13.8 76 13.5 2.00 198 15.7 5.21 102 15.6 2.71 376 15.2 9.90 
35.0–39.9 17,965 6.5 22 3.9 1.22 120 9.5 6.68 59 9.0 3.31 201 8.1 11.19 
≥40.0 10,520 3.8 19 3.4 1.81 87 6.9 8.27 43 6.6 4.13 149 6.0 14.16 
Unknown 510 0.2 6 1.1 - 5 0.4 - 5 0.8 - 16 0.6 - 
* All data limited to mothers who were registered for care with an LMC (a midwife, obstetrician or GP) claiming from the Section 88 
Primary Maternity Services Notice. 
BMI = body mass index. 
Sources: Numerator: PMMRC's perinatal data extract 2014–2018; Denominator: MAT births 2014–2018. 
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Figure 3.15: Perinatal related death rates (per 1,000 births, with 95% CIs) by maternal BMI* 2014–2018 
 
* All data limited to mothers who were registered for care with an LMC (a midwife, obstetrician or GP) claiming from the Section 88 
Primary Maternity Services Notice. 
BMI = body mass index. 
Sources: Numerator: PMMRC’s perinatal data extract where matched to MAT data, 2014–2018; Denominator: MAT births 
 2014‒2018. 
Parity 
Overall, mortality rates showed a U-shaped curve by parity, with the highest rates for primiparous women 
(women having their first baby after 20 weeks’ gestation, also referred to as ‘parity 0’) and multiparous 
women with four or more previous babies. This was largely driven by the high rate of stillbirths. Rates of 
neonatal death were statistically significantly higher for primiparous women compared with women with one 
previous baby. Terminations of pregnancy showed no statistically significant variation in mortality by parity 
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Figure 3.16: Perinatal related mortality rates (per 1,000 births, with 95% CIs) by maternal parity* 2014–
2018 
 
* All data limited to mothers who were registered for care with an LMC (a midwife, obstetrician or GP) claiming from the Section 88 
Primary Maternity Services Notice. 
Parity ‘0’ indicates women having their first baby or babies of 20 weeks’ or greater gestation. 
Sources: Numerator: PMMRC’s perinatal data extract where matched to MAT data, 2014–2018; Denominator: MAT births  
2014‒2018. 






deaths (total) Termination of 
pregnancy 
Stillbirths 
N=275,887 n=550 n=1,260 n=655 n=2,465 
N % n % Rate n % Rate n % Rate n % Rate 
0 112,965 40.9 245 44.5 2.17 604 47.9 5.35 320 48.9 2.85 1,169 47.4 10.35 
1 93,086 33.7 186 33.8 2.00 316 25.1 3.39 180 27.5 1.94 682 27.7 7.33 
2 40,733 14.8 86 15.6 2.11 175 13.9 4.30 96 14.7 2.37 357 14.5 8.76 
3 16,084 5.8 20 3.6 1.24 72 5.7 4.48 39 6.0 2.44 131 5.3 8.14 
4 6,855 2.5 9 1.6 1.31 49 3.9 7.15 9 1.4 1.32 67 2.7 9.77 
≥5 6,044 2.2 4 0.7 0.66 44 3.5 7.28 11 1.7 1.83 59 2.4 9.76 
Unknown 120 0.0 - - - - - - - - - - - - 
Data not supplied to MAT  15   14   <3   30   
* All data limited to mothers who were registered for care with an LMC (a midwife, obstetrician or GP) claiming from the Section 88 
Primary Maternity Services Notice. 
Parity ‘0’ indicates women having their first baby or babies of 20 weeks’ or greater gestation. 
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Maternal smoking 
Smoking is a significant risk to health outcomes for babies, and the literature provides evidence of 
improved outcomes after pregnant mothers stop smoking.35 Data on smoking in pregnancy come from MAT 
and are based on LMC registration data; specifically, the smoking status of the woman at first LMC 
registration.36 
Our data showed mortality rates were statistically significantly higher in babies of mothers who smoked, 
compared with those who did not smoke, for all types of death, except for termination of pregnancy (Figure 
3.17 and Table 3.23). 
Figure 3.17: Perinatal related mortality rates (per 1,000 births, with 95% CIs) by smoking at registration with 
maternity care* 2014–2018 
 
* All data limited to mothers who were registered for care with an LMC (a midwife, obstetrician or GP) claiming from the Section 88 
Primary Maternity Services Notice. 
Sources: Numerator: PMMRC’s perinatal data extract where matched to MAT data, 2014–2018; Denominator: MAT births  
2014‒2018. 
 
35 McCowan L, Dekker GA, Chan E, et al. 2009. Spontaneous preterm birth and small for gestational age infants in women who 
stop smoking early in pregnancy: prospective cohort study. BMJ 338: b1081. doi: 10.1136/bmj.b1081 (accessed 15 August 2019).   
36 National Health Board Business Unit. 2011. National Maternity Collection Data Mart Data Dictionary. URL: 





























Fourteenth Annual Report of the Perinatal and Maternal Mortality Review Committee   55 









deaths (total) Termination of 
pregnancy 
Stillbirths 
N=275,887 n=550 n=1,260 n=655 n=2,465 
N % n % Rate n % Rate n % Rate n % Rate 
Smoker 37,952 13.8 52 9.5 1.37 248 19.7 6.53 148 22.6 3.93 448 18.2 11.80 
Non-smoker 237,849 86.2 498 90.5 2.09 1,012 80.3 4.25 507 77.4 2.15 2,017 81.8 8.48 
Unknown 86 0.0 - - - - - - - - - - - - 
Data not supplied to MAT 15   14   <3   30   
* All data limited to mothers who were registered for care with an LMC (a midwife, obstetrician or GP) claiming from the Section 88 
Primary Maternity Services Notice. 
Sources: Numerator: PMMRC’s perinatal data extract where matched to MAT data, 2014–2018; Denominator: MAT births  
2014‒2018. 
DHB of residence 
Mortality rates by DHB may vary for a number of reasons. Influences on mortality rates include underlying 
population characteristics, geographic isolation, resourcing, delivery of care and other factors. Despite this, 
DHBs are charged with meeting the needs of the population they serve. Furthermore, DHBs that have a 
mortality rate similar to the national rate may still have groups within their region who do not experience the 
same level of care and outcomes as others, suggesting that an assessment of any subgroups that are 
experiencing worse outcomes within each DHB could be beneficial. 
Perinatal related mortality rates varied by DHB of residence. The rates in Waitematā and Capital & Coast 
DHBs were statistically significantly lower than the national rate of 10.15 per 1,000 births. Conversely, the 
rates in Counties Manukau DHB were statistically significantly higher than the national rate (Figure 3.18 
and Table 3.24). 
Figure 3.18: Unadjusted perinatal related mortality rates (per 1,000 births, with 95% CIs) by DHB of 
maternal residence compared with New Zealand perinatal related mortality 2014–2018 
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Table 3.24: Perinatal related mortality rates (per 1,000 births) by DHB of maternal residence 2014–2018 






deaths (total) Termination of 
pregnancy 
Stillbirths 
N=300,205 n=673 n=1,545 n=828 n=3,046 
N % n % Rate n % Rate n % Rate n % Rate 
Northland 11,072 3.7 27 4.0 2.44 73 4.7 6.59 30 3.6 2.73 130 4.3 11.74 
Waitematā 39,041 13.0 108 16.0 2.77 164 10.6 4.20 78 9.4 2.01 350 11.5 8.96 
Auckland 29,548 9.8 85 12.6 2.88 116 7.5 3.93 67 8.1 2.28 268 8.8 9.07 
Counties Manukau 41,695 13.9 100 14.9 2.40 279 18.1 6.69 173 20.9 4.19 552 18.1 13.24 
Waikato 26,934 9.0 63 9.4 2.34 152 9.8 5.64 83 10.0 3.11 298 9.8 11.06 
Bay of Plenty 14,794 4.9 26 3.9 1.76 86 5.6 5.81 51 6.2 3.47 163 5.4 11.02 
Lakes 7,624 2.5 16 2.4 2.10 48 3.1 6.30 19 2.3 2.51 83 2.7 10.89 
Hauora Tairāwhiti 3,675 1.2 4 0.6 1.09 23 1.5 6.26 8 1.0 2.19 35 1.1 9.52 
Taranaki 7,540 2.5 13 1.9 1.72 31 2.0 4.11 25 3.0 3.34 69 2.3 9.15 
Hawke's Bay 10,506 3.5 18 2.7 1.71 55 3.6 5.24 19 2.3 1.82 92 3.0 8.76 
Whanganui 4,136 1.4 6 0.9 1.45 22 1.4 5.32 16 1.9 3.89 44 1.4 10.64 
MidCentral 10,732 3.6 21 3.1 1.96 44 2.8 4.10 33 4.0 3.09 98 3.2 9.13 
Wairarapa 2,450 0.8 3 0.4 1.22 15 1.0 6.12 5 0.6 2.06 23 0.8 9.39 
Capital & Coast 17,468 5.8 19 2.8 1.09 80 5.2 4.58 38 4.6 2.19 137 4.5 7.84 
Hutt Valley 9,801 3.3 12 1.8 1.22 52 3.4 5.31 28 3.4 2.88 92 3.0 9.39 
Nelson Marlborough 7,402 2.5 16 2.4 2.16 26 1.7 3.51 19 2.3 2.58 61 2.0 8.24 
West Coast 1,727 0.6 3 0.4 1.74 14 0.9 8.11 5 0.6 2.92 22 0.7 12.74 
Canterbury 31,582 10.5 78 11.6 2.47 158 10.2 5.00 79 9.5 2.52 315 10.3 9.97 
South Canterbury 3,243 1.1 5 0.7 1.54 13 0.8 4.01 10 1.2 3.10 28 0.9 8.63 
Southern 16,947 5.6 48 7.1 2.83 91 5.9 5.37 34 4.1 2.02 173 5.7 10.21 
Other* 2,288 0.8 <3 x - 3 0.2 - 8 1.0 - 13 0.4 - 
Total 300,205 100.0 673 100.0 2.24 1,545 100.0 5.15 828 100.0 2.78 3,046 100.0 10.15 
* Other includes Overseas, Unknown and Other. 
‘x’ indicates percentage suppressed due to small numbers. 
Sources: Numerator: PMMRC’s perinatal data extract 2014–2018; Denominator: MAT births 2014–2018. 
Stillbirth rates varied substantially by DHB of residence. Compared with mothers nationally, mothers in 
Waitematā and Auckland DHBs had statistically significantly lower rates. In contrast, mothers living in 
Northland and Counties Manukau DHBs had statistically significantly higher rates than the national rate 
(Figure 3.19). 
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Figure 3.19: Unadjusted stillbirth rates (per 1,000 births, with 95% CIs) by DHB of maternal residence 
compared with average stillbirth rates 2014–2018 
 
Sources: Numerator: PMMRC’s perinatal data extract stillbirths only, 2014–2018; Denominator: MAT births 2014–2018. 
Because they involve smaller numbers, the neonatal death rates by DHB of residence are more prone to 
variation and have wider confidence intervals. When compared with the national rate, Waitematā DHB had 
a statistically significantly lower rate, while Counties Manukau DHB had a statistically significantly higher 
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Figure 3.20: Unadjusted neonatal mortality rates (per 1,000 live births, with 95% CIs) by DHB of maternal 
residence compared with New Zealand neonatal mortality 2014–2018 
 
Sources: Numerator: PMMRC’s perinatal data extract, neonatal deaths only, 2014–2018; Denominator: MAT births excluding fetal 
deaths 2014–2018. 
Gestational age and birthweight 
Perinatal related mortality by gestational age has seen little change over the period 2010–2018. While the 
risk of death appears highest from 41 weeks’ gestation onwards, this is influenced by the number of 
ongoing pregnancies (the denominator). As there are fewer ongoing pregnancies at this gestational age 
compared with 23–24 weeks’ gestation, the mortality ratio (per 1,000 ongoing pregnancies) is higher from 
41 weeks (Figure 3.21). While the rate of death at later gestational ages is lower (1.70 per 1,000 births at 
≥41 weeks’ gestation compared with 735.54 per 1,000 births at 23–24 weeks’ gestation) (Table 3.25), a 
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Figure 3.21: Perinatal related mortality risk (per 1,000 ongoing pregnancies) by gestational age at birth and 
year 2010–2018 
 
















































Gestational age at birth (weeks)
2010–2012 2013–2015 2016–2018
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deaths (total) Termination of 
pregnancy 
Stillbirths 
N % n % Rate n % Rate n % Rate n % Rate 
Gestational age at birth (weeks) 
20–22 228 0.4 87 64.4 * 100 31.7 * 51 33.1 * 238 39.4 * 
23–24 121 0.2 26 19.3 214.88 29 9.2 239.67 34 22.1 515.15 89 14.7 735.54 
25–27 170 0.3 16 11.9 94.12 23 7.3 135.29 6 3.9 45.80 45 7.5 264.71 
28–31 469 0.8 <3 x s 27 8.6 57.57 14 9.1 31.82 43 7.1 91.68 
32–36 3,553 6.0 3 2.2 0.84 56 17.8 15.76 15 9.7 4.29 74 12.3 20.83 
37–40 45,126 76.2 <3 x s 69 21.9 1.53 31 20.1 0.69 101 16.7 2.24 
≥41 8,217 13.9 - - - 11 3.5 1.34 3 1.9 0.37 14 2.3 1.70 
Unknown 1,374 2.3 - - - - - - - - - - - - 
Birthweight (g) 
<500  258 0.4 92 68.1 * 125 39.7 * 44 28.6 * 261 43.2 * 
500–999 267 0.5 36 26.7 134.83 41 13.0 153.56 50 32.5 263.16 127 21.0 475.66 
1,000–1,499 358 0.6 5 3.7 13.97 26 8.3 72.63 9 5.8 27.52 40 6.6 111.73 
1,500–1,999 655 1.1 <3 x s 19 6.0 29.01 8 5.2 12.60 28 4.6 42.75 
2,000–2,499 2,118 3.6 <3 x s 20 6.3 9.44 11 7.1 5.25 32 5.3 15.11 
2,500–2,999 7,940 13.4 - - - 24 7.6 3.02 11 7.1 1.39 35 5.8 4.41 
3,000–3,499 18,568 31.3 - - - 34 10.8 1.83 9 5.8 0.49 43 7.1 2.32 
3,500–3,999 17,168 29.0 - - - 11 3.5 0.64 6 3.9 0.35 17 2.8 0.99 
4,000–4,499 6,466 10.9 - - - 7 2.2 1.08 5 3.2 0.77 12 2.0 1.86 
≥4,500 1,299 2.2 - - - <3 x s <3 x s 3 0.5 2.31 
Unknown 4,161 7.0 - - - 6 1.9 - - - - 6 1.0 - 
* Denominator data unreliable and therefore rates have not been calculated. 
‘x’ indicates percentage suppressed due to small numbers. 
‘s’ indicates rate suppressed due to small numbers. 
Sources: Numerator: PMMRC’s perinatal data extract 2018; Denominator: MAT births 2018. 
Over the period 2007–2018, there is some evidence of a statistically significant decrease in the risk of 
death for babies born at 28–31, 37–38 and ≥41 weeks’ gestation (see Table 3.26 for years 2009–2018). 
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Table 3.26: Perinatal related mortality risk (per 1,000 ongoing pregnancies) by year 2009–2018 
Gestation at birth (weeks) 































20–22 210 216 231 248 230 235 231 247 215 217 245 253 169 175 206 216 211 210 228 238 
23–24 137 105 122 81 129 95 119 94 123 85 137 98 117 92 126 84 110 81 121 89 
25–27 237 70 227 73 185 52 219 70 192 55 187 49 206 52 189 50 212 64 170 45 
28–31 539 66 560 52 511 58 505 50 471 49 462 46 458 41 483 48 477 49 469 43 
32–36 3,978 90 4,005 101 3,909 87 3,933 73 3,724 91 3,729 85 3,652 78 3,824 79 3,750 76 3,553 74 
37–38 13,145 78 13,611 62 13,175 64 13,445 65 13,398 38 13,682 56 13,604 42 14,499 59 14,713 45 14,362 53 
39–40 34,633 72 34,595 65 33,874 59 33,596 51 32,208 51 32,161 60 32,134 69 32,084 56 32,032 51 30,764 48 
≥41  11,740 32 11,547 26 10,729 17 10,325 20 9,479 14 9,093 12 9,075 29 8,787 20 8,467 17 8,217 14 
Unknown 584 <3 551 - 501 - 913 - 327 - 384 - 368 - 408 - 506 - 1,374 - 
 
2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 
Risk Risk Risk Risk Risk Risk Risk Risk Risk Risk 
20–22 3.34  3.82  3.75  3.96  3.63  4.24  2.95  3.59  3.50  4.11  
23–24 1.63  1.25  1.52  1.51  1.43  1.65  1.55  1.40  1.36  1.54  
25–27 1.09  1.13  0.83  1.13  0.92  0.83  0.88  0.84  1.07  0.78  
28–31 1.03  0.81  0.93  0.81  0.83  0.78  0.70  0.80  0.82  0.75  
32–36 1.42  1.58  1.41  1.19  1.55  1.45  1.33  1.33  1.29  1.30  
37–38 1.31  1.04  1.11  1.13  0.69  1.02  0.77  1.07  0.82  0.99  
39–40 1.55  1.41  1.32  1.16  1.22  1.45  1.67  1.37  1.26  1.23  
≥41  2.73  2.25  1.58  1.94  1.48  1.32  3.20  2.28  2.01  1.70  
Unknown  -  -  -  -  -  -  -  -  -  - 
Sources: Numerator: PMMRC’s perinatal data extract 2009–2018; Denominator: MAT births 2009–2018. 
No significant change in termination of pregnancy rates by gestational age (from 20 weeks’ gestation onwards) occurred over the study period 2007–2018 
(data not shown). Table 3.27 presents the rates of termination of pregnancy by gestational age for the years 2009–2018. 
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Table 3.27: Termination of pregnancy risk (per 1,000 ongoing pregnancies) by year 2009–2018 
Gestation at 
birth (weeks) 































20–22 210 88 231 92 230 107 231 118 215 83 245 91 169 66 206 87 211 81 228 87 
23–24 137 31 122 20 129 29 119 32 123 32 137 31 117 27 126 32 110 25 121 26 
25–27 237 9 227 20 185 15 219 14 192 16 187 10 206 8 189 13 212 16 170 16 
28–31 539 4 560 6 511 11 505 5 471 5 462 7 458 3 483 14 477 5 469 <3 
≥32 63,496 6 63,758 13 61,687 9 61,299 3 58,809 5 58,665 11 58,465 3 59,194 <3 58,962 6 56,896 4 
Unknown 584 - 551 - 501 - 913 - 327 - 384 - 368 - 408 - 506 - 1,374 - 
 
2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 
Risk Risk Risk Risk Risk Risk Risk Risk Risk Risk 
20–22 1.36 1.42 1.71 1.89 1.39 1.52 1.11 1.45 1.35 1.50 
23–24 0.48 0.31 0.46 0.51 0.54 0.52 0.46 0.53 0.42 0.45 
25–27 0.14 0.31 0.24 0.23 0.27 0.17 0.14 0.22 0.27 0.28 
28–31 0.06 0.09 0.18 0.08 0.08 0.12 0.05 0.23 0.08 s 
≥32 0.09 0.20 0.15 0.05 0.09 0.19 0.05 s 0.10 0.07 
Unknown - - - - - - - - - - 
‘s’ indicates rate suppressed due to small numbers. 
Sources: Numerator: PMMRC’s perinatal data extract, terminations of pregnancy only, 2009–2018; Denominator: MAT births 2009–2018. 
There is some evidence of a statistically significant decrease in stillbirths at 28–31 weeks’ gestation,37 and strong evidence for a decrease at term (37–40 
weeks)38 over the period 2007–2018. Table 3.28 shows the risk of stillbirth per 1,000 ongoing pregnancies by year. 
 
37 Chi-squared test for trend p=0.012. 
38 Chi-squared test for trend p=0.0014. 
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Stillbirths                     
20–22 210 88 231 94 230 90 231 85 215 88 245 110 169 73 206 83 211 72 228 100 
23–24 137 43 122 31 129 37 119 28 123 29 137 28 117 32 126 29 110 27 121 29 
25–27 237 39 227 32 185 24 219 36 192 25 187 25 206 31 189 26 212 30 170 23 
28–31 539 48 560 32 511 34 505 30 471 32 462 31 458 29 483 22 477 31 469 27 
32–36 3,978 60 4,005 66 3,909 55 3,933 54 3,724 63 3,729 58 3,652 48 3,824 60 3,750 48 3,553 56 
37–40 47,778 111 48,206 78 47,049 83 47,041 78 45,606 60 45,843 72 45,738 72 46,583 76 46,745 68 45,126 69 
≥41 11,740 19 11,547 14 10,729 9 10,325 9 9,479 9 9,093 3 9,075 20 8,787 14 8,467 12 8,217 11 
Unknown 584 <3 551 - 501 - 913 - 327 - 384 - 368 - 408 - 506 - 1,374 - 
 
2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 
Risk Risk Risk Risk Risk Risk Risk Risk Risk Risk 
Stillbirths           
20–22 1.36 1.45 1.43 1.36 1.47 1.84 1.23 1.38 1.20 1.73 
23–24 0.67 0.48 0.59 0.45 0.49 0.47 0.54 0.48 0.45 0.50 
25–27 0.61 0.50 0.38 0.58 0.42 0.42 0.52 0.43 0.50 0.40 
28–31 0.75 0.50 0.55 0.49 0.54 0.52 0.49 0.37 0.52 0.47 
32–36 0.94 1.04 0.89 0.88 1.07 0.99 0.82 1.01 0.81 0.98 
37–40 1.86 1.31 1.44 1.36 1.09 1.31 1.31 1.37 1.23 1.29 
≥41 1.62 1.21 0.84 0.87 0.95 0.33 2.20 1.59 1.42 1.34 
Unknown - - - - - - - - - - 
Sources: Numerator: PMMRC’s perinatal data extract, stillbirths only, 2009–2018; Denominator: MAT births 2009–2018. 
During the period 2007–2018 there was a statistically significant reduction in the rates of neonatal death for those born at ≥41 weeks’ gestation,39 but a 
statistically significant increase in deaths at 20–22 weeks’ gestation.40 Table 3.29 shows the risk of neonatal death per 1,000 ongoing pregnancies by year. 
 
39 Chi-squared test for trend p=0.006. 
40 Chi-squared test for trend p=0.001. 
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Table 3.29: Neonatal death risk (per 1,000 ongoing pregnancies) by year 2009–2018 
Gestation at birth 
(weeks) 































20–22 34 40 45 62 33 38 28 44 44 46 44 52 30 36 36 46 58 57 41 51 
23–24 63 31 71 30 63 29 59 34 62 24 78 39 58 33 65 23 58 29 66 34 
25–27 189 22 175 21 146 13 169 20 151 14 152 14 167 13 150 11 166 18 131 6 
28–31 487 14 522 14 466 13 470 15 434 12 424 8 426 9 447 12 441 13 440 14 
32–36 3,913 25 3,930 26 3,846 24 3,876 16 3,657 24 3,666 22 3,601 27 3,762 17 3,697 23 3,494 15 
37–40 47,666 38 48,124 45 46,965 39 46,963 38 45,545 28 45,765 38 45,666 39 46,507 39 46,676 27 45,056 31 
≥41 11,721 13 11,533 12 10,720 8 10,316 11 9,470 5 9,090 9 9,055 9 8,773 6 8,455 5 8,206 3 
Unknown 583 - 551 - 501 - 913 - 327 - 384 - 368 - 408 - 506 - 1,374 - 
 
2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 
Risk Risk Risk Risk Risk Risk Risk Risk Risk Risk 
20–22 0.62 0.96 0.61 0.71 0.77 0.88 0.61 0.77 0.96 0.89 
23–24 0.48 0.47 0.47 0.55 0.40 0.66 0.56 0.39 0.49 0.59 
25–27 0.34 0.33 0.21 0.32 0.24 0.24 0.22 0.18 0.30 0.10 
28–31 0.22 0.22 0.21 0.24 0.20 0.14 0.15 0.20 0.22 0.24 
32–36 0.39 0.41 0.39 0.26 0.41 0.38 0.46 0.29 0.39 0.26 
37–40 0.64 0.75 0.68 0.66 0.51 0.69 0.71 0.71 0.49 0.58 
≥41 1.11 1.04 0.75 1.07 0.53 0.99 0.99 0.68 0.59 0.37 
Unknown - - - - - - - - - - 
Sources: Numerator: PMMRC’s perinatal data extract specific neonatal deaths 2009–2018; Denominator: MAT births excluding fetal deaths 2009–2018. 
Over the period 2007–2018, there was some evidence of a decrease in the mortality rate from intrapartum stillbirth in babies aged 23–27 weeks.41 Strong 
evidence points to a reduction in intrapartum stillbirth in babies born at term (37 weeks onwards)42 (Table 3.30 and Figure 3.22). The reduction in deaths of 
babies in Māori mothers was similar to that in New Zealand European mothers (data not shown). 
 
41 Chi-squared test for trend p=0.016. 
42 Chi-squared test for trend p<0.001. 
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Table 3.30: Intrapartum stillbirth risk (per 1,000 ongoing pregnancies) by gestational age excluding congenital anomalies by year 2009–2018 
Gestation at 
birth (weeks) 
2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 
n N n N n N n N n N n N n N n N n N n N 
23–27 18 64,409 13 64,667 16 62,512 10 62,142 10 59,595 8 59,451 8 59,246 6 59,992 4 59,761 8 57,656 
28–36 5 64,035 <3 64,318 4 62,198 3 61,804 <3 59,280 3 59,127 <3 58,923 <3 59,677 3 59,439 <3 57,365 
≥37 22 59,518 16 59,753 9 57,778 12 57,366 3 55,085 10 54,936 17 54,813 12 55,370 10 55,212 8 53,343 
 
2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 
Rate Rate Rate Rate Rate Rate Rate Rate Rate Rate 
23–27 0.28 0.20 0.26 0.16 0.17 0.13 0.14 0.10 0.07 0.14 
28–36 0.08 s 0.06 0.05 s 0.05 s s 0.05 s 
≥37 0.37 0.27 0.16 0.21 0.05 0.18 0.31 0.22 0.18 0.15 
‘s’ indicates rate suppressed due to small numbers. 
Sources: Numerator: PMMRC’s perinatal data extract, stillbirths only (excluding congenital anomalies) 2009–2018; Denominator: MAT births 2009–2018. 
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Figure 3.22: Intrapartum stillbirth risks (per 1,000 ongoing pregnancies) by gestational age at birth (weeks) 
excluding congenital anomalies 2007–2018 
 
‘s’ indicates risk suppressed due to small numbers. 
Sources: Numerator: PMMRC’s perinatal data extract, stillbirths only (excluding congenital anomalies), 2007–2018; Denominator: 
MAT births 2007–2018. 
Mortality by customised birthweight centile group 
Very little change has occurred in the perinatal related mortality rate in singleton babies who have no 
congenital anomalies and are appropriate or large for gestational age over the last 10 years. However, 
deaths in small for gestational age babies are trending down (Figure 3.23 and Table 3.31). 
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Figure 3.23: Perinatal related mortality rates by customised centile group among singleton births* from 
26 weeks’ gestation without congenital anomalies and by year 2009–2018 
 
* All data limited to mothers who were registered for care with an LMC (a midwife, obstetrician or GP) claiming from the Section 88 
Primary Maternity Services Notice. 
Sources: Numerator: PMMRC’s perinatal data extract where matched to MAT data, from 26 weeks’ gestation without congenital 
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Table 3.31: Perinatal related mortality rates by customised birthweight centile group among singleton births* from 26 weeks’ gestation without congenital 
anomalies and by year 2009–2018 
Year of death 
Small for gestational age Appropriate for gestational age Large for gestational age Unknown/missing data Total 
N=54,602 n=493  N=422,681 n=1,020  N=70,263 n=192  N=27,235 n=116  N=574,781 n=1,821  
N n Rate N n Rate N n Rate N n Rate N n Rate 
2009 5,032 52 10.33 37,102 110 2.96 6,159 21 3.41 2,566 19 7.40 50,859 202 3.97 
2010 5,100 52 10.20 38,167 96 2.52 6,305 22 3.49 2,690 7 2.60 52,262 177 3.39 
2011 5,117 44 8.60 37,977 80 2.11 6,137 21 3.42 2,748 13 4.73 51,979 158 3.04 
2012 5,054 44 8.71 39,200 95 2.42 6,540 11 1.68 2,248 6 2.67 53,042 156 2.94 
2013 4,903 42 8.57 37,975 86 2.26 6,208 21 3.38 2,362 7 2.96 51,448 156 3.03 
2014 4,988 44 8.82 38,668 93 2.41 6,390 15 2.35 2,261 5 2.21 52,307 157 3.00 
2015 4,881 43 8.81 39,217 102 2.60 6,383 18 2.82 2,477 6 2.42 52,958 169 3.19 
2016 4,979 36 7.23 39,602 97 2.45 6,670 17 2.55 2,417 16 6.62 53,668 166 3.09 
2017 4,786 43 8.98 39,832 92 2.31 6,713 12 1.79 2,271 10 4.40 53,602 157 2.93 
2018 4,934 43 8.72 38,455 72 1.87 6,589 15 2.28 2,485 10 4.02 52,463 140 2.67 
* MAT data limited to mothers who were registered for care with an LMC (a midwife, obstetrician or GP) claiming from the Section 88 Primary Maternity Services Notice. 
Sources: Numerator: PMMRC’s perinatal data extract where matched to MAT data, among singleton births from 26 weeks’ gestation without congenital anomalies 2009–2018; 
Denominator: MAT births among singleton births from 26 weeks’ gestation 2009–2018. 
From 26 weeks’ gestation onwards, mortality decreased significantly as baby birthweight approached the 50th–74th customised centile group. Those babies 
with a customised birthweight under the 5th centile had a substantially higher mortality rate, even compared with those in the 5th–9th centile. Mortality was 
lowest in those with a birthweight in the 50th–74th centile group. Babies with a birthweight in the customised centile group 90th or above had a statistically 
significantly higher mortality rate than those in the 50th–74th centile group (Figure 3.24).  
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Figure 3.24: Perinatal related mortality rates (with 95% CIs) by customised birthweight centile group among 
singleton births from 26 weeks’ gestation without congenital anomalies 2009–2018* 
 
* All data limited to mothers who were registered for care with an LMC (a midwife, obstetrician or GP) claiming from the Section 88 
Primary Maternity Services Notice. 
Sources: Numerator: PMMRC’s perinatal data extract where matched to MAT data, among singleton births from 26 weeks’ 
gestation without congenital anomalies 2009–2018; Denominator: MAT births among singleton births from 26 weeks’ gestation 








































Customised birthweight centile group
 
Fourteenth Annual Report of the Perinatal and Maternal Mortality Review Committee   70 
Multiple pregnancies 
Mortality rates for babies born in multiple pregnancies, at 38.6 per 1,000 births, are four times higher than 
those in singletons, at 9.7 per 1,000 births.43 The mortality rates in multiple pregnancies have not changed 
significantly over the period 2007–2018 (Figure 3.25 and Table 3.32). However, there has been a 
statistically significant reduction in mortality in singletons over this time.44 
Figure 3.25: Perinatal related mortality rates (per 1,000 births) among babies born in multiple pregnancies 
by year 2007–2018 
 
Sources: Numerator: PMMRC’s perinatal data extract among babies born in multiple pregnancies 2007–2018; Denominator: MAT 
births among babies born in multiple pregnancies 2007–2018. 
 
43 Multiple:singleton mortality rate ratio is 3.99, 95% CI 3.71–4.28. 
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Table 3.32: Perinatal related mortality rates among babies born in multiple pregnancies by year 2007–2018 






deaths (total) Termination of 
pregnancy 
Stillbirths 
n Rate n Rate n Rate n Rate 
2007 2,011 3 1.49 34 16.91 25 12.66 62 30.83 
2008 1,924 3 1.56 33 17.15 18 9.53 54 28.07 
2009 1,849 5 2.70 32 17.31 31 17.11 68 36.78 
2010 1,906 9 4.72 35 18.36 35 18.80 79 41.45 
2011 1,827 18 9.85 48 26.27 27 15.33 93 50.90 
2012 1,806 14 7.75 34 18.83 32 18.20 80 44.30 
2013 1,741 8 4.60 40 22.98 16 9.45 64 36.76 
2014 1,727 10 5.79 34 19.69 40 23.77 84 48.64 
2015 1,665 <3 s 29 17.42 20 12.24 51 30.63 
2016 1,631 3 1.84 33 20.23 11 6.90 47 28.82 
2017 1,552 4 2.58 29 18.69 22 14.48 55 35.44 
2018 1,491 9 6.04 37 24.82 32 22.15 78 52.31 
Chi-squared test for trend (p) 0.47 0.20 0.39 0.091 
‘s’ indicates rate suppressed due to small numbers. 
Sources: Numerator: PMMRC’s perinatal data extract among babies born in multiple pregnancies 2007–2018; Denominator: MAT 
births among babies born in multiple pregnancies 2007–2018. 
Death investigation 
Overall, around 40% of babies had optimal investigation into the cause(s) of their death. ‘Optimal 
investigation’ is defined here as post-mortem or karyotype confirming chromosomal abnormality, or clinical 
examination or investigation confirming the diagnosis. What is considered to be ‘optimal’ will vary 
depending on the clinical picture. The rate of optimal investigation was higher for terminations of 
pregnancy, and lower for stillbirths and neonatal deaths (Table 3.33). 
Table 3.33: Perinatal related deaths and completeness of perinatal death investigations 2018 




deaths (total) Termination of 
pregnancy 
Stillbirths 
n % n % n % n % 
Optimal investigation* 67 49.63 125 39.68 58 37.66 250 41.39 
Post-mortem 35 25.93 108 34.29 37 24.03 180 29.80 
Karyotype 29 21.48 16 5.08 14 9.09 59 9.77 
Clinical examination/investigations confirm diagnosis 7 5.19 13 4.13 9 5.84 29 4.80 
Partial investigations# 54 40.00 139 44.13 80 51.95 273 45.20 
Placental pathology performed+ 62 45.93 235 74.60 112 72.73 409 67.72 
No investigation^ 12 8.89 46 14.60 13 8.44 71 11.75 
Unknown <3 x 5 1.59 3 1.95 10 1.66 
* Optimal investigation is defined as post-mortem or karyotype confirming congenital abnormality, or clinical examination or 
investigation confirming diagnosis. Note: more than one option can be selected for each case. 
# No full post-mortem undertaken; investigations may have included placental pathology, magnetic resonance imaging (MRI), 
ultrasound scan or x-ray. 
+ Includes both placental histology with post-mortem and as part of partial investigation. 
^ No post-mortem, placental pathology, MRI, ultrasound scan or x-ray. 
‘x’ indicates percentage not calculated due to small numbers. 
Source: PMMRC’s perinatal data extract 2018. 
Table 3.34 shows the degree to which perinatal deaths were investigated. A higher proportion of Māori 
mothers was offered a post-mortem that was then not undertaken, and consequently a higher number of 
Māori babies had no investigation than other ethnic groups. The proportion of women who were not offered 
a post-mortem for their babies was reasonably consistent among prioritised ethnic groups, with the 
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exception of MELAA, who were not offered a post-mortem more frequently than other groups (Table 3.34). 
In some clinical situations, a full post-mortem is not required to identify the cause of death.
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Table 3.34: Perinatal related deaths and perinatal death investigations by maternal prioritised ethnic group* 2014–2018 




















n % n % n % n % n % n % n % n % n % n % 
Full post-mortem offered and undertaken 180 22.2 116 30.4 96 39.2 106 39.4 202 39.3 28 43.1 495 45.2 88 49.2 583 45.8 1,111 36.5 
Full post-mortem offered and not undertaken 557 68.8 239 62.6 138 56.3 145 53.9 283 55.1 30 46.2 524 47.9 71 39.7 595 46.7 1,704 55.9 
Full post-mortem not offered 63 7.8 23 6.0 8 3.3 18 6.7 26 5.1 7 10.8 63 5.8 17 9.5 80 6.3 199 6.5 
Unknown# 10 1.2 4 1.0 3 1.2 - - 3 0.6 - - 12 1.1 3 1.7 15 1.2 32 1.1 
Karyotype 41 5.1 28 7.3 20 8.2 39 14.5 59 11.5 11 16.9 115 10.5 23 12.8 138 10.8 277 9.1 
Clinical examination/investigations confirm diagnosisƗ 34 4.2 11 2.9 5 2.0 11 4.1 16 3.1 <3 x 52 4.8 7 3.9 59 4.6 121 4.0 
Partial investigations^ 367 45.3 193 50.5 117 47.8 104 38.7 221 43.0 22 33.8 420 38.4 52 29.1 472 37.1 1,275 41.9 
No investigation 195 24.1 41 10.7 11 4.5 15 5.6 26 5.1 4 6.2 52 4.8 15 8.4 67 5.3 333 10.9 
Investigations unknown 5 0.6 <3 x - - <3 x <3 x - - 10 0.9 - - 10 0.8 18 0.6 
Ɨ In some clinical situations, a full post-mortem is not required to determine the cause of death. 
* Excludes two unknown maternal ethnicity. 
# Includes unknown and two cases where a post-mortem was offered and consent unknown. 
^ Investigations may have included partial post-mortem, placental pathology, magnetic resonance imaging (MRI), ultrasound scan or x-ray. 
‘x’ indicates percentage suppressed due to small numbers. 
Source: PMMRC’s perinatal data extract 2014–2018. 
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Contributory factors 
Local review of cases showed a number of deaths had potentially avoidable aspects. Contributory factors 
were thought to be present in around one quarter of perinatal related deaths (excluding termination of 
pregnancy) (Table 3.35). 





deaths (total) Termination of 
pregnancy 
Stillbirths 
n % n % n % n % 
Contributory factors         
Present 16 11.9 91 28.9 46 29.9 153 25.3 
Absent 117 86.7 218 69.2 108 70.1 443 73.3 
Missing data <3 x 6 1.9 - - 8 1.3 
Potentially avoidable         
Yes 7 5.2 44 14.0 28 18.2 79 13.1 
Contributory factors present but 
not potentially avoidable 
9 6.7 42 13.3 17 11.0 68 11.3 
Contributory factors present but 
avoidability unknown 
- - 3 1.0 <3 x 4 0.7 
‘x’ indicates percentage suppressed due to small numbers. 
Source: PMMRC’s perinatal data extract 2018, local review data. 
Contributory factors included organisational and/or management factors, personnel factors, and barriers to 
access. Of these, ‘barriers to access and/or engagement with care’ was the most common contributory 
factor cited (Table 3.36). 




Any contributory factor 1,693 26.4 
Organisational and/or management factors 335 5.2 
Personnel factors 524 8.2 
Barriers to access and/or engagement with care 1,211 18.9 
Source: PMMRC’s perinatal data extract 2009–2018, local review data. 
Barriers to care were most notable for perinatal infection, maternal conditions and situations with no 
obstetric antecedent. Personnel factors were more common in hypertension and hypoxic peripartum death 
(Figure 3.26 and Table 3.37). 
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Figure 3.26: Main contributory factor(s)* in potentially avoidable perinatal related deaths (as a percentage 




* Excludes one death where the contributory factor was not identified.  
# Spontaneous preterm labour or rupture of membranes (<37 weeks’ gestation). 
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Table 3.37: Main contributory factor(s)* in potentially avoidable perinatal related death by perinatal death 
classification (PSANZ-PDC) 2014–2018 








Personnel Barriers to care 
n n % n % n % 
Congenital anomaly 856 4 0.5 5 0.6 11 1.3 
Perinatal infection 122 5 4.1 16 13.1 21 17.2 
Hypertension 75 4 5.3 12 16.0 8 10.7 
Antepartum haemorrhage 357 6 1.7 14 3.9 25 7.0 
Maternal conditions 176 15 8.5 21 11.9 56 31.8 
Complications of multiple pregnancy 108 4 3.7 6 5.6 <3 x 
Specific perinatal conditions 151 <3 x 5 3.3 5 3.3 
Hypoxic peripartum death 66 15 22.7 20 30.3 13 19.7 
Placental dysfunction or causative placental pathology 251 11 4.4 26 10.4 26 10.4 
Spontaneous preterm labour or rupture of membranes 
(<37 weeks’ gestation) 
470 15 3.2 20 4.3 29 6.2 
Unexplained antepartum fetal death 384 9 2.3 27 7.0 34 8.9 
Neonatal death without obstetric antecedent 30 4 13.3 3 10.0 17 56.7 
* Excludes one death where the contributory factor was not identified.  
‘x’ indicates percentage suppressed due to small numbers. 
Source: PMMRC’s perinatal data extract 2014–2018, local review data. 
Barriers to accessing care were frequent among Māori and Pacific mothers, while personnel was the most 
significant factor identified for those in Indian and MELAA ethnic groups (Figure 3.27 and Table 3.38). 
Figure 3.27: Main contributory factor(s) in potentially avoidable perinatal related deaths (as a percentage of 
all deaths) by maternal prioritised ethnic group 2014–2018 
 
* Excludes one death where the contributory factor was not identified.  
MELAA = Middle Eastern, Latin American, or African. 
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Table 3.38: Main contributory factor(s) in potentially avoidable perinatal related deaths by maternal 






Organisation/management Personnel Barriers to care 
n n % n % n % 
Māori# 810 26 3.2 47 5.8 119 14.7 
Pacific peoples 382 12 3.1 28 7.3 60 15.7 
Asian 514 10 1.9 30 5.8 10 1.9 
Indian 245 8 3.3 20 8.2 8 3.3 
Other Asian 269 <3 x 10 3.7 <3 x 
MELAA 65 3 4.6 8 12.3 <3 x 
European 1,273 43 3.4 62 4.9 55 4.3 
NZ European 1,094 40 3.7 59 5.4 48 4.4 
Other European 179 3 1.7 3 1.7 7 3.9 
* Excludes two perinatal related deaths (total) with unknown maternal ethnicity. 
# Excludes one death where the contributory factor was not identified.  
‘x’ indicates percentage suppressed due to small numbers. 
Source: PMMRC’s perinatal data extract 2014–2018, local review data. 
As the level of deprivation increased, barriers to accessing care became more significant, particularly 
among mothers living in NZDep2013 quintile 5 (Figure 3.28 and Table 3.39). 
Figure 3.28: Main contributory factor(s) in potentially avoidable perinatal related deaths (as a percentage of 
all deaths) by NZDep2013 quintile 2014–2018 
 
* Excludes one death where the contributory factor was not identified.  
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Personnel Barriers to care 
n n % n % n % 
1 (least deprived) 378 10 2.6 17 4.5 16 4.2 
2 425 12 2.8 18 4.2 14 3.3 
3 509 25 4.9 26 5.1 32 6.3 
4* 673 15 2.2 33 4.9 41 6.1 
5 (most deprived)  1,043 30 2.9 80 7.7 141 13.5 
Unknown 18 <3 x <3 x 3 16.7 
* Excludes one death where the contributory factor was not identified.  
‘x’ indicates percentage suppressed due to small numbers. 
Source: PMMRC’s perinatal data extract 2014–2018, local review data. 
Resuscitation 
Resuscitation of babies born at 23–26 weeks’ gestation requires careful discussion with parents about the 
implications of resuscitating and of not doing so. We are unable to identify the babies for whom 
resuscitation was discussed, offered and declined, and the babies for whom resuscitation was not 
discussed or offered. Table 3.40 shows the number of babies for whom resuscitation was attempted, by 
maternal prioritised ethnic group. 
Table 3.40: Resuscitation and survival (to 28 days) by maternal prioritised ethnic group for live born babies 






Resuscitation attempted Resuscitation not attempted 
Total 
n % n % 
Māori 556 114 20.5 40 7.2 154 
Pacific 230 42 18.3 27 11.7 69 
Asian 209 36 17.2 15 7.2 51 
Indian 89 14 15.7 12 13.5 26 
Other Asian 120 22 18.3 3 2.5 25 
MELAA 31 5 16.1 3 9.7 8 
European 593 103 17.4 27 4.6 130 
NZ European 482 87 18.0 23 4.8 110 
Other European 111 16 14.4 4 3.6 20 
Unknown/Other - - - - - - 
Total 1,619 300  112  412 
* Includes babies with congenital anomalies. 
MELAA = Middle Eastern, Latin American, or African. 
Sources: Numerator: PMMRC’s perinatal data extract where matched to MAT data, 23–26 weeks’ gestation, 2009–2018; 
Denominator: Live births: MAT data 2009–2018.  
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Perinatal mortality appended tables 
Table 3.41: Perinatal related death and perinatal death classification (PSANZ-PDC) 2018 
Refer to Table 3.44 for the full code list. 




1 Congenital anomaly   
1.1 Structural anomaly <3 s 
1.11 Nervous system 25 0.42 
1.12 Cardiovascular system 25 0.42 
1.13 Genitourinary system 10 0.17 
1.15 Musculoskeletal 10 0.17 
1.151 Congenital diaphragmatic hernia <3 s 
1.18 Multiple congenital anomaly (no chromosomal/genetic cause or not tested) 15 0.25 
1.19 Other congenital anomaly   
1.192 Idiopathic hydrops fetalis <3 s 
1.193 Fetal tumour (includes sacro-coccygeal teratoma) <3 s 
1.198 Other specified 3 0.05 
1.199 Congenital anomaly, unspecified <3 s 
1.2 Chromosomal anomaly <3 s 
1.21 Trisomy 21 (Down syndrome) 13 0.22 
1.22 Trisomy 18 (Edward syndrome) and Trisomy 13 (Patau syndrome) 22 0.37 
1.23 
Other trisomies and partial trisomies of the autosomes, not elsewhere classified (includes pathogenic 
duplications, unbalanced translocations and insertions) 
6 0.10 
1.24 
Monosomies and deletions from the autosomes, not elsewhere classified (includes pathogenic deletions, eg, 
22q11.2 deletion syndrome (diGeorge syndrome), Wolff-Hirschorn syndrome, Cri-du-chat syndrome 
7 0.12 
1.25 Turner syndrome (monosomy X) <3 s 
1.28 Other chromosomal abnormalities, not elsewhere specified (includes triploidy) 6 0.10 
1.3 Genetic condition   
1.31 
Genetic condition, specified (includes inborn errors of metabolism (eg, Tay-Sachs disease, Fragile X syndrome, 
imprinting syndromes) and other syndromes with demonstrated genetic mutations (eg, Kabuki syndrome, 
Fraser syndrome) 
6 0.10 
1.32 Syndrome/association with demonstrated chromosomal/gene anomaly 4 0.07 
2 Perinatal infection   
2.1 Bacterial   
2.11 Group B Streptococcus 5 0.08 
2.12 E coli <3 s 
2.14 Spirochaetal, eg, syphilis <3 s 
2.18 Other bacterial <3 s 
2.19 Unspecified bacterial 3 0.05 
2.2 Viral   
2.21 Cytomegalovirus <3 s 
2.22 Parvovirus <3 s 
2.23 Herpes simplex virus <3 s 
2.3 Protozoal, eg, toxoplasma <3 s 
2.9 Other unspecified organism or no organism identified 3 0.05 
3 Hypertension   
3.1 Chronic hypertension: essential 3 0.05 
3.5 Pre-eclampsia 13 0.22 
3.6 Pre-eclampsia superimposed on chronic hypertension 3 0.05 
4 Antepartum haemorrhage (APH)   
4.1 Placental abruption 18 0.30 
4.2 Placenta praevia <3 s 
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5 Maternal conditions   
5.1 Termination of pregnancy for maternal psychosocial indications 8 0.14 
5.2 Diabetes   
5.21 Gestational diabetes <3 s 
5.22 Pre-existing diabetes 14 0.24 
5.3 Maternal injury <3 s 
5.31 Accidental 6 0.10 
5.32 Non-accidental <3 s 
5.4 Maternal sepsis <3 s 
5.5 Antiphospholipid syndrome <3 s 
5.6 Obstetric cholestasis <3 s 
5.8 Other specified maternal conditions   
5.88 Other specified maternal medical or surgical conditions 6 0.10 
6 Complications of multiple pregnancy   
6.1 Monochorionic twins <3 s 
6.11 Twin to twin transfusion syndrome (TTTS) 12 0.20 
6.12 Selective fetal growth restriction (FGR) (ie, affecting only one twin) 5 0.08 
6.13 Monoamniotic twins (including cord entanglement) 3 0.05 
6.18 Other <3 s 
6.19 Unknown or unspecified 3 0.05 
6.2 Dichorionic twins   
6.21 Early fetal death in a multiple pregnancy (<20 weeks’ gestation) 4 0.07 
6.28 Other <3 s 
6.29 Unknown or unspecified <3 s 
7 Specific perinatal conditions   
7.1 Fetomaternal haemorrhage 7 0.12 
7.2 Antepartum cord or fetal vessel complications (excludes monochorionic twins or higher order multiples)   
7.21 Cord vessel haemorrhage <3 s 
7.22 Cord occlusion (true knot with evidence of occlusion or other) <3 s 
7.28 Other cord complications 5 0.08 
7.3 Uterine abnormalities   
7.31 Developmental anatomical abnormalities (eg, bicornuate uterus) <3 s 
7.5 Fetal antenatal intracranial injury   
7.52 Fetal antenatal ischaemic brain injury <3 s 
7.53 Fetal antenatal haemorrhagic brain injury 4 0.07 
7.6 Other specific perinatal conditions   
7.63 Amniotic band 4 0.07 
7.68 Other <3 s 
8 Hypoxic peripartum death   
8.1 With intrapartum complications (sentinel events)   
8.12 Cord prolapse <3 s 
8.15 Birth trauma <3 s 
8.2 Evidence of significant fetal compromise (excluding other complications) 3 0.05 
8.9 Unspecified hypoxic peripartum death <3 s 
9 Placental dysfunction or causative placental pathology   
9.1 Maternal vascular malperfusion 17 0.29 
9.2 Fetal vascular malperfusion 13 0.22 
9.3 High grade villitis of unknown etiology (VUE) 9 0.15 
9.4 Massive perivillous fibrin deposition/maternal floor infarction <3 s 
9.5 Severe chronic intervillositis (Histiocytic intervillositis) 3 0.05 
9.6 Placental hypoplasia (small for gestation placenta) 4 0.07 
9.7 
No causal placental pathology demonstrated, with antenatal evidence of poor placental function identified (such as 
abnormal fetal umbilical artery Doppler) 
<3 s 
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Placental pathological examination was not performed, with antenatal evidence of poor placental function was 
identified (such as abnormal fetal umbilical artery Doppler) 
3 0.05 
9.9 Other placental pathology (eg, multiple pathologies with evidence of loss of placental function leading to death) 4 0.07 
10 Spontaneous preterm labour or rupture of membranes (<37 weeks’ gestation)   
10.1 Spontaneous preterm <3 s 
10.11 With histological chorioamnionitis 42 0.71 
10.12 Without histological chorioamnionitis 15 0.25 
10.13 With clinical evidence of chorioamnionitis, no examination of placenta 4 0.07 
10.17 No clinical signs of chorioamnionitis, no examination of placenta 9 0.15 
10.19 Unspecified or not known whether placenta examined <3 s 
10.2 Spontaneous preterm preceded by premature cervical shortening 26 0.44 
11 Unexplained antepartum fetal death   
11.1 Unexplained antepartum fetal death despite full investigation 22 0.37 
11.2 Unclassifiable antepartum fetal death with incomplete investigation 54 0.91 
11.3 Unclassifiable antepartum fetal death due to unknown level of investigation <3 s 
12 Neonatal death without obstetric antecedent   
12.1 Neonatal death with no obstetric antecedent factors despite full investigation <3 s 
Categories where no deaths occurred have been removed from the table (refer to Table 3.44 for full code list). 
‘s’ indicates rate suppressed due to small numbers. 
Sources: Numerator: PMMRC’s perinatal data extract 2018; Denominator: MAT births 2018. 
Table 3.42: Neonatal death and primary neonatal death classification (PSANZ-NDC) 2018 
Refer to Table 3.45 for the full code list. 




1 Congenital anomaly   
1.1 Structural anomaly <3 s 
1.11 Nervous system <3 s 
1.12 Cardiovascular system 6 0.10 
1.13 Genitourinary system <3 s 
1.15 Musculoskeletal <3 s 
1.151 Congenital diaphragmatic hernia <3 s 
1.18 Multiple congenital anomaly (no chromosomal/genetic cause or not tested) 4 0.07 
1.19 Other congenital anomaly   
1.193 Fetal tumour (includes sacro-coccygeal teratoma) <3 s 
1.2 Chromosomal anomaly <3 s 
1.21 Trisomy 21 (Down syndrome) <3 s 
1.22 Trisomy 18 (Edward syndrome) and Trisomy 13 (Patau syndrome) 8 0.14 
1.23 
Other trisomies and partial trisomies of the autosomes, not elsewhere classified (includes pathogenic 
duplications, unbalanced translocations and insertions) 
<3 s 
1.24 
Monosomies and deletions from the autosomes, not elsewhere classified (includes pathogenic deletions, eg, 
22q11.2 deletion syndrome (diGeorge syndrome), Wolff-Hirschorn syndrome, Cri-du-chat syndrome 
<3 s 
1.28 Other chromosomal abnormalities, not elsewhere specified (includes triploidy) <3 s 
1.3 Genetic condition   
1.31 
Genetic condition, specified (includes inborn errors of metabolism (eg, Tay-Sachs disease, Fragile X 
syndrome, imprinting syndromes) and other syndromes with demonstrated genetic mutations (eg, Kabuki 
syndrome, Fraser syndrome) 
4 0.07 
1.32 Syndrome/association with demonstrated chromosomal/gene anomaly <3 s 
2 Periviable infants (typically <24 weeks)   
2.1 
Not resuscitated (including infants where there is an antenatal plan for no resuscitation at birth or in the 
circumstance of re-directed care) 
55 0.94 
2.2 Unsuccessful resuscitation 8 0.14 
3 Cardio-respiratory disorders   
3.1 Hyaline membrane disease/Respiratory distress syndrome (RDS) 9 0.15 
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3.2 Meconium aspiration syndrome <3 s 
3.3 Primary persistent pulmonary hypertension <3 s 
3.4 Pulmonary hypoplasia <3 s 
3.6 Air leak syndromes   
3.6.1 Pneumothorax <3 s 
3.9 Other   
3.9.1 Neonatal anaemia/hypovolaemia <3 s 
4 Neonatal infection   
4.1 Congenital/Perinatal bacterial infection (early onset <48 hrs)   
4.11 Blood stream infection/septicaemia   
4.111 Positive culture of a pathogen 4 0.07 
4.13 Bacterial pneumonia <3 s 
4.15 Multiple site bacterial infection <3 s 
4.19 Unspecified congenital infection <3 s 
4.4 Acquired bacterial infection (late onset >48hrs)   
4.41 Blood stream infection/septicaemia   
4.411 Positive culture of a pathogen 4 0.07 
5 Neurological   
5.1 Hypoxic ischaemic encephalopathy/Perinatal asphyxia 13 0.22 
5.2 Cranial haemorrhage   
5.21 Intraventricular haemorrhage 3 0.05 
6 Gastrointestinal   
6.1 Necrotising enterocolitis (NEC) 7 0.12 
6.3 Gastric or intestinal perforation (excluding NEC) <3 s 
6.8 Other <3 s 
7 Other   
7.1 Sudden unexpected death in infancy (SUDI)   
7.13 Unclassified sudden infant death in the neonatal period   
7.131 Bed sharing/unsafe sleep <3 s 
7.2 Multisystem failure   
7.29 Unspecified/undetermined primary cause or trigger event <3 s 
7.3 Trauma   
7.31 Accidental <3 s 
7.4 Treatment complications   
7.41 Surgical <3 s 
Categories where no deaths occurred have been removed from the table (refer to Table 3.45 for full code list). 
‘s’ indicates rate suppressed due to small numbers. 
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Table 3.43: Summary of New Zealand perinatal related mortality rates using New Zealand definition (≥20 weeks or ≥400g if gestation unknown), babies of ngā 
māmā Māori and New Zealand European mothers by year 2009–2018 
Māori 
Maternal prioritised ethnic group: Māori  
n 
2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 
Total births 17,224 17,102 16,518 16,391 15,241 14,881 15,116 15,367 15,244 14,898 
Fetal deaths (terminations of pregnancy and stillbirths)* 140 124 126 111 106 108 91 120 94 119 
Terminations of pregnancy 29 19 31 34 24 20 20 35 21 21 
Stillbirths 111 105 95 77 82 88 71 85 73 98 
Early neonatal deaths <7 days 49 53 39 43 44 47 38 48 48 34 
Late neonatal deaths 7–27 days 20 16 11 9 6 11 14 14 11 13 
Neonatal deaths <28 days# 69 69 50 52 50 58 52 62 59 47 
Perinatal mortalities+ 189 177 165 154 150 155 129 168 142 153 
Perinatal related mortalities^ 209 193 176 163 156 166 143 182 153 166 
Perinatal mortalities excluding lethal and terminated fetal abnormalities• 155 146 119 112 111 127 101 124 115 132 
Perinatal related mortalities excluding lethal and terminated fetal abnormalities• 168 158 127 120 116 135 110 136 125 143 
  
Rate  
2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 
Total births                     
Fetal deaths (terminations of pregnancy and stillbirths)* 8.13 7.25 7.63 6.77 6.95 7.26 6.02 7.81 6.17 7.99 
Terminations of pregnancy 1.68 1.11 1.88 2.07 1.57 1.34 1.32 2.28 1.38 1.41 
Stillbirths 6.44 6.14 5.75 4.70 5.38 5.91 4.70 5.53 4.79 6.58 
Early neonatal deaths <7 days                     
Late neonatal deaths 7–27 days                     
Neonatal deaths <28 days# 4.04 4.06 3.05 3.19 3.30 3.93 3.46 4.07 3.89 3.18 
Perinatal mortalities+       10.97        10.35          9.99          9.40          9.84        10.42          8.53        10.93          9.32        10.27  
Perinatal related mortalities^ 12.13 11.29 10.66 9.94 10.24 11.16 9.46 11.84 10.04 11.14 
Perinatal mortalities excluding lethal and terminated fetal abnormalities• 9.00 8.54 7.20 6.83 7.28 8.53 6.68 8.07 7.54 8.86 
Perinatal related mortalities excluding lethal and terminated fetal abnormalities• 9.75 9.24 7.69 7.32 7.61 9.07 7.28 8.85 8.20 9.60 
* Fetal death rate per 1,000 babies born (includes terminations and stillbirths). 
# Neonatal death rate per 1,000 live born babies. 
+ Fetal deaths and early neonatal deaths per 1,000 babies born. 
^ Fetal deaths and early and late neonatal deaths per 1,000 babies born. 
• Lethal and terminated fetal abnormalities are all perinatal related deaths with Perinatal Society of Australia and New Zealand Perinatal Death Classification (PSANZ-PDC) of congenital anomaly, and neonatal deaths 
with PSANZ Neonatal Death Classification (PSANZ-NDC) of congenital anomaly. 
Sources: Numerator: PMMRC’s perinatal data extract 2009–2018; Denominator: MAT births 2009–2018. 
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Table 3.43: Summary of New Zealand perinatal related mortality rates using New Zealand definition (≥20 weeks or ≥400g if gestation unknown), babies of ngā 
māmā Māori and New Zealand European mothers by year 2009–2018 (continued) 
NZ European 
Maternal prioritised ethnic group: NZ European 
n 
2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 
Total births 26,541 26,105 24,820 24,040 22,895 22,304 21,900 21,379 20,929 20,209 
Fetal deaths (terminations of pregnancy and stillbirths)* 234 201 205 189 179 203 172 168 137 159 
Terminations of pregnancy 69 74 77 66 59 70 58 56 51 54 
Stillbirths 165 127 128 123 120 133 114 112 86 105 
Early neonatal deaths <7 days 43 55 51 47 35 53 41 34 31 47 
Late neonatal deaths 7–27 days 15 15 7 14 16 6 11 5 15 12 
Neonatal deaths <28 days# 58 70 58 61 51 59 52 39 46 59 
Perinatal mortalities+ 277 256 256 236 214 256 213 202 168 206 
Perinatal related mortalities^ 292 271 263 250 230 262 224 207 183 218 
Perinatal mortalities excluding lethal and terminated fetal abnormalities• 191 166 171 166 153 172 146 139 113 138 
Perinatal related mortalities excluding lethal and terminated fetal 
abnormalities• 
202 176 175 173 164 176 150 143 124 146 
  
Rate 
2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 
Total births                     
Fetal deaths (terminations of pregnancy and stillbirths)* 8.82 7.70 8.26 7.86 7.82 9.10 7.85 7.86 6.55 7.87 
Terminations of pregnancy 2.60 2.83 3.10 2.75 2.58 3.14 2.65 2.62 2.44 2.67 
Stillbirths 6.22 4.86 5.16 5.12 5.24 5.96 5.21 5.24 4.11 5.20 
Early neonatal deaths <7 days                     
Late neonatal deaths 7–27 days                     
Neonatal deaths <28 days# 2.20 2.70 2.36 2.56 2.25 2.67 2.39 1.84 2.21 2.94 
Perinatal mortalities+       10.44          9.81        10.31          9.82          9.35        11.48          9.73          9.45          8.03        10.19  
Perinatal related mortalities^ 11.00 10.38 10.60 10.40 10.05 11.75 10.23 9.68 8.74 10.79 
Perinatal mortalities excluding lethal and terminated fetal abnormalities• 7.20 6.36 6.89 6.91 6.68 7.71 6.67 6.50 5.40 6.83 
Perinatal related mortalities excluding lethal and terminated fetal 
abnormalities• 
7.61 6.74 7.05 7.20 7.16 7.89 6.85 6.69 5.92 7.22 
* Fetal death rate per 1,000 babies born (includes terminations and stillbirths). 
# Neonatal death rate per 1,000 live born babies. 
+ Fetal deaths and early neonatal deaths per 1,000 babies born. 
^ Fetal deaths and early and late neonatal deaths per 1,000 babies born. 
• Lethal and terminated fetal abnormalities are all perinatal related deaths with Perinatal Society of Australia and New Zealand Perinatal Death Classification (PSANZ-PDC) of congenital anomaly, and neonatal deaths with PSANZ 
Neonatal Death Classification (PSANZ-NDC) of congenital anomaly. 
Sources: Numerator: PMMRC’s perinatal data extract 2009–2018; Denominator: MAT births 2009–2018. 
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Table 3.44: Perinatal Society of Australia and New Zealand Perinatal Death Classification (PSANZ-PDC) Version 2017 full code list 
1 Congenital anomaly 
1.1 Structural anomaly  
 1.11 Nervous system 
 1.12 Cardiovascular system 
 1.13 Genitourinary system 
 1.14 Gastrointestinal system 
 1.15 Musculoskeletal 
  1.151 Congenital diaphragmatic hernia 
  1.152 Gastroschisis/omphalocele 
 1.16 Respiratory system (includes congenital pulmonary airway malformation (CPAM)) 
 1.17 Haematological 
 1.18 Multiple congenital anomaly (no chromosomal/genetic cause or not tested) 
 1.19 Other congenital anomaly 
  1.192 Idiopathic hydrops fetalis 
  1.193 Fetal tumour (includes sacro-coccygeal teratoma) 
  1.198 Other specified 
  1.199 Congenital anomaly, unspecified 
1.2 Chromosomal anomaly 
 1.21 Trisomy 21 (Down syndrome) 
 1.22 Trisomy 18 (Edward syndrome) and Trisomy 13 (Patau syndrome) 
 1.23 
Other trisomies and partial trisomies of the autosomes, not elsewhere classified (includes 
pathogenic duplications, unbalanced translocations and insertions) 
 1.24 
Monosomies and deletions from the autosomes, not elsewhere classified (includes pathogenic 
deletions, eg, 22q11.2 deletion syndrome (diGeorge syndrome), Wolff-Hirschorn syndrome, 
Cri-du-chat syndrome) 
 1.25 Turner syndrome (monosomy X) 
 1.26 Other sex chromosome abnormalities (eg, Klinefelter syndrome) 
 1.28 Other chromosomal abnormalities, not elsewhere specified (includes triploidy) 
 1.29 Unspecified 
1.3 Genetic condition  
 1.31 
Genetic condition, specified (includes inborn errors of metabolism (eg, Tay-Sachs disease, 
Fragile X syndrome, imprinting syndromes) and other syndromes with demonstrated genetic 
mutations (eg, Kabuki syndrome, Fraser syndrome) 
 1.32 Syndrome/association with demonstrated chromosomal/gene anomaly 
 1.39 Genetic condition, unspecified 
2 Perinatal infection 
2.1 Bacterial 
 2.11 Group B streptococcus 
 2.12 E coli  
 2.13 Listeria monocytogenes 
 2.14 Spirochaetal, eg, syphilis 
 2.18 Other bacterial 
 2.19 Unspecified bacterial 
   
2.2 Viral   
 2.21 Cytomegalovirus 
 2.22 Parvovirus 
 2.23 Herpes simplex virus 





 2.28 Other viral 
 2.29 Unspecified viral 
2.3 Protozoal, eg, toxoplasma 
2.5 Fungal   
2.8 Other specified organism 
2.9 Other unspecified organism or no organism identified 
3 Hypertension  
3.1 Chronic hypertension: essential 
3.2 Chronic hypertension: secondary, eg, renal disease 
3.3 Chronic hypertension: unspecified 
3.4 Gestational hypertension 
3.5 Pre-eclampsia  
3.6 Pre-eclampsia superimposed on chronic hypertension 
3.9 Unspecified hypertension 
4 Antepartum haemorrhage (APH) 
4.1 Placental abruption  
4.2 Placenta praevia  
4.3 Vasa praevia  
4.9 APH of undetermined origin 
5 Maternal conditions 
5.1 Termination of pregnancy for maternal psychosocial indications 
5.2 Diabetes   
 5.21 Gestational diabetes 
 5.22 Pre-existing diabetes 
5.3 Maternal injury  
 5.31 Accidental 
 5.32 Non-accidental 
5.4 Maternal sepsis  
5.5 Antiphospholipid syndrome 
5.6 Obstetric cholestasis 
5.8 Other specified maternal conditions 
 5.81 Maternal suicide 
 5.88 Other specified maternal medical or surgical conditions 
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6 Complications of multiple pregnancy 
6.1 Monochorionic twins 
 6.11 Twin to twin transfusion syndrome (TTTS) 
 6.12 Selective fetal growth restriction (FGR) (ie, affecting only one twin) 
 6.13 Monoamniotic twins (including cord entanglement) 
 6.18 Other  
 6.19 Unknown or unspecified 
6.2 Dichorionic twins  
 6.21 Early fetal death in a multiple pregnancy (<20 weeks’ gestation) 
 6.22 Selective fetal growth restriction (FGR) 
 6.28 Other  
 6.29 Unknown or unspecified 
6.3 Complications of higher order multiples (3 or more fetuses) 
 6.31 Twin to twin transfusion syndrome (TTTS) 
 6.32 Selective fetal growth restriction (FGR) 
 6.33 Monoamniotic multiples (including cord entanglement) 
 6.34 Early fetal death in a multiple pregnancy (<20 weeks’ gestation) 
 6.38 Other  
 6.39 Unknown or unspecified 
6.4 Complications where chorionicity is unknown 
6.8 Other   
6.9 Unspecified  
7 Specific perinatal conditions 
7.1 Fetomaternal haemorrhage 
7.2 Antepartum cord or fetal vessel complications (excludes monochorionic twins or higher order multiples) 
 7.21 Cord vessel haemorrhage 
 7.22 Cord occlusion (true knot with evidence of occlusion or other) 
 7.28 Other cord complications 
 7.29 Unspecified cord complications 
7.3 Uterine abnormalities 
 7.31 Developmental anatomical abnormalities (eg, bicornuate uterus) 
 7.38 Other  
 7.39 Unspecified 
7.4 Alloimmune disease 
 7.41 Rhesus isoimmunisation 
 7.42 Other red cell antibody 
 7.43 Alloimmune thrombocytopenia 
 7.48 Other  
 7.49 Unspecified 
7.5 Fetal antenatal intracranial injury 
 7.51 Subdural haematoma 
 7.52 Fetal antenatal ischaemic brain injury 
 7.53 Fetal antenatal haemorrhagic brain injury 
7.6 Other specific perinatal conditions 
 7.61 Rupture of membranes after amniocentesis 
 7.62 Termination of pregnancy for suspected but unconfirmed congenital anomaly 
 7.63 Amniotic band 
 7.68 Other  
7. 8 Unspecified  
8 Hypoxic peripartum death 
8.1 With intrapartum complications (sentinel events) 
 8.11 Uterine rupture 
 8.12 Cord prolapse 
 8.13 Shoulder dystocia 
 8.14 Complications of breech presentation 
 8.15 Birth trauma 
 8.16 Intrapartum haemorrhage 
 8.18 Other  
8.2 Evidence of significant fetal compromise (excluding other complications) 
8.3 No intrapartum complications and no evidence of significant fetal compromise identified 
8.9 Unspecified hypoxic peripartum death 
9 Placental dysfunction or causative placental pathology 
9.1 Maternal vascular malperfusion 
9.2 Fetal vascular malperfusion 
9.3 High grade villitis of unknown etiology (VUE) 
9.4 Massive perivillous fibrin deposition/maternal floor infarction 
9.5 Severe chronic intervillositis (histiocytic intervillositis) 
9.6 Placental hypoplasia (small for gestation placenta) 
9.7 
No causal placental pathology demonstrated, with antenatal evidence of poor placental function identified 
(such as abnormal fetal umbilical artery Doppler) 
9.8 
Placental pathological examination was not performed, with antenatal evidence of poor placental function 
was identified (such as abnormal fetal umbilical artery Doppler) 
9.9 
Other placental pathology (eg, multiple pathologies with evidence of loss of placental function leading to 
death) 
10 Spontaneous preterm labour or rupture of membranes (<37 weeks’ gestation) 
10.1 Spontaneous preterm 
 10.11 With histological chorioamnionitis 
 10.12 Without histological chorioamnionitis 
 10.13 With clinical evidence of chorioamnionitis, no examination of placenta 
 10.17 No clinical signs of chorioamnionitis, no examination of placenta 
 10.19 Unspecified or not known whether placenta examined 
10.2 Spontaneous preterm preceded by premature cervical shortening 
11 Unexplained antepartum fetal death 
11.1 Unexplained antepartum fetal death despite full investigation 
11.2 Unclassifiable antepartum fetal death with incomplete investigation 
11.3 Unclassifiable antepartum fetal death due to unknown level of investigation 
12 Neonatal death without obstetric antecedent 
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12.1 Neonatal death with no obstetric antecedent factors despite full investigation 
12.2 Neonatal death unclassifiable as to obstetric antecedent with incomplete investigation 
12.3 Neonatal death unclassifiable as to obstetric antecedent due to unknown level of investigation 
Table 3.45: PSANZ Neonatal Death Classification (PSANZ-NDC) Version 2017 full code list 
1 Congenital anomaly 
1.1 Structural anomaly 
 1.11 Nervous system 
 1.12 Cardiovascular system 
 1.13 Genitourinary system 
 1.14 Gastrointestinal system 
 1.15 Musculoskeletal 
  1.151 Congenital diaphragmatic hernia 
  1.152 Gastroschisis/omphalocele 
 1.16 Respiratory system (includes congenital pulmonary airway malformation (CPAM)) 
 1.17 Haematological 
 1.18 Multiple congenital anomaly (no chromosomal/genetic cause or not tested) 
 1.19 Other congenital anomaly 
  1.192 Idiopathic hydrops fetalis 
  1.193 Fetal tumour (includes sacro-coccygeal teratoma) 
  1.198 Other specified 
  1.199 Congenital anomaly, unspecified 
1.2 Chromosomal anomaly 
 1.21 Trisomy 21 (Down syndrome) 
 1.22 Trisomy 18 (Edward syndrome) and Trisomy 13 (Patau syndrome) 
 1.23 
Other trisomies and partial trisomies of the autosomes, not elsewhere classified (includes 
pathogenic duplications, unbalanced translocations and insertions) 
 1.24 
Monosomies and deletions from the autosomes, not elsewhere classified (includes pathogenic 
deletions eg, 22q11.2 deletion syndrome (diGeorge syndrome), Wolff-Hirschorn syndrome, 
Cri-du-chat syndrome) 
 1.25 Turner syndrome (monosomy X) 
 1.26 Other sex chromosome abnormalities (eg, Klinefelter syndrome) 
 1.28 Other chromosomal abnormalities, not elsewhere specified (includes triploidy) 
 1.29 Unspecified 
1.3 Genetic condition 
 1.31 
Genetic condition, specified (includes inborn errors of metabolism (eg, Tay-Sachs disease, 
Fragile X syndrome, imprinting syndromes) and other syndromes with demonstrated genetic 
mutations (eg, Kabuki syndrome, Fraser syndrome) 
 1.32 Syndrome/association with demonstrated chromosomal/gene anomaly 
 1.39 Genetic condition, unspecified 
2  Periviable infants (typically <24 weeks) 
2.1  
Not resuscitated (including infants where there is an antenatal plan for no resuscitation at birth or in the 
circumstance of re-directed care) 
2.2  Unsuccessful resuscitation 
2.9  Unspecified or not known whether resuscitation attempted 
3  Cardio-respiratory disorders 
3.1  Hyaline membrane disease/Respiratory distress syndrome (RDS) 
3.2  Meconium aspiration syndrome 
3.3  Primary persistent pulmonary hypertension 
3.4  Pulmonary hypoplasia 
3.5  Pulmonary haemorrhage 
3.6 Air leak syndromes 
 3.6.1  Pneumothorax 
 3.6.2  Pulmonary interstitial emphysema 
 3.6.3  Other  
3.7  Patent ductus arteriosus 
3.8  Chronic neonatal lung disease (typically, bronchopulmonary dysplasia) 
3.9  Other   
 3.9.1  Neonatal anaemia/hypovolaemia 
4  Neonatal infection 
4.1  Congenital/Perinatal bacterial infection (early onset <48 hrs) 
 4.11  Blood stream infection/septicaemia 
  4.111  Positive culture of a pathogen 
  4.112  Clinical signs of sepsis + ancillary evidence but culture negative 
 4.12  Bacterial meningitis 
 4.13  Bacterial pneumonia 
 4.15  Multiple site bacterial infection 
 4.18  Other congenital bacterial infection eg, gastroenteritis, osteomyelitis, cerebral abscess 
 4.19  Unspecified congenital infection 
4.2  Congenital/Perinatal viral infection 
4.3  Congenital fungal, protozoan, parasitic infection 
4.4  Acquired bacterial infection [late onset >48hrs] 
 4.41  Blood stream infection/septicaemia 
  4.411  Positive culture of a pathogen 
  4.412  Clinical signs of sepsis + ancillary evidence but culture negative 
 4.42  Bacterial meningitis 
 4.43  Bacterial pneumonia 
 4.48  Other acquired bacterial infection eg, gastroenteritis, osteomyelitis 
 4.49  Unspecified acquired infection 
4.5  Acquired viral infection 
4.6  Acquired fungal, protozoan, parasitic infection 
5  Neurological 
5.1  Hypoxic ischaemic encephalopathy/Perinatal asphyxia 
5.2  Cranial haemorrhage 
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 5.21  Intraventricular haemorrhage 
 5.22  Subgaleal haemorrhage 
 5.23  Subarachnoid haemorrhage 
 5.24  Subdural haemorrhage 
 5.28  Other intracranial haemorrhage 
5.3  Post haemorrhagic hydrocephalus 
5.4  Periventricular leukomalacia 
5.8  Other   
6  Gastrointestinal 
6.1  Necrotising enterocolitis (NEC) 
6.2  Short gut syndrome 
6.3  Gastric or intestinal perforation (excluding NEC) 
6.4  Gastrointestinal haemorrhage 
6.8 Other   
7  Other   
7.1  Sudden unexpected death in infancy (SUDI) 
 7.11  Sudden infant death syndrome (SIDS) 
  7.112  SIDS Category IA: Classic features of SIDS present and completely documented 
  7.113  SIDS Category IB: Classic features of SIDS present but incompletely documented 
  7.114  
SIDS Category II: Infant deaths that meet category I except for one or more 
features 
 7.12 Unknown/Undetermined 
 7.13 Unclassified sudden infant death in the neonatal period 
  7.131 Bed sharing/unsafe sleep 
  7.132  Not bed sharing 
7.2  Multisystem failure 
 7.21  Secondary to intrauterine growth restriction 
 7.28  Other specified 
 7.29  Unspecified/undetermined primary cause or trigger event 
7.3  Trauma   
 7.31  Accidental 
 7.32  Non accidental 
 7.39  Unspecified 
7.4  Treatment complications 
 7.41  Surgical 
 7.42  Medical  
7.5  Unsuccessful resuscitation in infants of 28 weeks’ gestation or more without an obvious sentinel event 
7.8  Other specified 
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4 Neonatal encephalopathy | Te māuiui roro i ngā pēpi whānau hou 
Introduction 
Neonatal encephalopathy (NE) is a clinically defined syndrome of disturbed neurological function within the 
first week after birth in an infant born from 35 weeks’ gestation, manifested by difficulty in initiating and 
maintaining respiration, depression of tone and reflexes, subnormal level of consciousness and often 
seizures. The severity of the encephalopathy is measured by the Sarnat stages 1, 2 or 3 or as mild, 
moderate or severe.45  
The PMMRC collects data on babies who present with moderate or severe NE in the first seven days after 
birth. Data have been collected on NE babies from 37 weeks’ gestation onwards since 2010. In 2016, the 
PMMRC started collecting data on babies from 35 weeks’ gestation. Over the period 2010–2018, we have 
collected information on a total of 62046 NE babies, including 17 babies born before 37 weeks’ gestation. 
Due to the small number of cases in 35–36 weeks’ gestation babies collected to date, in this chapter we 
present only data relating to babies born at 37 weeks or later.47 About 67 babies with moderate to severe 
NE in Aotearoa/New Zealand are reported each year to the PMMRC.  
There are a number of risk factors for NE as identified in the peer reviewed literature. These include 
antenatal risk factors, such as maternal diabetes, obesity, thyroid dysfunction, pre-eclampsia and previous 
caesarean section, evidence of fetal growth restriction, abnormal amniotic fluid volume and abnormal fetal 
heart tracing before labour. Intrapartum risk factors include clinical chorioamnionitis and ominous fetal heart 
tracing,48 cord prolapse, placental abruption and uterine rupture.49  (PMMRC 13th report50) 
 
45 Nelson KB, Leviton A. 1991. How much of neonatal encephalopathy is due to birth asphyxia? American Journal of Diseases of 
Children 145(11): 1325–31. 
46 Includes two late notifications. 
47 Information on late notifications is not presented in the remainder of the chapter. 
48 Locatelli A, Incerti M, Paterlini G, et al. 2010. Antepartum and intrapartum risk factors for neonatal encephalopathy at term. 
American Journal of Perinatology 27(8): 649–54. 
49 Martinez-Biarge M, Madero R, González A, et al. 2012. Perinatal morbidity and risk of hypoxic-ischemic encephalopathy 
associated with intrapartum sentinel events. American Journal of Obstetrics & Gynecology 206: 148.e1–7.  
50 PMMRC. 2019. Te Pūrongo ā-Tau Tekau mā Toru o te Komiti Arotake Mate Pēpi, Mate Whaea Hoki | Thirteenth Annual Report 
of the Perinatal and Maternal Mortality Review Committee: Te tuku pūrongo mō te mate me te whakamate 2017 | Reporting 
mortality and morbidity 2017. Wellington: Health Quality & Safety Commission. URL: 
https://www.hqsc.govt.nz/assets/PMMRC/Publications/13thPMMRCreport/13thPMMRCAnnualReportWebFINAL.pdf (accessed 18 
September 2020). p 87.  
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Figure 4.1: NE annual and three-year rolling rates* (per 1,000 term births) 2010–2018 
 
* Rolling three-year mortality rates represented at final year of triennium. 
Sources: Numerator: PMMRC’s NE data extract ≥37 weeks 2010–2018; Denominator: MAT births ≥37 weeks 2010–2018. 
International comparisons 
It is frequently difficult to compare NE rates in New Zealand with those of other countries, due to 
differences in definitions of terms and in inclusion and exclusion criteria, as well as data quality issues. A 
previous meta-analysis estimated the NE incidence in high-income regions to be 1.6 per 1,000 live births.51 
The New Zealand rate of 1.2 per 1,000 live births over the period 2010–2018 is therefore similar to other 
comparable countries. 
Findings 
The number of NE cases ranged from 55 to 82 per year over the period 2010–2018. The rate of NE cases 
per 1,000 term births fluctuated from year to year, with a high of 1.38 per 1,000 live births in 2012 and a low 
of 1.00 in 2014. However, between the years 2010 and 2018, the rate has not shown a statistically 
significant trend either up or down52 (Figure 4.1).  
There was some variation in rates of NE by maternal prioritised ethnic group, with ‘Other European’ and 
‘Other Asian’ mothers having the lowest rates (Figure 4.2 and Table 4.11). 
NE rates varied substantially by NZDep2013 quintile. Babies whose mothers lived in quintiles 2 to 5 were 
statistically significantly more likely to develop NE than those living in quintile 153 (Figure 4.3 and  
Table 4.11). 
 
51 Lee ACC, Kozuki N, Blencowe H, et al, 2013. Intrapartum-related neonatal encephalopathy incidence and impairment at regional 
and global levels for 2010 with trends from 1990. Pediatric Research 74(a1): 50–72. 
52 Chi-squared test for trend=2.74, p=0.10 
53 The rate ratio comparing quintile 2 with quintile 1 was 1.49 (95% CI 1.07–2.09). For quintile 4 compared with quintile 1, the 
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Figure 4.2: NE rates (per 1,000 term births, with 95% CIs) by maternal prioritised ethnic group 2010–2018 
 
MELAA = Middle Eastern, Latin American, or African. 
Sources: Numerator: PMMRC’s NE data extract ≥37 weeks 2010–2018; Denominator: MAT births ≥37 weeks 2010–2018. 
Figure 4.3: NE rates (per 1,000 term births, with 95% CIs) by NZDep quintile 2010–2018 
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NE rates also varied considerably by the DHB in which the mother lived. The rates in most DHBs were not 
statistically significantly different to the national rate of 1.19 per 1,000 term births. However, over the nine-
year reporting period 2010–2018, Waitematā and Auckland DHBs had rates lower than the national 
average, while Capital & Coast and Waikato DHBs had rates higher than the national average (Figure 4.4 
and Table 4.12). Because the frequency of cases was statistically low, it was not possible to identify any 
trends of an increasing or decreasing rate for individual DHBs. In future research, the Neonatal 
Encephalopathy Working Group will compare reporting to the Australian & New Zealand Neonatal Network 
and to PMMRC in terms of establishing mortality and morbidity and frequency of cases.  
Figure 4.4: NE rates (per 1,000 term births, with 95% CIs) by DHB of maternal residence (compared with 
New Zealand NE rate) 2010–2018 
 
Sources: Numerator: PMMRC’s NE data extract ≥37 weeks 2010–2018; Denominator: MAT births ≥37 weeks 2010–2018. 
Rates of NE varied by gestational age, with higher rates in babies at 37 weeks’ and at ≥41 weeks’ gestation 
(Table 4.1 and Figure 4.5). This finding is probably due to a number of different factors, and further case 
review will be required to analyse it in detail. There were no statistically significant differences by the sex of 
the baby. Babies with lower birthweight had higher rates of NE, with those under 2,500g having the highest 
rate. Babies who were multiples had an incidence rate nearly double that of singletons. However, this was 
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Figure 4.5: NE rates (per 1,000 term births) by gestational age at birth (≥37 weeks) 2010–2018 
 
Sources: Numerator: PMMRC’s NE data extract ≥37 weeks 2010–2018; Denominator: MAT births ≥37 weeks 2010–2018. 






(per 1,000 term births) 
N=503,656 n=601  
n % n % /1,000 95% CI 
Gestational age at birth (weeks)       
37 35,491 7.0 67 11.1 1.89 1.46–2.40 
38 88,998 17.7 95 15.8 1.07 0.86–1.30 
39 145,397 28.9 137 22.8 0.94 0.78–1.10 
40 148,051 29.4 151 25.1 1.02 0.86–1.18 
41 74,918 14.9 135 22.5 1.80 1.50–2.11 
≥42 10,801 2.1 16 2.7 1.48 0.85–2.41 
Sex       
Male 257,490 51.1 323 53.7 1.25 1.12–1.39 
Female 246,150 48.9 278 46.3 1.13 1.00–1.26 
Undetermined/unknown 16 0.0 - - - - 
Birthweight (g)       
<2,500 9,340 1.9 23 3.8 2.46 1.56–3.69 
2,500–3,999 396,867 78.8 498 82.9 1.25 1.14–1.37 
4,000–4,499 62,134 12.3 58 9.7 0.93 0.71–1.21 
≥4,500 12,576 2.5 22 3.7 1.75 1.10–2.65 
Unknown 22,739 4.5 - - - - 
Plurality       
Singleton 495,598 98.4 589 98.0 1.19 1.09–1.28 
Multiple 5,932 1.2 12 2.0 2.02 1.05–3.53 
Unknown 2,126 0.4 - - - - 
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Babies of primiparous women (women having their first baby after 20 weeks’ gestation, also referred to as 
‘parity 0’) had the highest rates of NE, which were statistically significantly higher than babies of 
multiparous women regardless of parity (Figure 4.6). The rate ratio for NE in babies of primiparous 
compared with multiparous women was 2.20 (95% CI 1.85–2.62). While women having their first baby 
make up 41% of the birthing population, they gave birth to 60% of babies with NE (Table 4.2 and  
Figure 4.6). 
Figure 4.6: NE rates (per 1,000 term births) by parity prior to index birth* 2010–2018 
 
* All data limited to mothers who were registered for care with an LMC (a midwife, obstetrician or GP) claiming from the Section 88 
Primary Maternity Services Notice. 
Parity ‘0’ indicates women having their first baby/babies of 20 weeks’ or greater gestation. 
Sources: Numerator: PMMRC’s NE data extract where matched to MAT data, ≥37 weeks 2010–2018; Denominator: MAT births 
≥37 weeks 2010–2018. 
In analyses by both parity and gestational age, the same patterns remained. Rates of NE were higher in 
babies born at 37 and 41 weeks’ gestation. Rates were elevated in primiparous women, regardless of 
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Figure 4.7: NE rates (per 1,000 term births) by parity and gestational age* 2010–2018 
 
* All data limited to mothers who were registered for care with an LMC (a midwife, obstetrician or GP) claiming from the Section 88 
Primary Maternity Services Notice. Excludes gestational age at birth greater than 41 weeks with fewer than three cases among 
parity ≥1.  
Sources: Numerator: PMMRC’s NE data extract where matched to MAT data, ≥37 weeks 2010–2018; Denominator: MAT births 
≥37 weeks 2010–2018. 
During the study period, NE rates did not differ between babies of mothers who smoked and those who did 
not smoke. However, smoking is a risk factor for late stillbirth54 and small for gestational age.55 NE rates 
were statistically significantly higher in babies of women who had a BMI of 35 or greater, compared with 
women with a BMI of less than 25. This finding supports the Ministry of Health’s Guidelines for Consultation 
with Obstetric and Related Medical Services (Referral Guidelines), which state that LMCs of all women with 
a BMI of 35 or greater should recommend that they have an obstetric consultation.56  
NE rates did not vary significantly by gestational age at first antenatal visit. Note, however, that 35% of 
mothers whose babies developed NE did not have antenatal care in the first trimester. This was similar to 
the percentage of all mothers who did not register with an LMC in the first trimester (32%). The PMMRC 
has previously recommended that the Ministry of Health, DHBs and professional colleges explore barriers 
to early registering with a view to increasing the number of women who register with an LMC before 10 
weeks’ gestation. This issue requires ongoing consideration and action. Consistent with the international 
literature, babies who were small for gestational age were nearly twice as likely to have moderate to severe 
NE compared with babies who were appropriate size for gestational age.57  
 
54 Cronin RS, Li M, Thompson JMD, et al. 2019. An individual participant data meta-analysis of maternal going-to-sleep position, 
interactions with fetal vulnerability, and the risk of late stillbirth. The Lancet 10: 49–57. doi: 10.1016/j.eclinm.2019.03.014 (accessed 
15 August 2019).  
55 McCowan L, Horgan RP. 2009. Risk factors for small for gestational age infants. Best Practice & Research: Clinical Obstetrics & 
Gynaecology 23(6): 779–93. 
56 Ministry of Health. 2012. Guidelines for Consultation with Obstetric and Related Medical Services (Referral Guidelines). 
Wellington: Ministry of Health. 
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As part of its NE prevention programme, the Accident Compensation Corporation (ACC) has funded the 
implementation of the Growth Assessment Protocol (GAP) in DHBs, which continues to be rolled out 
nation-wide. The Neonatal Encephalopathy Working Group has previously commended ACC on its action 
on this important issue and anticipates that an evaluation of the effectiveness of this programme will follow 
once it has been established throughout Aotearoa/New Zealand. 
Table 4.2: Maternal smoking, BMI, gestational age at first antenatal visit, customised birthweight centiles 






(per 1,000 term births) 
N=453,883 n=525  
n % n % /1,000 95% CI 
Currently smoking       
Yes 63,671 14.0 74 14.1 1.16 0.91–1.46 
No 390,187 86.0 451 85.9 1.16 1.05–1.26 
Unknown 25 0.0 - - - - 
Maternal BMI (kg/m2)        
<18.5 12,591 2.8 7 1.3 0.56 0.22–1.15 
18.5–24.9 220,333 48.5 210 40.0 0.95 0.82–1.08 
25.0–29.9 117,589 25.9 149 28.4 1.27 1.06–1.47 
30.0–34.9 59,965 13.2 84 16.0 1.40 1.12–1.73 
35.0–39.9 27,192 6.0 47 9.0 1.73 1.27–2.30 
≥40.0 15,521 3.4 28 5.3 1.80 1.20–2.61 
Missing data for height and/or weight 692 0.2 - - - - 
Gestational age first antenatal visit (weeks)       
≤14 306,737 67.6 342 65.1 1.11 1.00–1.23 
15–27 125,943 27.7 158 30.1 1.25 1.06–1.45 
≥28 18,944 4.2 23 4.4 1.21 0.77–1.82 
Postnatal registration 2,249 0.5 <3 x s s 
Unknown 10 0.0 - - - - 
Customised birthweight centiles       
Small for gestational age 41,461 9.1 84 16.0 2.03 1.62–2.51 
Appropriate for gestational age 335,977 74.0 373 71.0 1.11 1.00–1.22 
Large for gestational age 53,681 11.8 68 13.0 1.27 0.98–1.61 
Unknown 22,764 5.0 - - - - 
Parity       
0 184,917 40.7 316 60.2 1.71 1.52–1.90 
1 154,399 34.0 119 22.7 0.77 0.63–0.91 
2 67,771 14.9 50 9.5 0.74 0.55–0.97 
3 26,083 5.7 24 4.6 0.92 0.59–1.37 
≥4 20,683 4.6 16 3.0 0.77 0.44–1.26 
Unknown 30 0.0 - - - - 
* All data limited to mothers who were registered for care with an LMC (a midwife, obstetrician or GP) claiming from the Section 88 
Primary Maternity Services Notice. 
‘x’ indicates percentage suppressed due to small numbers. 
‘s’ indicates rate suppressed due to small numbers. 
BMI = body mass index. 
Sources: Numerator: PMMRC’s NE data extract where matched to MAT data, ≥37 weeks 2010–2018; Denominator: MAT births 
≥37 weeks 2010–2018. 
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Women whose babies developed NE had a range of antenatal complications recorded, such as antepartum 
haemorrhage and hypertension, including gestational hypertension and pre-eclampsia. Both primiparous 
and multiparous mothers of babies with NE experienced antenatal complications. The percentages of those 
affected generally followed patterns that would be expected from the birthing population – that is, the 
numbers of multiparous women with pre-eclampsia were lower than they were for primiparous women. A 
number of women were induced through a variety of means and had epidural anaesthesia. Without 
denominator data – that is, without knowing the rates and use of these procedures during delivery of babies 
that did not have NE – we cannot comment on whether these factors indicated increased risk to babies. Of 
women whose babies developed NE, most did not themselves have significant adverse maternal 
outcomes. However, a number experienced an adverse outcome. Of those with an adverse outcome, 4 
women died and 17 survived but with serious morbidity (Table 4.3). 
Table 4.3: Antenatal complications, obstetric interventions, and maternal outcome among NE cases by 
parity and Sarnat stage 2010–2018 
  
NE cases Primiparous# Multiparous† 
Sarnat stage 
Moderate Severe 
n=601 n=351 n=248 n=413 n=188 
n % n % n % n % n % 
Antenatal complications           
Antepartum haemorrhage 
 (≥20 weeks vaginal bleeding) 
60 10.0 33 9.4 27 10.9 39 9.4 21 11.2 
Hypertension 75 12.5 54 15.4 21 8.5 56 13.6 19 10.1 
Maternal trauma (antenatal)* 12 2.0 5 1.4 7 2.8 6 1.5 6 3.2 
Induction/augmentation of labour           
Induction of labour 146 24.3 96 27.4 50 20.2 108 26.2 38 20.2 
Induced or augmented labour (any method) 278 46.3 191 54.4 87 35.1 208 50.4 70 37.2 
Oxytocin for induction or augmentation 135 22.5 99 28.2 36 14.5 105 25.4 30 16.0 
Epidural anaesthesia  150 25.0 111 31.6 39 15.7 120 29.1 30 16.0 
Maternal outcome           
Deceased, or alive with serious morbidity 21 3.5 8 2.3 13 5.2 12 2.9 9 4.8 
Alive and well 580 96.5 343 97.7 235 94.8 401 97.1 179 95.2 
* Vehicular, violent personal injury, other. 
# Primiparous: parity = 0 defined prior to current birth. 
† Multiparous: parity ≥1 defined prior to current birth. 
Source: PMMRC’s NE data extract ≥37 weeks 2010–2018. 
Around one quarter of babies with NE had an acute peripartum event, including abruption (7.8%) and 
shoulder dystocia (7.0%). Table 4.4 points to many antenatal and intrapartum factors that may indicate  
risk for NE for the babies. This table is not definitive in itself but indicates possible areas to focus on in  
the future. 
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Table 4.4: Peripartum complications and mode of birth among NE cases 2010–2018 
  
Total NE cases 
n=601 
n % 
Acute peripartum events 154 25.6 
Cord prolapse 24 4.0 
Abruption 47 7.8 
Uterine rupture 12 2.0 
Shoulder dystocia 42 7.0 
Breech complication 15 2.5 
Other complication 23 3.8 
Liquor   
Blood stained 49 8.2 
Thick meconium 136 22.6 
Thin meconium 80 13.3 
MODE OF BIRTH   
Normal vaginal birth 236 39.3 
Operative vaginal birth  94 15.6 
Forceps 38 6.3 
Ventouse 54 9.0 
Unknown <3 x 
Vaginal breech birth   12 2.0 
Caesarean section birth 259 43.1 
Elective 11 1.8 
Prelabour emergency 63 10.5 
Antepartum haemorrhage/Abruption 9 1.5 
Suspected fetal distress 47 7.8 
Other 7 1.2 
In labour emergency 185 30.8 
Antepartum haemorrhage/Abruption 15 2.5 
Suspected fetal distress 126 21.0 
Failure to progress/cephalopelvic disproportion 18 3.0 
Other 26 4.3 
Attempt at operative vaginal birth before caesarean 17 2.8 
‘x’ indicates percentage suppressed due to small numbers. 
Source: PMMRC’s NE data extract ≥37 weeks 2010–2018. 
Rates of NE varied somewhat by the facility of birth (Figure 4.8 and Table 4.5). When examining rates of 
NE by the facility of birth, it is important to consider other information also. This includes where the intended 
place of birth was and, if transferred, the stage in the pregnancy or birthing process that the transfer 
occurred. Also important is whether the chosen facility of birth would be recommended for each particular 
woman and baby. This is the subject of a proposed research project by the Neonatal Encephalopathy 
Working Group. 
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Figure 4.8: NE rates (per 1,000 term births, with 95% CIs) by place of birth* 2010–2018 
 
* All data limited to mothers who were registered for care with an LMC (a midwife, obstetrician or GP) claiming from the Section 88 
Primary Maternity Services Notice. 
Sources: Numerator: PMMRC’s NE data extract where matched to MAT data, ≥37 weeks 2010–2018; Denominator: MAT births 
≥37 weeks 2010–2018. 
Table 4.5: NE rates (per 1,000 term births) by place of birth* 2010–2018 
Facility of birth 
MAT births 
≥37 weeks 
NE cases Rate 
(per 1,000 term births) 
N=453,883 n=525 
n % n % /1,000 95% CI 
Home 17,212 3.8 19 3.6 1.10 0.66–1.72 
Primary 49,018 10.8 41 7.8 0.84 0.60–1.13 
Secondary 194,702 42.9 242 46.1 1.24 1.09–1.40 
Tertiary 188,839 41.6 218 41.5 1.15 1.00–1.31 
Unknown 4,112 0.9 5 1.0 - - 
* All data limited to mothers who were registered for care with an LMC (a midwife, obstetrician or GP) claiming from the Section 88 
Primary Maternity Services Notice. 
Sources: Numerator: PMMRC’s NE data extract where matched to MAT data, ≥37 weeks 2010–2018; Denominator: MAT births 
≥37 weeks 2010–2018. 
Neonatal wellbeing just after birth, measured by Apgar scores, was consistently poor at one minute. In 
those babies with moderate to severe NE, 76.5% had an Apgar score less than 7 at five minutes. The 
percentage of babies who had cord blood gases recorded has fluctuated over the years. Overall across 
2010–2018, around 18% of babies with NE did not have cord blood gases recorded. Of all babies who 
developed NE, 66% had abnormal gases, whereas 15% of babies with clinically significant NE had normal 
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Table 4.6: Immediate newborn wellbeing among NE babies by year 2010–2018 
  
2010 2011 2012 2013 2014 2015 2016 2017 2018 Total 
n=82 n=67 n=79 n=70 n=55 n=70 n=56 n=63 n=59 n=601 
n % n % n % n % n % n % n % n % n % n % 
Apgar scores                     
Apgar score <3 at 1 minute 48 58.5 41 61.2 47 59.5 40 57.1 37 67.3 39 55.7 37 66.1 36 57.1 39 66.1 364 60.6 
Apgar score <5 at 1 minute 65 79.3 54 80.6 62 78.5 58 82.9 49 89.1 51 72.9 48 85.7 50 79.4 51 86.4 488 81.2 
Apgar score <7 at 1 minute 73 89.0 61 91.0 70 88.6 65 92.9 53 96.4 59 84.3 51 91.1 56 88.9 55 93.2 543 90.3 
Apgar score <7 at 5 minutes 61 74.4 54 80.6 62 78.5 57 81.4 43 78.2 50 71.4 46 82.1 42 66.7 45 76.3 460 76.5 
Apgar score <7 at 10 minutes 39 47.6 38 56.7 49 62.0 32 45.7 29 52.7 35 50.0 33 58.9 29 46.0 34 57.6 318 52.9 
Apgar score <9 at 10 minutes 52 63.4 52 77.6 62 78.5 52 74.3 45 81.8 48 68.6 44 78.6 41 65.1 46 78.0 442 73.5 
Cord blood gases: summary data                     
Normal (none of pH ≤7, BE ≤−12, lactate ≥6) 12 14.6 14 20.9 11 13.9 13 18.6 7 12.7 8 11.4 6 10.7 10 15.9 10 16.9 91 15.1 
Abnormal (any of pH ≤7, BE ≤−12, lactate ≥6) 47 57.3 41 61.2 55 69.6 48 68.6 40 72.7 47 67.1 42 75.0 39 61.9 41 69.5 400 66.6 
No gases reported 23 28.0 12 17.9 13 16.5 9 12.9 8 14.5 15 21.4 8 14.3 14 22.2 8 13.6 110 18.3 
No gases and Apgar <7 at 1 minute 14 17.1 8 11.9 8 10.1 6 8.6 8 14.5 6 8.6 6 10.7 10 15.9 7 11.9 73 12.1 
No gases and Apgar ≥7 at 1 minute 8 9.8 4 6.0 5 6.3 3 4.3 - - 9 12.9 <3 x 3 4.8 <3 x 35 5.8 
No gases and unknown Apgar <3 x - - - - - - - - - - - - <3 x - - <3 x 
BE = base excess. 
‘x’ indicates percentage suppressed due to small numbers. 
Source: PMMRC’s NE data extract ≥37 weeks 2010–2018. 
Table 4.7: Induced cooling therapy among NE babies by year 2010–2018 
Cooling 
2010 2011 2012 2013 2014 2015 2016 2017 2018 Total 
n=82 n=67 n=79 n=70 n=55 n=70 n=56 n=63 n=59 n=601 
n % n % n % n % n % n % n % n % n % n % 
Yes 56 68.3 51 76.1 62 78.5 58 82.9 45 81.8 56 80.0 44 78.6 43 68.3 45 76.3 460 76.5 
No 26 31.7 16 23.9 17 21.5 12 17.1 10 18.2 14 20.0 12 21.4 20 31.7 14 23.7 141 23.5 
Age at cooling           
≤6 hours 46 82.1 39 76.5 53 85.5 47 81.0 39 86.7 44 78.6 34 77.3 36 83.7 32 71.1 370 80.4 
>6 hours 10 17.9 8 15.7 9 14.5 11 19.0 6 13.3 11 19.6 10 22.7 7 16.3 12 26.7 84 18.3 
Unknown time - - 4 7.8 - - - - - - <3 x - - - - <3 x 6 1.3 
‘x’ indicates percentage suppressed due to small numbers. 
Source: PMMRC’s NE data extract ≥37 weeks 2010–2018. 
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Table 4.7 reports on cooling therapy in babies with NE by year of birth. While the number and percentage 
of babies who were cooled in 2017 decreased slightly, the percentage of babies cooled in 2018 is 
comparable with previous years.  
The majority of babies with NE were resuscitated at birth (93%). Resuscitation ranged from giving oxygen 
only, through to cardiac massage, and adrenaline. A small percentage of babies had a positive blood 
culture. Around 75% of babies were given anticonvulsants (Table 4.8). 






n=601 n=413 n=188 
n % n % n % 
Resuscitation at birth       
Yes 555 92.3 380 92.0 175 93.1 
No 46 7.7 33 8.0 13 6.9 
Type of resuscitation at birth*       
Oxygen only 9 1.5 8 1.9 <3 x 
IPPV with mask 402 66.9 287 69.5 115 61.2 
IPPV with ETT 310 51.6 177 42.9 133 70.7 
Cardiac massage 237 39.4 123 29.8 114 60.6 
Adrenaline 96 16.0 33 8.0 63 33.5 
Respiratory and ventilation management       
Mechanical ventilation 465 77.4 298 72.2 167 88.8 
Nitric oxide 141 23.5 87 21.1 54 28.7 
Infection       
Positive blood culture 23 3.8 18 4.4 5 2.7 
Antibiotics 544 90.5 386 93.5 158 84.0 
Anticonvulsant therapy 427 71.0 286 69.2 141 75.0 
Phenobarbitone 380 63.2 248 60.0 132 70.2 
Phenytoin 128 21.3 67 16.2 61 32.4 
Benzodiazepines 156 26.0 96 23.2 60 31.9 
Other 98 16.3 67 16.2 31 16.5 
* Categories not mutually exclusive. 
IPPV = intermittent positive pressure ventilation. 
ETT = endotracheal tube. 
‘x’ indicates percentage supressed due to small numbers. 
Source: PMMRC’s NE data extract ≥37 weeks 2010–2018. 
Overall, 77% of babies were cooled; the proportion was slightly higher for babies with moderate NE. The 
rates of cooling were the same for babies of Māori mothers as for those of New Zealand European 
mothers. Mortality was much higher in babies with severe NE at 60%, compared with 2% of babies with 
moderate NE (Table 4.9). 





n=601 n=413 n=188 
n % n % n % 
Induced cooling       
Yes 460 76.5 330 79.9 130 69.1 
No 141 23.5 83 20.1 58 30.9 
Deceased       
Yes 120 20.0 7 1.7 113 60.1 
No 481 80.0 406 98.3 75 39.9 
Source: PMMRC’s NE data extract ≥37 weeks 2010–2018. 
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Of those babies with NE who survived, nearly half of those with moderate NE had a normal physical 
examination on discharge or transfer, compared with 16% of those with severe NE. Nearly all babies (97%) 
with severe NE had magnetic resonance imaging (MRI) prior to discharge (Table 4.10). The PMMRC has 
previously recommended that all babies with moderate and severe NE should receive an MRI scan.58  






n=481 n=406 n=75 
n % n % n % 
Examination on discharge/transfer       
Normal 210 43.7 198 48.8 12 16.0 
Mild or moderate abnormality 171 35.6 142 35.0 29 38.7 
Severe abnormality 35 7.3 9 2.2 26 34.7 
Not examined 24 5.0 21 5.2 3 4.0 
Examined but finding unknown 19 4.0 15 3.7 4 5.3 
Missing data 22 4.6 21 5.2 <3 x 
MRI (investigation done) 375 78.0 302 74.4 73 97.3 
No MRI or Unknown 106 22.0 104 25.6 <3 x 
Results of MRI*       
Moderately/Severely abnormal 141 29.3 93 22.9 48 64.0 
Normal or only mildly abnormal 226 47.0 202 49.8 24 32.0 
Unknown result 8 1.7 7 1.7 <3 x 
MRI = magnetic resonance imaging (of the brain). 
‘x’ indicates percentage suppressed due to small numbers. 
Source: PMMRC’s NE data extract ≥37 weeks 2010–2018. 
 
 
58 PMMRC. 2013. Seventh Annual Report of the Perinatal and Maternal Mortality Review Committee: Reporting mortality 2011. 
Wellington: Health Safety & Quality Commission. URL: https://www.hqsc.govt.nz/assets/PMMRC/Publications/Seventh-PMMRC-
Report-FINAL-June-2013.pdf (accessed 1 December 2020). 
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Neonatal encephalopathy appended tables 







(per 1,000 term births) 
N=503,656* N=601  
n % n % /1,000 95% CI 
Maternal prioritised ethnic group 
Māori 126,555 25.1 158 26.3 1.25 1.05–1.44 
Pacific peoples 54,010 10.7 79 13.1 1.46 1.16–1.82 
Asian 75,276 14.9 77 12.8 1.02 0.81–1.28 
Indian 24,092 4.8 33 5.5 1.37 0.94–1.92 
Other Asian 51,184 10.2 44 7.3 0.86 0.62–1.15 
MELAA 11,354 2.3 10 1.7 0.88 0.42–1.62 
European 236,438 46.9 277 46.1 1.17 1.03–1.31 
NZ European 187,282 37.2 243 40.4 1.30 1.13–1.46 
Other European 49,156 9.8 34 5.7 0.69 0.48–0.97 
Other - - - - - - 
Maternal age (years) 
<20 25,988 5.2 35 5.8 1.35 0.94–1.87 
20–34 372,119 73.9 452 75.2 1.21 1.10–1.33 
35–39 85,188 16.9 92 15.3 1.08 0.87–1.32 
≥40 20,336 4.0 22 3.7 1.08 0.68–1.64 
Unknown 25 0.0 - - - - 
Deprivation quintile 
1 (least deprived) 72,204 14.3 55 9.2 0.76 0.57–0.99 
2 79,159 15.7 90 15.0 1.14 0.91–1.40 
3 91,958 18.3 111 18.5 1.21 0.98–1.43 
4 114,448 22.7 154 25.6 1.35 1.13–1.56 
5 (most deprived) 142,576 28.3 191 31.8 1.34 1.15–1.53 
Unknown 3,311 0.7 - - - - 
* Includes 23 unknown maternal ethnicity among MAT births. 
MELAA = Middle Eastern, Latin American, or African. 
Sources: Numerator: PMMRC’s NE data extract ≥37 weeks 2010–2018; Denominator: MAT births ≥37 weeks 2010–2018. 
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Table 4.12: NE rates (per 1,000 term births) by DHB of maternal residence 2010–2018 




NE cases Rate 
(per 1,000 term births) 
N=503,656 n=601 
n n /1,000 95% CI 
Northland 18,812 21 1.12 0.69–1.71 
Waitematā 65,356 59 0.90 0.69–1.16 
Auckland 51,711 45 0.87 0.63–1.16 
Counties Manukau 69,577 75 1.08 0.85–1.35 
Waikato 44,557 71 1.59 1.24–2.01 
Bay of Plenty 24,272 33 1.36 0.94–1.91 
Lakes 12,698 17 1.34 0.78–2.14 
Hauora Tairāwhiti 6,023 9 1.49 0.68–2.84 
Taranaki 12,692 22 1.73 1.09–2.62 
Hawke's Bay 17,749 25 1.41 0.91–2.08 
Whanganui 6,944 14 2.02 1.10–3.38 
MidCentral 17,877 21 1.17 0.73–1.80 
Wairarapa 4,201 3 0.71 0.15–2.09 
Capital & Coast 30,161 52 1.72 1.29–2.26 
Hutt Valley 16,375 22 1.34 0.84–2.03 
Nelson Marlborough 12,801 18 1.41 0.83–2.22 
West Coast 3,046 6 1.97 0.72–4.29 
Canterbury 51,579 50 0.97 0.72–1.28 
South Canterbury 5,363 11 2.05 1.02–3.67 
Southern 28,800 27 0.94 0.62–1.36 
Other* 3,062 - - - 
* Other includes Overseas, Unknown and Other. 
Sources: Numerator: PMMRC’s NE data extract ≥37 weeks 2010–2018; Denominator: MAT births ≥37 weeks 2010–2018. 
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5 Maternal mortality | Te mate o ngā whaea 
Definitions 
Maternal death is the death of a woman while pregnant or within 42 days of termination of pregnancy 
(miscarriage, termination or birth), irrespective of the duration and site of the pregnancy, from any cause 
related to or aggravated by the pregnancy or its management, but not from accidental or incidental 
causes.59   
The cause of maternal death is sub-classified into the following categories based on The WHO 
Application of ICD-10 to Deaths during Pregnancy, Childbirth and Puerperium: ICD-MM.60 
• Direct maternal deaths: those resulting from obstetric complications of the pregnant state 
(pregnancy, labour or puerperium) from interventions, omissions, incorrect treatment or from a chain 
of events resulting from the above. In 2018, the PMMRC adopted the World Health Organization 
(WHO) revision to include deaths by suicide with direct maternal deaths. We then applied it 
retrospectively to data from previous years.  
• Indirect maternal deaths: those resulting from previous existing disease or disease that developed 
during pregnancy and was not due to direct obstetric causes but that was aggravated by the 
physiologic effects of pregnancy.  
• Unknown/Undetermined (or Unclassifiable) maternal death is a death during pregnancy, 
childbirth and the puerperium where the underlying cause is unknown or was not determined.  
• Coincidental maternal deaths: deaths from unrelated causes that happen to occur in pregnancy or 
the puerperium. 
Over the period 2006–2018, the PMMRC has collected information on a total of 154 maternal deaths during 
pregnancy or within 42 days postpartum, including 28 coincidental deaths. Unless stated otherwise, this 
analysis excludes data relating to coincidental maternal deaths.  
Findings 
The number of maternal deaths has varied substantially over the period 2006–2018. The annual maternal 
mortality ratio has fluctuated from being too small to meaningfully calculate61 up to 24.4 deaths per 100,000 
maternities. Although the trend is not statistically significant, the total number of maternal deaths followed a 
general downward pattern over the period (Figure 5.1 and Table 5.1). 
 
 
59 World Health Organization. nd. Number of maternal deaths. URL: https://www.who.int/data/gho/data/indicators/indicator-
details/GHO/number-of-maternal-deaths (accessed 15 December 2020). 
60 World Health Organization. 2012. The WHO Application of ICD-10 to Deaths during Pregnancy, Childbirth and the Puerperium: 
ICD-MM. Geneva: World Health Organization. URL: 
https://apps.who.int/iris/bitstream/handle/10665/70929/9789241548458_eng.pdf;jsessionid=CC029155D5B4A0E7BB4AE0129A0A
6CEB?sequence=1 (accessed 1 December 2020). 
61 Where the numerator is fewer than three deaths. 
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Figure 5.1: Maternal mortality ratios (per 100,000 maternities) (rolling one-year and three-year)* 2006–2018 
 
Note: the number of deaths in 2016 was too small to calculate a reliable rate for this year. 
* Rolling three-year maternal mortality ratio represented at final year of triennium. 
MMR = maternal mortality ratio. 
Sources: Numerator: PMMRC’s maternal mortality data extract 2006–2018; Denominator: MAT data 2006–2018. 
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Table 5.1: Single-year and three-year rolling maternal mortality ratios (per 100,000 maternities) 2006–2018 
 
2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2006–2018 
Chi-squared test 
for trend (p) 
             Cause specific ratio 
n n n n n n n n n n n n n /100,000 maternities 
Total maternal deaths 15 11 9 14 9 9 10 13 4 11 <3 9 10 15.56 
0.097 
Single-year MMR 24.40 16.87 13.71 21.47 13.75 14.23 15.80 21.62 6.66 18.40 s 14.88 16.88 - 
Three-year rolling MMR 
- - 06–08 07–09 08–10 09–11 10–12 11–13 12–14 13–15 14–16 15–17 16–18 - 
  18.20 17.34 16.30 16.50 14.59 17.14 14.71 15.56 9.42 12.16 11.64 - 
MMR = maternal mortality ratio. 
‘s’ indicates rate not calculated due to small numbers. 
Sources: Numerator: PMMRC’s maternal mortality data extract 2006–2018; Denominator: MAT data 2006–2018. 
Substantial gains have been made in lowering the rate of maternal death since the 1970s. Figure 5.2 shows the maternal mortality ratio over time, and by the 
different data sources that were available at various time periods. As well as demonstrating an overall reduction in deaths over time, this figure shows that in 
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Figure 5.2: New Zealand maternal mortality ratio (per 100,000 maternities) by mortality data source  
1973–2018 
 
MMR = maternal mortality ratio. 
MDAC = Maternal Deaths Assessment Committee. 
Sources:  
MMR: MDAC: Data from the MDAC, including maternal deaths to three months postpartum. 
MMR: routine sources: Data from routine New Zealand data sets (ie, the Births, Deaths and Marriages (BDM) Mortality Collection 
and the National Minimum Dataset), including maternal deaths to six weeks postpartum. 
MMR: PMMRC: PMMRC’s maternal mortality data extract 2006–2018, including maternal deaths to six weeks postpartum; 
Denominator: MAT data 2006–2018. 
The incidence of maternal death increased with age, with those aged 40 years and over having the highest 
rate (39.2 per 100,000 maternities). In an analysis by prioritised ethnic group, Māori and Pacific women had 
the highest rates, with 23.5 and 22.2 deaths per 100,000 maternities respectively. The mortality rate for 
wāhine Māori was statistically significantly higher than the rate for New Zealand European women (Table 
5.2). 
Our analysis also examined the rate of maternal deaths by NZDep2013 quintile. There was a general 
pattern of increasing mortality with increasing deprivation. However, this was not statistically significant 
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Table 5.2: Demographic characteristics among maternal deaths 2006–2018 
  




95% CI RR 95% CI 
n % n % 
/100,000 
maternities 
Maternal age (years)         
<20 48,848 6.0 6 4.8 12.28 4.51–26.73 0.94 0.39–2.25 
20–24 141,745 17.5 17 13.5 11.99 6.99–19.20 0.92 0.51–1.65 
25–29 208,859 25.8 33 26.2 15.80 10.88–22.19 1.21 0.74–1.97 
30–34 236,748 29.2 31 24.6 13.09 8.90–18.59 1.00 - 
35–39 140,187 17.3 26 20.6 18.55 12.12–27.18 1.42 0.84–2.39 
≥40 33,156 4.1 13 10.3 39.21 20.88–67.05 2.99 1.57–5.72 
Unknown 288 0.0 - - - - - - 
Maternal prioritised ethnic group        
Māori 208,724 25.8 49 38.9 23.48 17.37–31.04 1.78 1.18–2.70 
Pacific peoples 89,964 11.1 20 15.9 22.23 13.58–34.33 1.69 0.99–2.88 
Asian 105,481 13.0 13 10.3 12.32 6.56–21.08   
Indian 33,922 4.2 5 4.0 14.74 4.79–34.40 1.12 0.44–2.83 
Other Asian 71,559 8.8 8 6.3 11.18 4.83–22.03 0.85 0.40–1.81 
MELAA 16,656 2.1 - - - - - - 
European 388,512 48.0 44 34.9 11.33 8.23–15.20   
NZ European 310,878 38.4 41 32.5 13.19 9.46–17.89 1.00 - 
Other European 77,634 9.6 3 2.4 3.86 0.80–11.29 0.29 0.09–0.95 
Other - - - - - - - - 
Unknown 494 0.1 - - - - - - 
Deprivation quintile         
1 (least deprived) 114,222 14.1 12 9.5 10.51 5.43–18.35 1.00 - 
2 123,856 15.3 12 9.5 9.69 5.01–16.92 0.92 0.41–2.05 
3 146,518 18.1 23 18.3 15.70 9.95–23.55 1.49 0.74–3.00 
4 185,680 22.9 35 27.8 18.85 13.13–26.22 1.79 0.93–3.46 
5 (most deprived) 232,068 28.7 44 34.9 18.96 13.78–25.45 1.80 0.95–3.42 
Unknown 7,487 0.9 - - - - - - 
MELAA = Middle Eastern, Latin American, or African. 
Sources: Numerator: PMMRC’s maternal mortality data extract 2006–2018; Denominator: MAT data 2006–2018. 
Parity was unknown in 66,000 women over this period, therefore it is not possible to comment on how 
parity might be associated with maternal death (Table 5.3). This gap is largely due to a technical issue in 
the MAT data set. While the Ministry of Health is working to rectify this issue, it still requires urgent 
resolution.  
The literature recognises that high maternal BMI is associated with adverse outcomes for both the mother62 
and baby.63 However, again our records have substantial amounts of missing data. In nearly 169,000 
records (21%) for the entire period, either height or weight data were incomplete or inaccurately recorded. 
The proportion of records with missing height or weight data did decrease over time, from over 85% in 2006 
and 2007 down to 3.6% in 2014. However, since then the proportion of records with incomplete or 
inaccurate height and weight information has remained at around 5%. This is of concern given the 
significance of body mass as a risk factor (Table 5.3). 
 
62 McCall SJ, Li Z, Kurinczuk JJ, et al. 2017. Binational cohort study comparing the management and outcomes of pregnant women 
with a BMI >50–59.9 kg/m2 and those with a BMI ≥60 kg/m2. British Medical Journal Open 8:e021055. doi: 10.1136/bmjopen-2017-
021055 (accessed 1 December 2020).  
63 PMMRC. 2018. Twelfth Annual Report of the Perinatal and Maternal Mortality Review Committee: Reporting mortality 2016. 
Wellington: Health Safety & Quality Commission. URL: https://www.hqsc.govt.nz/assets/PMMRC/Publications/12th-PMMRC-report-
final.pdf (accessed 1 December 2020). 
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Table 5.3: Characteristics among maternal deaths, by parity and BMI 2006–2018 
 
Maternities Maternal mortality 
N=809,831 n=126 
N % n % 
Parity*     
0 295,607 36.5 33 26.2 
1–3 408,353 50.4 62 49.2 
4+ 39,606 4.9 28 22.2 
Unknown 66,265 8.2 3 2.4 
Maternal BMI (kg/m2)#     
<18.5 17,668 2.2 3 2.4 
18.5–24.9 310,122 38.3 41 32.5 
25.0–29.9 165,866 20.5 21 16.7 
30.0–34.9 85,322 10.5 23 18.3 
35.0–39.9 39,010 4.8 16 12.7 
≥40.0 22,858 2.8 17 13.5 
Missing data for height and/or weight 168,985 20.9 5 4.0 
* Mortality rates by parity not calculated as denominator data unreliable. 
# Mortality rates by BMI not calculated as denominator data unreliable. 
BMI = body mass index. 
Sources: Numerator: PMMRC’s maternal mortality data extract 2006–2018; Denominator: MAT data 2006–2018. 
In an analysis by prioritised ethnic group, wāhine Māori, until recently, had higher mortality rates than 
New Zealand European women. Over the period 2006–2018, no statistically significant change occurred for 
wāhine Māori or for New Zealand European women (Figure 5.3). 
Figure 5.3: Maternal three-year rolling mortality ratios (per 100,000 maternities) by prioritised ethnic group 
(Māori and New Zealand European) and year 2006–2018 
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Table 5.4: Maternal mortality ratios (per 100,000 maternities) and cause of maternal death* 2006–2018 
  2006–2018 2006–2018 
  n=126 Cause specific ratio 
  n % /100,000 maternities 
Maternities 809,831   
Direct maternal death 68 54.0 8.40 
Suicide  30 23.8 3.70 
Pregnancies with abortive outcome (ectopic and miscarriage)# 3 2.4 0.37 
Hypertensive disorders 4 3.2 0.49 
Obstetric haemorrhage 4 3.2 0.49 
Pregnancy-related infection 6 4.8 0.74 
Other obstetric complications 21 16.7 2.59 
Amniotic fluid embolism 14 11.1 1.73 
Venous thrombo-embolism 6 4.8 0.74 
Indirect maternal death 50 39.7 6.17 
Cardiac 13 10.3 1.61 
Neurological 13 10.3 1.61 
Infections not a direct result of pregnancy 9 7.1 1.11 
Other non-obstetric complications 14 11.1 1.73 
Unknown/undetermined 8 6.3 0.99 
* Other causes with small numbers have been suppressed. 
# This is the WHO category that includes first trimester pregnancy complications such as miscarriages and ectopic pregnancy. 
Sources: Numerator: PMMRC’s maternal mortality data extract 2006–2018; Denominator: MAT data 2006–2018. 
There were 68 direct maternal and 50 indirect maternal deaths over the study period 2006–2018 inclusive. 
The single largest cause of maternal death in Aotearoa/New Zealand was suicide, accounting for 30 deaths 
during this time (23.8%).  
The second most common cause was amniotic fluid embolism (AFE), which caused 14 deaths (11.1%) 
(Table 5.4). The mortality rate from AFE has reduced from nine maternal deaths for 2008–2010 to fewer 
than three in 2016–2018 (data not shown). A recent study, which included New Zealand data, identified 
‘having an obstetrician and/or anaesthetist present at the time of the event and the use of interventions to 
correct blood clotting abnormalities’ was associated with lower mortality.64 Massive transfusion protocols 
have been established throughout Aotearoa/New Zealand; they recognise the importance of prompt 
resuscitation and managing large blood loss with blood products and medications to support haemostasis. 
Regardless of whether the cause of a postpartum haemorrhage is AFE or another cause, where the 
bleeding is ongoing and uncontrolled the New Zealand national postpartum haemorrhage guidelines 
recommend using tranexamic acid to promote coagulation.65 
Maternal suicide 
While 56% of maternal deaths occurred during the postpartum period, around 41% of deaths occurred 
during pregnancy,66 mostly before 20 weeks’ gestation (data not shown). This finding shows that, in 
contrast to previous thinking, pregnancy is not necessarily protective of death by suicide. For a detailed 
review of maternal deaths due to suicide, see the PMMRC’s 11th report.  
Suicide deaths particularly affect wāhine Māori, who have both the largest number of deaths and the 
highest rate, compared with other ethnic groups. Wāhine Māori were 3.35 times more likely to die by 
suicide, mostly involving self-injury rather than self-poisoning means, than New Zealand European women 
(Table 5.5). A previous review of maternal suicide in wāhine Māori highlighted that nearly half of the women 
 
64 Fitzpatrick KE, van den Akker T, Bloemenkamp KWM, et al. 2019. Risk factors, management, and outcomes of amniotic fluid 
embolism: A multicountry, population-based cohort and nested case-control study. PLOS Medicine 16(11):e1002962. doi: 
10.1371/journal.pmed.1002962 (accessed 1 December 2020). 
65 Ministry of Health. 2013. National Consensus Guideline for Treatment of Postpartum Haemorrhage. Wellington: Ministry of 
Health. URL: https://www.health.govt.nz/publication/national-consensus-guideline-treatment-postpartum-haemorrhage (accessed: 
30 June 2020). 
66 Three percent of maternal deaths occurred during the intrapartum period or the timing was unknown. 
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who died by suicide had engaged in self-harm or made a suicide attempt during their pregnancy, and were 
known to be exposed to significant other stressors. The review made a number of recommendations 
around early recognition of risk factors, comprehensive assessment and active follow-up.67  In addition, 
suicide prevention needs to be considered in the wider context of the structural drivers of suicide.68  
Table 5.5: Maternal suicide by prioritised ethnic group* 2006–2018 
Ethnicity (prioritised) N n Rate RR 95% CI 
Māori 208,724 18 8.62 3.35 1.46–7.71 
NZ European 310,878 8 2.57 1.00 - 
* Excludes four cases that were in Pacific and ‘Other Asian’ ethnic groups. There were no deaths due to suicide in Indian; 
Middle Eastern, Latin American, or African (MELAA); Other European; or other ethnic groups. 
Sources: Numerator: PMMRC’s maternal mortality data extract 2006–2018; Denominator: MAT data 2006–2018. 
Figure 5.4 shows that rates of maternal death in Aotearoa/New Zealand are generally higher than those in 
the United Kingdom, and the higher rate of direct deaths is statistically significant. For most individual 
causes there were no statistically significant differences between rates in Aotearoa/New Zealand and the 
UK, except for suicide, where the rate in Aotearoa/New Zealand was substantially higher.  
While both suicide prevention and mental wellbeing are topical, no governmental budget has been provided 
specifically to reduce maternal suicide deaths, and investment in maternal wellbeing is limited. In contrast, 
the UK has a proportionately lower maternal mortality from suicide and in July 2019 the NHS England 
invested significant funding (£239 million) over the five years 2019/20–2023/24 towards specialist and 
community-based services for improving maternal and perinatal mental health.69 The Maternal Mortality 
Review Working Group recommends making targeted investment in maternal mental health a key priority 
for funding by the Ministry of Health. Maternal wellbeing, the development of culturally appropriate maternal 
screening tools and treatment for women and their babies continue to be areas in urgent need of 
investment, alongside addressing the wider societal drivers of suicide. Investment should prioritise 
populations who would benefit the most, such as ngā māma Māori, and be informed by research findings 
about when that support is most needed.   
 
67 PMMRC. 2017. Eleventh Annual Report of the Perinatal and Maternal Mortality Review Committee: Reporting mortality 2015. 
Wellington: Health Safety & Quality Commission. URL: 
https://www.hqsc.govt.nz/assets/PMMRC/Publications/2017_PMMRC_Eleventh_Annual_Report.pdf (accessed 1 December 2020). 
68 Ngā Pou Arawhenua, Child and Youth Mortality Review Committee, Suicide Mortality Review Committee. 2020. Te Mauri – the 
Life Force: Rangatahi suicide report – Te pūrongo mō te mate whakamomori o te rangatahi. Wellington: Health Quality & Safety 
Commission. URL: https://www.hqsc.govt.nz/assets/SUMRC/PR/TeMauriTheLifeForce_final.pdf (accessed 1 December 2020). 
69 NHS. 2019. NHS Mental Health Implementation Plan 2019/20–2023/24. URL: https://www.longtermplan.nhs.uk/wp-
content/uploads/2019/07/nhs-mental-health-implementation-plan-2019-20-2023-24.pdf (accessed 1 July 2020). 
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Figure 5.4: Cause-specific maternal mortality ratios* (per 100,000 maternities, with 95% CIs) in New Zealand 2012–2018 and the UK 2012–2017 
 
* Includes coincidental deaths. 
MMR = maternal mortality ratio. AFE = amniotic fluid embolism. VTE = venous thromboembolism. 
‘s’ indicates rate not calculated due to small numbers.  
 ‘Other direct’ includes cardiomyopathy. 
‘Other indirect’ includes endocrine, respiratory, neoplasm, other pre-existing medical. 
‘Coincidental’ includes motor vehicle accident, external causes of accidental injury, assault, malignancy not related to pregnancy. 
The shaded bars represent total of direct, indirect, unclassifiable and coincidental deaths. 
Sources: NZ MMR: Numerator: PMMRC's maternal mortality data extract 2012–2018; Denominator: MAT data 2012–2018. UK MMR: Numerator: Maternal Deaths and Morbidity, includes surveillance data 
on women who died during or up to one year after pregnancy 2012–2017 in the UK; Denominator: The number of pregnancies that result in a live birth at any gestation or stillbirths occurring at or after 24 
completed weeks of gestation, supplied by organisations such as the Office for National Statistics, the Scotland General Registrar Office, Northern Ireland Statistical Research Agency and Hospital Episode 
Statistics 2012–2017. UK MMR: Mothers and Babies: Reducing Risk through Audits and Confidential Enquiries across the UK (MBRRACE-UK) November 2019, ‘Saving Lives, Improving Mothers’ Care: 
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Appendix A: Maternal morbidity in Aotearoa/New Zealand |  
Te manaaki i te whaea matemate i Aotearoa  
While most women are healthy throughout their pregnancy, a small number experience 
severe acute maternal morbidity, also known as maternal ‘near miss mortality’. One way of 
describing this is when a pregnant or recently pregnant woman became so unwell that she 
‘would have died had it not been luck or good care was on her side’.70 
Rates of severe maternal morbidity can be used alongside maternal mortality as a measure 
of the quality of maternity care that can help to address health and disability system failures, 
with the goal of improving maternity care. Research shows that nearly all maternity intensive 
care unit (ICU) admissions are cases of severe morbidity (ie, high specificity) and make up 
more than three quarters of all severe acute maternal morbidity (ie, high sensitivity).71,72  
Research shows there are significant health inequities in maternity in Aotearoa/New 
Zealand. The impact of these inequities is particularly evident for Māori and Pacific peoples. 
Oversight of maternal morbidity 
In January 2020, the PMMRC committed to providing direct oversight of the maternal 
morbidity collection and reporting, beginning retrospectively from 1 July 2019. Previously, 
the Maternal Morbidity Working Group (MMWG) had received funding for three years to 
oversee and provide advice on maternal morbidity review, which ended on 30 June 2019.  
The PMMRC acknowledges the dedication and expertise of the MMWG in working towards 
the goal of improving outcomes for mothers in Aotearoa/New Zealand. It has made this 
contribution in particular through its woman-centred maternal morbidity reviews. Offering 
women the opportunity to describe their experiences has been extraordinarily valuable to 
inform case reviews, panel findings and recommendations. In addition, the MMWG has 
developed successful quality improvement initiatives, including the sepsis pathways and 
bundles, the maternity early warning system (MEWS) and the maternal morbidity review 
toolkit. It also collaborated in the development of the Severity Assessment Code (SAC) to 
provide guidance around reporting of adverse events in maternity services. 
The PMMRC aims to provide and maintain a sustainable maternal morbidity review function 
and plans to include maternal morbidity findings in its annual reports. The Chair of the 
PMMRC and the co-Chairs of the MMWG agree that work in this area is important and 
should continue.  
 
However, in taking on this important role the PMMRC has identified some key areas of data 
quality and reporting that require dedicated focus and resource to meet our responsibilities 
to Te Tiriti o Waitangi and to achieve equitable maternal outcomes that benefit all mothers 
and babies in Aotearoa/New Zealand. 
  
 
70  Mantel GD, Buchmann E, Rees H, et al. 1998. Severe acute maternal morbidity: a pilot study of a definition for 
a near-miss. BJOG: An International Journal of Obstetrics and Gynaecology 105(9): 985–90. doi: 10.1111/j.1471-
0528.1998.tb10262.x (accessed 30 December 2020). 
71  Geller S, Rosenberg D, Cox S, et al. 2004. A scoring system identified near-miss maternal morbidity during 
pregnancy. Journal of Clinical Epidemiology 57(7): 716–20. doi: 10.1016/j.jclinepi.2004.01.003 (accessed 30 
December 2020). 
72  You W, Chandrasekaran S, Sullivan J, et al. 2013. Validation of a scoring system to identify women with near-
miss maternal morbidity. American Journal of Perinatology 30(1): 21–4. doi: 10.1055/s-0032-1321493 (accessed 
30 December 2020). 
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Key focus areas to improve maternal morbidity review and reporting 
 
Engage with hospitals and district health boards to improve ethnicity data to better align 
with the Principles of Māori Data Sovereignty73 and the guidelines set out in Health 
Information Standards Organisation (HISO) 10001:2017 Ethnicity Data Protocols (Ministry 
of Health 2017).74 
 
Review the maternal morbidity notification form to contribute to a robust approach to 
collecting data. 
 
Explore ways to improve case ascertainment75 in order to analyse maternal morbidity 
more accurately in Aotearoa New Zealand. 
 
 
Te manaaki i te whaea matemate i Aotearoa – Maternal morbidity in Aotearoa/New 
Zealand 
Ngā whakamōhiotanga - data quality 
The PMMRC recognises the desperate need for a robust approach to ethnicity data 
collection to allow accurate and thorough analysis. Through such analysis, we aim to 
address systemic factors, such as racism and the ongoing effects of colonisation, that 
contribute to more severe illness. 
 
The PMMRC acknowledges that the data currently collected on maternal morbidity require 
significant review to better align with our commitment to the Principles of Māori Data 
Sovereignty73 and the guidelines set out in HISO 10001:2017 Ethnicity Data Protocols 
(Ministry of Health 2017).74  
 
Part of best practice is for ethnicity data collection to be self-identified; people should be able 
to identify with more than one ethnic group (multiple ethnicities) and information systems 
must be capable of recording up to six responses.74 However, the approach to collecting the 
ethnicity data that are in the maternal morbidity notification database falls well short of best 
practice: the data come from the ethnicity recorded on the patient’s clinical file; only one 
ethnicity can be selected even though the maternal morbidity notification form has six 
options of ethnicity to choose from; and ICU or high dependency unit (HDU) staff fill out the 
form.  
Ngā whakamōhiotanga – reporting 
Reporting cases of maternal morbidity in Aotearoa/New Zealand is recommended and 
requested, yet it is not required. If we are to effectively analyse maternal morbidity trends, it 
 
73 Te Mana Rauranga. 2018. Principles of Māori Data Sovereignty. URL: 
https://static1.squarespace.com/static/58e9b10f9de4bb8d1fb5ebbc/t/5bda208b4ae237cd89ee16e9/1541021836
126/TMR+Ma%CC%84ori+Data+Sovereignty+Principles+Oct+2018.pdf (accessed 30 December 2020). 
74 Ministry of Health. 2017. HISO 10001:2017 Ethnicity Data Protocols. Wellington: Ministry of Health. URL: 
https://www.health.govt.nz/publication/hiso-100012017-ethnicity-data-protocols (accessed 30 December 2020). 
75 Case ascertainment refers to the completeness and accuracy of information collected 
 
Fourteenth Annual Report of the Perinatal and Maternal Mortality Review Committee 116 
is important to have full case ascertainment, which requires robust, self-identified ethnicity 
data.   
Inconsistent reporting across hospitals and district health boards will lead to an 
underestimate of the incidence of maternal morbidity. This is particularly concerning for 
Māori, Pacific peoples and those with multiple risk factors.  
 
For this reason, this year the PMMRC has agreed to not report on the maternal morbidity 
data at the same level of detail as previous years. Although the trends they reveal can be 
useful, analysis and comparisons of specific rates are of limited value due to the variations in 
reporting and do not meet our commitment to improve ethnicity data. Reporting of these 
current data may lead some readers to misinterpret them and may not fully represent any 
existing inequities or the realities of the experiences of the women and babies involved.   
Ngā whakamōhiotanga – notifications 
Health providers send maternal morbidity notifications to the Commission for women who 
have been admitted to an HDU or ICU while pregnant, or within 42 days of the end of the 
pregnancy. These notifications include demographics, the reason for admission and the 
treatment the women received. Some women who experience severe maternal morbidity 
receive specialised care in other areas of hospitals, such as birthing/delivery suites. The 
maternal morbidity notification database does not include these women. While data 
collection for these cases is not yet robust, it does not discount or diminish the experiences 
of those women, their whānau or the people who care for them. 
 
Between 1 September 2018 and 31 August 2019, there were 421 notifications of 401 women 
admitted to an HDU or ICU. The leading reason for admission was postpartum 
haemorrhage, which accounted for 37.1% of cases (Figure A1). This was followed by 
hypertensive disorders (31.2%) and sepsis (14%).  
 
Fourteenth Annual Report of the Perinatal and Maternal Mortality Review Committee 117 
Figure A1: Number of pregnant or recently pregnant women admitted to an HDU or ICU by 
reason(s) for admission 1 September 2018–31 August 2019 
 
Note: ‘Other’ includes a wide range of other conditions or causes for admission, including but not limited to 
cardiac issues, anaphylaxis and chronic co-morbidities. ‘Multiple conditions’ includes all women who were 
admitted with more than  one diagnosis; these women are counted in the data collection multiple times. 
PPH = postpartum haemorrhage. 
Source: MMWG Notifications Database: Admissions to an HDU or ICU during or within 42 days of pregnancy. 
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As Figure A2 shows, women aged over 40 years made up the highest admission rate 
(13.3:1,000 women giving birth) followed by those aged under 20 years (8.9:1,000 women 
giving birth).  
Figure A2: Rate per 1,000 women giving birth with an HDU or ICU notification by age 
1 September 2018–31 August 2019 
 
Sources: Numerator: MMWG notification database: Admissions to an HDU or ICU during or within 42 
days of pregnancy; Denominator: MAT: Women who had babies born ≥20 weeks, average between 
2017 and 2018. 
 
The notifications suggest the rate of maternal morbidity in Aotearoa/New Zealand during this 
reporting period was 6.69 per 1,000 women giving birth. This rate is in line with other high-
income countries, where the maternal morbidity incidence rate is suggested to range from 
3.8 (95% CI 3.3–4.4) to 12 (95% CI 11.2–13.2) per 1,000 births.76  
 
Note that the classification of maternal morbidity varies internationally. The rate in this report 
reflects notifications in Aotearoa/New Zealand of women who were severely unwell and 
received HDU and/or ICU care; it does not include women who were very unwell and 
received care in other areas.  
 
Numerator data for notifications 
The numerator data come from the MMWG notification database on admissions to an HDU 
or ICU during or within 42 days of pregnancy. 
 
The Commission provides all HDUs and ICUs in Aotearoa/New Zealand with a maternal 
morbidity notification form. The form gives the following instructions: ‘Please fill in the details 
 
76 van Roosmalen J, Zwart J. 2009. Severe acute maternal morbidity in high-income countries. Best Practice & 
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below for each woman admitted to HDU and/or ICU who was pregnant or had delivered 
within 42 days prior to admission.’ 
 
After a pregnant or recently pregnant woman is admitted to an HDU or ICU, organisations 
are responsible for returning the completed notification form to the Commission. All 
notification data presented in this report came from the MMWG’s notification database, 
which is managed by the Commission.  
 
Denominator data for notifications 
The denominator data for notifications come from MAT data on women who had babies born 
≥20 weeks, averaged between 2017 and 2018. See Methods and definitions for Perinatal 
and Maternal Mortality Review Committee (PMMRC) reporting document, available at: 
www.hqsc.govt.nz/our-programmes/mrc/pmmrc/publications-and-
resources/publication/4210.  
Maternal morbidity review toolkit for maternity services | Te kete arotake mate 
whakawhānau mō ngā ratonga whakawhānau  
The PMMRC and the MMWG continue to 
recommend using the Maternal Morbidity Review 
Toolkit (the toolkit) for maternity services to guide 
local DHB review of maternal morbidity.   
 
In 2018 the MMWG released this toolkit to provide 
a sustainable reviewing method of maternal 
morbidity. It intended that this practice would 
become business as usual from July 2019.   
 
The purpose of the toolkit is to provide maternity 
services with clear, easy-to-use, evidence-based 
guidance and resources for implementing a 
consistent process for reviewing cases of 
significant maternal morbidity.  
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Appendix B: PMMRC recommendations for government departments and agencies 2007‒2019 
The table below is a subset of recommendations yet to be implemented and made by the PMMRC since its first report in 2007. The 
recommendations are aimed at government departments and agencies. The reports referenced in the third column are all available on the 
Health Quality & Safety Commission’s website at: www.hqsc.govt.nz/our-programmes/mrc/pmmrc/publications-and-resources.  
 
It is vital that government ensures adequate funding and infrastructure to enable DHBs and clinicians to implement PMMRC recommendations. 
While there has been significant work towards implementing recommendations, further priority must be given to them because a number of 
preventable deaths continue to occur. 
   
This table is one of five (see also Appendices C‒F), each directed towards different areas of maternity services and governing bodies. 
Government departments and agencies need to view the recommendations below alongside the other tables.  
 
Importantly, we must all continue to support the work of our colleagues and organisations in owning these responsibilities. Together, we can 
make the greatest and most valuable impact towards changing the outcomes of women and their babies, families and whānau. 
 
 PMMRC recommendations yet to be fully implemented 
Perinatal mortality Antenatal 
care/screening  
URGENT RECOMMENDATION: All women should commence maternity care before 10 weeks, for the following 
reasons: 
• opportunity to offer screening for congenital abnormalities, sexualy transmitted infections, family violence, and 
maternal mental health: and to refer as appropriate 
• education around nutrition (including appropriate weight gain), smoking, alcohol and drug use, and other at risk 
behaviours 
• recognition of underlying medical conditions with referral for secondary care as appropriate 
• identification of vunerable women at increase risk of perinatal related mortality. (Fifth Annual Report, 2011) 
As smoking is a significant modifiable risk factor for both stillbirth and neonatal death, every effort must be made to 
encourage women to engage in effecttive smoking cessation programmes prior to, during and after pregnancy 
(Eighth Annual Report, 2014) 
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URGENT RECOMMENDATION: We strongly recommend to the Government/Ministry for Primary Industries that folic 
acid fortification of bread be mandatory to reduce both mortality and serious morbidity from neural tube defects 
(Thirteenth Annual Report, 2013) 
Strategies to improve awareness of antenatal care services and increase access among women who are isolated for 
social, economic, cultural or language reasons should be developed (Third Annual Report, 2009) 
Guidelines The PMMRC recommends a review of epilepsy in the Guidelines for Consultation with Obstetric and Related Medical 
Services (Referral Guidelines). (Ninth Annual Report, 2015) 
Data collection The Ministry of Health should continue to support and fund DHBs and lead maternity carers (LMCs) in their collection 
of complete perinatal mortality statistics. (Third Annual Report, 2009) 
As a matter of urgency, the Ministry of Health update the National Maternity Collection (MAT), including the ethnicity 
data as identified by the parents in the birth registration process (Eleventh Annual Report, 2017 and Ninth Annual 
Report, 2015) 
The national Maternity Collection (MAT), linked to birth registration ethnicity data, be available for use by the mortality 
review committees. Access to these data would allow PMMRC to report the independent associations between 
ethnicity, maternal age, socioeconomic status and perinatal related death, adjusting for smoking and maternal body 
mass index (Seventh Annual Report, 2013) 
The PMMRC recommend the Ministry of Health: 
• urgently require DHBs to provide complete and accurate registration data to the MAT dataset (as required of 
LMCs providing services to pregnant women in order to receive funding for those services). Specifically, this 
should include women who present for birthing at DHB facilities without previous antenatal LMC registration and 
women who are provided primary maternity care by DHB maternity services 
• require that the MAT dataset include complete registration and antenatal data on live and stillborn babies from 20 
weeks gestation (including terminations for pregnancy). (Eleventh Annual Report, 2011) 
Mothers less 
than 20 years   
Maternity and primary care providers need to be aware of the increasing risk of perinatal mortality for mothers under 
20 years of age in New Zealand. Inequity in perinatal mortality for babies born to mothers under 20 years of age 
needs to be actively addressed. The PMMRC recommends the Ministry of Health and DHBs:  
• develop, in consultation with young mothers, acceptable and safe methods for mothers under 20 years of age to 
access and engage with care in order to achieve equitable health outcomes  
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• identify and adequately resource evidence-based solutions to address risks for mothers under 20 years of age, 
paying attention to smoking cessation, screening and treatment for infections, screening for fetal growth 
restriction, and providing adequate information about the causes and symptoms of preterm labour  
• consider how they can support LMCs caring for mothers aged under 20 years. (Twelfth Annual Report, 2018) 
Preterm birth The PMMRC recommends the Ministry of Health establish a multidisciplinary working group to review current 
evidence for implementation of a preterm birth prevention program such as that implemented in Western Australia, 
taking care to: 
• identify and adequately resource evidence-based solutions 
• ensure equitable access to screening and/or treatment for priority populations 
• ensure that priority populations have a voice in the development of health policy, process and practice in order to 
achieve equitable health outcomes 
• ensure that the outcomes of any implemented program, including equity of access, are evaluated. (Twelfth 
Annual Report, 2018) 
Birth in a tertiary centre is associated with improved outcomes for preterm babies at the lower limits of viability (prior 
to 25 weeks gestation). The PMMRC recommends the Ministry of Health leads the development of a national 
consensus pathway for the care of women in preterm labour or requiring delivery prior to 25 weeks gestation. The 
PMMRC recommends this pathway includes:  
• ensuring that all groups of women (irrespective of ethnicity, age, socioeconomic status or place of residence) are 
offered and provided the same level of care  
• strategies for secondary units for management of women in threatened or early preterm labour, or who require 
delivery, prior to 25 weeks gestation. Including:  
o administration of corticosteroids and magnesium sulphate  
o timely transfer from primary and secondary units to tertiary units  
o management of babies inadvertently born in their units at the lower limits of viability  
• ensuring that priority populations have a voice in the development of health policy, process and practice in order 
to achieve equitable health outcomes  
• guidance on monitoring that care provision is equitable by ethnicity, age, socioeconomic status and place of 
residence. (Twelfth Annual Report, 2018) 
URGENT RECOMMENDATION: There is a need to recognise the independent impact of socioeconomic deprivation 
on perinatal death, specifically on preterm birth, which after congenital abnormality is the leading cause of perinatal 
death. Addressing the impact of poverty requires wider societal commitment as has been highlighted in the recent 
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health select committee report on improving child health outcomes. The PMMRC supports the implementation of the 
recommendations. The report can be found at 
https://www.parliament.nz/en/pb/sc/reports/document/50DBSCH_SCR6007_1/inquiry-into-improving-child-health-
outcomes-and-preventing (Eight Annual Report, 2014) 
 SUDI 
prevention 
The PMMRC recommends that the Ministry of Health and DHBs have a responsibility to ensure that midwifery 
staffing ratios and staffing acuity tools:  
• enable active observation of mothers and babies who are undertaking skin-to-skin contact in the postnatal 
inpatient period  
• allow for the identification of, and additional needs of, mothers who have increased risk factors for sudden 
unexpected death in infancy (SUDI). (Twelfth Annual Report, 2018) 
Neonatal 
encephalopathy 
 The Neonatal Encephalopathy Working Group (NEWG) and PMMRC support the development of a guideline for the 
investigation and management of neonatal encephalopathy (Eighth Annual Report, 2014) 
Maternal mortality Maternal 
mental health 
URGENT RECOMMENDATION: The PMMRC recommends that a Maternal and Infant Mental Health Network is 
funded by the Ministry of Health and that the network then determine an achievable work stream by the end of 2018 
detailing work to be completed by the end of 2020, to include as potential areas of priority: 
a. a stocktake of current mental health services available across New Zealand for pregnant and recently pregnant 
women to identify both the strengths of services and gaps or inequity in current services and skills in the 
workforce 
b. a national pathway for accessing maternal mental health services, including: 
• cultural appropriateness to ensure of service access and provision  
• appropriate screening 
• care for women with a history of mental illness 
• communication and coordination. (Twelfth Annual Report, 2018) 
That a Perinatal and Infant Mental Health Network be established to provide an interdisciplinary and national forum to 
discuss perinatal mental health issues (Tenth Annual Report, 2016) 
A comprehensive perinatal and infant mental health service should include: 
• screening and assessment 
• timely interventions including case management, transition planning and referrals 
• access to respite care and specialist inpatient care for mothers and babies 
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• consultaiton and liaison services within the health system and with other agencies for example, primary care and 












 URGENT RECOMMENDATION: The Ministry of Health should resource, support and facilitate the development of a 
national perinatal bereavement pathway with key stakeholders, including governmental and non-governmental 
organisations, to ensure high-quality, appropriate and equitable care for all. (Thirteenth Annual Report, 2019) 
Develop and improve the provision of perinatal pathology services with regards to accessibility, training and 
appropriateness and ensure quality and equitable services are available across the country. (First Annual Report, 
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Appendix C: PMMRC recommendations for district health boards 2007‒2019 
The table below is a subset of recommendations yet to be implemented made by the PMMRC since its first report in 2007. These 
recommendations are aimed towards district health boards (DHBs). The reports referenced in the third column are all available on the Health 
Quality & Safety Commission’s website at: www.hqsc.govt.nz/our-programmes/mrc/pmmrc/publications-and-resources. 
 
While there has been significant work towards implementing recommendations, further priority must be given to them because a number of 
preventable deaths continue to occur. 
 
This table is one of five (see also Appendices A and D‒F), each directed towards different areas of maternity services and governing bodies. It 
is important that DHBs view the below recommendations alongside Appendix E recommendations for health practitioners. This is to ensure that 
DHBs, through good systems and processes, can effectively support clinicians to implement PMMRC recommendations.  
 
Importantly, we must all continue to support the work of our colleagues and organisations in owning these responsibilities. Together, we can 
make the greatest and most valuable impact towards changing the outcomes of women and their babies, families and whānau. 
 
 PMMRC recommendations yet to be fully implemented 
  DHBs should demonstate that they have co-developed and implemented models of care that meet the 
needs of mothers of Indian ethnicity. (Thirteenth Annual Report, 2019) 
That all maternity care providers identify women with modifiable risk factors for perinatal related death and 
work individually and collectivley to address these strategies to address modifiable risk factors include: 
• Improving update of periconceptual folate 
• Pre-pregnancy care for known medical disease such as diabetes  
• Access to antenatal care 
• Accurate height and weight measurement in pregnancy with advice on ideal weight gain 
• Prevention and appropriate management of multiple pregnancy  
• Smoking cessation 
• Antenatal recognition and management of threatened preterm labour 
• Following evidence based recommendations for indications for induction of labour 
• Advice to women and appropriate management of decreased fetal movements.  
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All DHBs should report the availablitiy and uptake of relevant services in their annual clinical report to 
ensure that these strategies are embedded and to identify areas for improvements. (Ninth Annual Report, 
2015) 
URGENT RECOMMENDATION: There is a need to recognise the independent impact of socioeconomic 
deprivation on perinatal death, specifically on preterm birth, which after congenital abnormality is the leading 
cause of perinatal death. Addressing the impact of poverty requires wider societal commitment as has been 
highlighted in the recent health select committee report on improving child health outcomes. The PMMRC 
supports the implementation of the recommendations. The report can be found at 
https://www.parliament.nz/en/pb/sc/reports/document/50DBSCH_SCR6007_1/inquiry-into-improving-child-
health-outcomes-and-preventing (Eighth Annual Report, 2014) 
For the management of suspected ectopic pregnancies, the PMMRC recommends DHB gynaecology 
services have: 
• Clear pathways/processess for primary care regarding early pregnancy management. 
Clear hospital guidelines for assessment of the collapsed woman of reproductive age that include the 
differential diagnosis of ectopic pregnancy.  Collapse due to ectopic pregnancy requires rapid assessment 
and surgical management. (Thirteenth Annual Report, 2019) 
Strategies to improve awareness of antenatal care services and increase access among women who are 




Pregnant women who are admitted to hospital for medical conditions not related to pregnancy need to have 
specific referral pathways for perinatal care (Fifth Annual Report, 2011) 
Education URGENT RECOMMENDATION: The PMMRC recommends that regulatory bodies require cultural 
competency training of all individuals working across all areas of the maternity and neonatal workforce. 
Training should address awareness of, and strategies to reduce and minimise the impact of, implicit bias 
and racism. (Twelfth Annual Report, 2018) 
The PMMRC recommends that DHBs provide free interdisciplinary fetal surveillance education for all 
clinicians involved in intrapartum care on a triennial basis. This is to be provided free for staff and at no cost 
to LMCs. The PMMRC encourages the Midwifery Council, the New Zealand College of Midwives (NZCOM) 
and Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG) to work 
with DHBs in the implementation of this recommendation: 
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• this education includes risk assessment for babies throughout pregnancy as well as intrapartum 
observations. 
The aims include strengthening of supervision and support to promote professional judgement, 
interdisciplinary conversations and reflective practice. (Thirteenth Annual Report, 2019 and Ninth Annual 
Report, 2015) 
Offer education to all clinicians so they are proficient at screening women, and are aware of local services 
and pathways to care for the following:  
• family violence 
• smoking  
• alcohol and other substance use. (Ninth Annual Report, 2015) 
All clinicians involved in the care of pregnant women should undertake regular multidisciplinary training in 
management of obstetric emergencies. (Tenth Annual Report, 2016 and Fifth Annual Report, 2011) 
Maternity and primary care providers need to be aware of the increasing risk of perinatal mortality for 
mothers under 20 years of age in New Zealand. Inequity in perinatal mortality for babies born to mothers 
under 20 years of age needs to be actively addressed. The PMMRC recommends the Ministry of Health and 
DHBs:  
• develop, in consultation with young mothers, acceptable and safe methods for mothers under 20 years 
of age to access and engage with care in order to achieve equitable health outcomes  
• identify and adequately resource evidence-based solutions to address risks for mothers under 20 years 
of age, paying attention to smoking cessation, screening and treatment for infections, screening for fetal 
growth restriction, and providing adequate information about the causes and symptoms of preterm 
labour  
consider how they can support LMCs caring for mothers aged under 20 years. (Twelfth Annual Report, 
2018) 
Mothers less 
than 20 years 
Maternity services for teenage mothers need to address this increased risk by the provision of services that 
specifically meet their needs, paying attention to: 
• Commencing maternity care before 10 weeks 
• Smoking cessation prevention of preterm birth (including smoking cessation, sexually transmitted 
infection screening and treatment, urinary tract infection screening and treatment) and screening for 
fetal growth restricition using regular fundal height measurement on customised growth charts 
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• Providing appropriate antenatal education (Fifth Annual Report, 2011) 
DHBs make available appropriate information, including appropriate counselling for parents, families and 
whānau about birth outcomes prior to 25 weeks gestation to enable shared decision making and planning of 
active care or palliative care options. (Twelfth Annual Report, 2018)  
Preterm birth DHB maternity services audit the rates of antenatal corticosteroid administration, including repeat doses 
when indicated, to mothers of neonates live born at less than 34 weeks gestation, including autditing 
whether administation is equitable by ethnicity, DHB of residence, and maternal age. (Twelfth Annual 
Report, 2018) 
The PMMRC recommends that LMCs and DHBs ensure that every baby will have access to a safe sleep 
place on discharge from the hospital or birth unit, or at home, that is their own place of sleep, on their back 
and with no pillow. If they do not have access to a safe sleep place, then a wahakura or Pēpi-Pod must be 
made available for the baby’s use prior to discharge from hospital. (Twelfth Annual Report, 2018) 
SUDI prevention  The PMMRC recommends that DHBs have a responsibility to ensure that midwifery staffing ratios and 
staffing acuity tools:  
• Enable active observation of mothers and babies who are undertaking skin-to-skin contact in the 
postnatal inpatient period. 
Allow for the identification of, and additional needs of, mothers who have increased risk factors for sudden 
unexpected death in infancy (SUDI). (Twelfth Annual Report, 2018) 
Clinicans and LMCs should be encouraged to collect accurate ethnicity details at the time of booking. 
(Fourth Annual Report, 2010)  
Data collection It is recommended that mothers who experience Intrapartum stillbirth, Intrapartum deaths of babies at term 
without obvious congenital abnormality are encouraged to have full investigation, including a post-mortem 
examination (Third Annual Report, 2009) 
Post-mortem All neonatal encephalopathy (NE) cases need to be considered for a Severity Assessment Code (SAC) 
rating. Neonatal hypoxic brain injury resulting in permanent brain damage (or permanent and severe loss of 
function) should be rated as SAC 1. Those who received cooling with as yet undetermined outcome should 
be rated as SAC 3. (Thirteenth Annual Report, 2019) 
 All babies with NE, regardless of severity, should have a multidisciplinary discussion about whether to refer 
to the Accident Compensation Corporation (ACC) for consideration for cover as a treatment injury, using 
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Neonatal 
encephalopathy 
ACC’s Treatment Injury Claim Lodgement Guide. Parents should be advised that not all treatment claims 
are accepted. All clinicians involved in the care of pregnant women should undertake regular 
multidisciplinary training in management of obstetric emergencies. (Tenth Annual Report, 2016 and Fifth 
Annual Report, 2011) 
DHBs with rates of neonatal encephalopathy significantly higher than the national rate review or continue to 
review, the higher rate of neonatal encephalopathy in their area and identify areas for improvement. (Twelfth 
Annual Report, 2018 and Eleventh Annual Report, 2017 and Tenth Annual Report, 2016) 
URGENT RECOMMENDATION: Widespread multidiscipinary education is required on the recognition of 
neonatal encephalopathy with a particular emphasis on babies with evidence of neonatal asphyxia (eg, 
babies who required resuscitation) for all providers of care for babies in the immediate postpartum period. 
This should include: 
• Recognition of babies at increased risk by their history 
• Signs suggestive of encephalopathy  
Knowledge of clinical pathways to induce cooling if required (Ninth Annual Report, 2015) 
All DHBs should undertake local review of cases of neonatal encephalopathy to identify area for 
improvement in care including adequacy of resuscitation and cooling. (Eighth Annual Report, 2014) 
Women with pre-existing medical conditions (such as epilepsy, hypertension or mental health) should have 
individualised pre-conceptual counselling about their condition and the medication they are taking. Health 
professionals providing care to these women need to communicate the importance of continuing their 
medication in pregnancy, if appropriate, and to advise women to seek early medical review. (Seventh 
Annual Report, 2013) 
Maternal mortality Antenatal 
care/screening 
Women with complex medical conditions require a multidisciplinary approach to care, often across more 
than one DHB. Each woman requiring such care should be assigned a key clinician to facilitate her care. 
(Third Annual Report, 2009) 
Women who are unstable or clinically unwell should be cared for in the most appropriate place within each 
unit in order for close observation to occur.  When observations are abnormal, clear documentation, early 
review by a senior clinican and development of a detailed management plan are required. (Eighth Annual 
Report, 2014) 
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Communication 
and coordination   
Pregnant women who are admitted to hospital for medical conditions that are not related to pregnancy need 
to have specific referral pathways for perinatal care. (Fifth Annual Report, 2011) 
Women with serious pre-existing medical conditions require a multidisciplinary management plan for the 
pregnancy, birth and postpartum period. This plan must be communicated to all relevant caregivers. (Eighth 
Annual Report, 2014) 
A comprehensive perinatal and infant mental health service includes: 
• Screening and assessment 
• Timely interventions including case management, transition planning and referrals 
• Access to respite care and specialist inpatient care for mothers and babies. 
Consultation and liaison services within the health system and with other agencies for example, primary 
care and termination of pregnancy services. (Sixth Annual Report, 2012) 
Maternal mental 
health 
Termination of pregnancy services should undertake holistic screening for maternal mental health and 
family violence and provide appropriate support and referral. (Sixth Annual Report, 2012) 
At first contact with services women should be asked: 
• Are you currently receiving, or have you ever received treatment for a serious mental illness such as 
severe depression, bipolar disorder, schizophrenia or psychosis? 
• Have you ever had treatment from a psychiatrist or specialist mental health team in the past? 
• Do you have a family history of mental illness including perinatal mental illness? 
Women with a previous history of serious affective disorder or other psychoses should be referred in 
pregnancy for psychiatric assessment and management even if they are well. Regular monitoring and 
support is recommended for at least three months following delivery. (Fifth Annual Report, 2011) 








All providers of maternity, obstetric, mental health and maternal mental health services should improve their 
systems, guidelines and professional development to ensure that they are responsive to the identified 
increased risk for Māori women. (Eleventh Annual Report, 2017) 
Māori women who have a history of serious mental illness and are currently well should be referred to 
specialist mental health services for a mental health birth plan, and monitored closely by their maternity care 
provider +/- mental health services. Where such a woman has a miscarriage, the GP should be notified 
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immediately and an explicity process for early follow up that includes a review of mental health status 
agreed with GP. (Eleventh Annual Report, 2017) 
Where Māori women exhibit symptoms suggesting serious mental illness or distress, an urgent mental 
health assessment, including consultant psychiatrist review and consultation with perinatal mental health 
services, on the same day these symptoms are first noted should be undertaken. (Eleventh Annual Report, 
2017) 
Primary care (GPs, FPA), LMCs, TOP services, alcohol and drug services, and secondary and tertiary 
providers of maternity, obstetric, mental health, and maternal mental health services should improve their 
systems, guidelines and professional development to ensure that they are responsive to the identified 
increased risk for Māori women. (Eleventh Annual Report, 2017) 
Communication and coordination between primary care (GPs, FPA), LMCs, TOP services, alcohol and drug 
services, and secondary providers of maternity, obstetric, mental health, and maternal mental health 
services should be improved and enhanced using a variety of means including but not limited to case 
management, integrated notes systems, and electronic transfer of information. (Eleventh Annual Report, 
2017) 
The PMMRC recommends that DHBs with rates of perinatal related mortality and neonatal encephalopathy 
significantly higher than the national rate review, or continue to review, the higher rater of mortality in their 
area and idenitfy areas for improvement. (Twelfth Annual Report, 2018 and Eleventh Annual Report, 2017 
and Tenth Annual Report, 2016) 
Auditing   URGENT RECOMMENDATION: DHBs should monitor key maternity indicators by ethnic group to identify 
variations in outcomes. They should then improve areas where there are differences in outcome. (Thirteenth 
Annual Report, 2019) 
Further research is warranted to understand the higher rate of perinatal related mortality in the Counties 
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Appendix D: PMMRC recommendations for health organisations, colleges and regulatory bodies 
2007‒2019 
The table below is a subset of recommendations yet to be implemented made by the PMMRC since its first report in 2007. These 
recommendations are aimed towards health organisations, colleges and regulatory bodies. The reports referenced in the third column are all 
available on the Health Quality & Safety Commission’s website at: www.hqsc.govt.nz/our-programmes/mrc/pmmrc/publications-and-resources. 
 
While there has been significant work towards implementing recommendations, further priority must be given to them because a number of 
preventable deaths continue to occur. 
 
This table is one of five (see also Appendices A‒C and E‒F), each directed towards different areas of maternity services and governing bodies. 
It is important that health organisations view the below recommendations alongside Appendix E recommendations for health practitioners. This 
is to ensure that health organisations, through good systems and education, can effectively support clinicians to implement PMMRC 
recommendations.  
 
Importantly, we must all continue to support the work of our colleagues and organisations in owning these responsibilities. Together, we can 
make the greatest and most valuable impact towards changing the outcomes of women and their babies, families and whānau. 
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 PMMRC recommendations yet to be fully implemented  
Perinatal mortality Antenatal 
care/screening 
The PMMRC recommends that DHBs provide free interdisciplinary fetal surveillance education for all clinicians 
involved in intrapartum care on a triennial basis. This is to be provided free for staff and at no cost to LMCs. The 
PMMRC encourages the Midwifery Council, the New Zealand College of Midwives (NZCOM) and Royal Australian 
and New Zealand College of Obstetricians and Gynaecologists (RANZCOG) to work with DHBs in the 
implementation of this recommendation: 
• This education includes risk assessment for babies throughout pregnancy as well as intrapartum observations. 
• The aims include strengthening of supervision and support to promote professional judgement, interdisciplinary 
conversations and reflective practice. (Thirteenth Annual Report, 2019 and Ninth Annual Report, 2015) 
The PMMRC endorses all recommendations of the audit of congenital abnormalities. Key recomendations from the 
audit include: 
• all primary care providers (if first contact of a pregnant woman with the health service) should offer first 
trimester screening and facilitate expeditious registration 
• achieving optimal use of preconceptual folate by young women in New Zealand requires a policy for 
foritification of bread 
• the National Screening Unit review the cost benefit of the current algorithms in the first and second trimester 
screening programme, so they are calibrated for maximal sensitivitiy for all chromosomal abnormalities 
• the National Screening Unit review false negative screening tests 
• the New Zealand National Maternal Fetal Medicine Network regularly audit time from referral to review to 
ensure that the majority of women are seen within seven days as recommended. (Seventh Annual Report, 
2013) 
Education URGENT RECOMMENDATION: The PMMRC recommends that regulatory bodies require cultural competency 
training of all individuals working across all areas of the maternity and neonatal workforce. Training should address 




 URGENT RECOMMENDATION: Widespread multidiscipinary education is required on the recognition of neonatal 
encephalopathy with a particular emphasis on babies with evidence of neonatal asphyxia (eg. babies who required 
resuscitation) for all providers of care for babies in the immediate postpartum period. This should include: 
• Recognition of babies at increased risk by their history 
• Signs suggestive of encephalopathy  
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• Knowledge of clinical pathways to induce cooling if required. (Ninth Annual Report, 2015) 
The Neonatal Encephalopathy Working Group (NEWG) and PMMRC support the development of a guideline for the 
investigation and management of neonatal encephalopathy (Eighth Annual Report, 2014) 







URGENT RECOMMENDATION: Improved awareness and responsiveness to the increased risk for Māori women 
(Eleventh Annual Report, 2017) 
URGENT RECOMMENDATION: Primary care (GPs, FPA), LMCs, TOP services, alcohol and drug services, and 
secondary and tertiary providers of maternity, obstetric, mental health, and maternal mental health services should 
improve their systems, guidelines and professional development to ensure that they are responsive to the identified 
increased risk for Māori women. (Eleventh Annual Report, 2017) 
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Appendix E: PMMRC recommendations for health practitioners involved in care of pregnant 
women 2007‒2019 
The table below is a subset of recommendations yet to be implemented made by the PMMRC since its first report in 2007. These 
recommendations are aimed towards health practitioners involved in the care of pregnant women. The reports referenced in the third column 
are all available on the Health Quality & Safety Commission’s website at: www.hqsc.govt.nz/our-programmes/mrc/pmmrc/publications-and-
resources. 
 
While there has been significant work towards implementing recommendations, further priority must be given to them because a number of 
preventable deaths continue to occur. 
 
This table is one of five (see also Appendices A‒D and F), each directed towards different areas of maternity services and governing bodies. It 
is important that government departments, agencies and DHBs fund, develop and maintain effective systems and processes to enable health 
practitioners to implement these recommendations.  
 
Importantly, we must all continue to support the work of our colleagues and organisations in owning these responsibilities. Together, we can 
make the greatest and most valuable impact towards changing the outcomes of women and their babies, families and whānau. 
 
 PMMRC recommendations yet to be fully implemented 
Perinatal mortality Antenatal care/ 
screening 
That all maternity care providers identify women with modifiable risk factors for perinatal related death and work 
individually and collectively to address these.  
Strategies to address modifiable risk factors include: 
• Improving update of periconceptual folate 
• Pre-pregnancy care for known medical disease such as diabetes  
• Access to antenatal care 
• Accurate height and weight measurement in pregnancy with advice on ideal weight gain 
• Prevention and appropriate management of multiple pregnancy  
• Smoking cessation 
• Antenatal recognition and management of threatened preterm labour 
• Following evidence based recommendations for indications for induction of labour 
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• Advice to women and appropriate management of decreased fetal movements.  
All DHBs should report the availability and uptake of relevant services in their annual clinical report to ensure that 
these strategies are embedded and to identify areas for improvements. (Ninth Annual Report, 2015) 
URGENT RECOMMENDATION: All women should commence maternity care before 10 weeks, for the following 
reasons: 
• Opportunity to offer screening for congenital abnormalities, sexualy transmitted infections, family violence, 
and maternal mental health: and to refer as appropriate 
• Education around nutrition (including appropriate weight gain), smoking, alcohol and drug use, and other at 
risk behaviours 
• Recognition of underlying medical conditions with referral for secondary care as appropriate 
• Identification of vunerable women at increase risk of perinatal related mortality. (Fifth Annual Report, 2011) 
If small for gestational age (SGA) is confirmed by ultrasound at term, timely delivery is recommended. (Sixth 
Annual Report, 2012) 
Pregnant women should consult their midwife, general practitioner or specialist services as soon as symptoms of 
influenza like illness develop or if other family members are unwell to allow: 
• Referral to hospital for assessment if there are symptoms of respiratory compromise due to influenza that is, 
worsening shortness of breath, espeically at rest, productive cough, pleuritic chest pain, haemoptysis 




Pregnant women who are admitted to hospital for medical conditions not related to pregnancy need to have 
specific referral pathways for perinatal care. (Fifth Annual Report, 2011) 
Data collection Clinicans and LMCs should be encourage to collect accurate ethnicity details at the time of booking. (Fourth 
Annual Report, 2010)  
Education  All clinicians involved in the care of pregnant women should undertake regular multidisciplinary training in 
management of obstetric emergencies and resuscitation. (Tenth Annual Report, 2016 and Fifth Annual Report, 
2011) 
 Maternity services for teenage mothers need to address this increased risk by the provision of services that 
specifically meet their needs, paying attention to: 
• Commencing maternity care before 10 weeks 
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• Smoking cessation prevention of preterm birth (including smoking cessation, sexually transmitted infection 
screening and treatment, urinary tract infection screening and treatment) and screening for fetal growth 
restricition using regular fundal height measurement on customised growth charts 
• Providing appropriate antenatal education. (Fifth Annual Report, 2011) 
SUDI 
prevention 
The PMMRC recommends that LMCs and DHBs ensure that every baby will have access to a safe sleep place 
on discharge from the hospital or birth unit, or at home, that is their own place of sleep, on their back and with no 
pillow. If they do not have access to a safe sleep place, then a wahakura or Pēpi-Pod must be made available for 
the baby’s use prior to discharge from hospital. (Twelfth Annual Report, 2018) 
Neonatal 
encephalopathy 
 All neonatal encephalopathy (NE) cases need to be considered for a Severity Assessment Code (SAC) rating. 
Neonatal hypoxic brain injury resulting in permanent brain damage (or permanent and severe loss of function 
should be rated as SAC 1. Those who received cooling with as yet undermined outcome should be rated as SAC 
3. (Thirteenth Annual Report, 2019) 
For all babies diagnosed with NE a multidisciplinary discussion about whether to refer to the Accident 
Compensation Corporation (ACC) for consideration for cover as a treatment injury, using ACC’s Treatment Injury 
Claim Lodgement Guide, should be arranged. Parents should be advised that not all treatment claims are 
accepted. (Thirteenth Annual Report, 2019) 
If neonatal encephalopathy is clinically suspected in the immediate hours after birth, early consultation with a 
neonatal paediatrician is recommended in order to avoid a delay in commencing cooling. (Sixth Annual Report, 
2012) 
Cord gases should be performed on all babies born with an Apgar 7 at one minute. (Sixth Annual Report, 2012) 
Maternal mortality Antenatal 
care/screening 
Women with serious pre-existing medical conditions require a multidisciplinary management plan for the 
pregnancy, birth and postpartum period. This plan must be communicated to all relevant caregivers. (Eighth 
Annual Report, 2014) 
Women who are unstable or clinically unwell should be cared for in the most appropriate place within each unit in 
order for close observation to occur.  When observations are abnormal, clear documentation, early review by a 
senior clinican and development of a detailed management plan are required. (Eighth Annual Report, 2014) 
Women with pre-existing medical conditions (such as epilepsy, hypertension or mental health) should have 
individualised pre-conceptual counselling about their condition and the medication they are taking. Health 
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professionals providing care to these women need to communicate the importance of continuing their medication 
in pregnancy, if appropriate, and to advise women to seek early medical review. (Seventh Annual Report, 2013) 
Pregnant women who are admitted to hospital for medical conditions not related to pregnancy need to have 




Women with complex medical conditions require a multidisciplinary approach to care, often across more than 
one DHB. Each woman requiring such care should be assigned a key clinician to facilitate her care. (Third 
Annual Report, 2009) 
Maternal 
mental health 
A comprehensive perinatal and infant mental health service should include: 
• Screening and assessment 
• Timely interventions including case management, transition planning and referrals 
• Access to respite care and specialist inpatient care for mothers and babies. 
Consultation and liaison services within the health system and with other agencies for example, primary care and 
termination of pregnancy services. (Sixth Annual Report, 2012) 
Termination of pregnancy services should undertake holistic screening for maternal mental health and family 
violence and provide appropriate support and referral. (Sixth Annual Report, 2012) 
At first contact with services women should be asked:  
• Are you currently receiving, or have you ever received treatment for a serious mental illness such as severe 
depression, bipolar disorder, schizophrenia or psychosis 
• Have you ever had treatment from a psychiatrist or specialist mental health team in the the past? 
• Do you have a family history of mental illness including perinatal mental illness? 
Women with a previous history of serious affective disorder or other psychoses should be referred in pregnancy 
for psychiatric assessment and management even if they are well. Regular monitoring and support is 





Improved awareness and responsiveness to the increased risk for Māori women. (Eleventh Annual Report, 2017) 
Communication and coordination between primary care (GPs, FPA), LMC’s TOP services, alcohol and drug 
services, and secondary providers of maternity, obstetric, mental health and maternal mental health services 
should be improved and enhanced using a variety of means including but not limited to case management, 
integrated notes systems, and electronic transfer to information. (Eleventh Annual Report, 2017) 
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maternal 
mental health 
Primary care (GPs, PA) LMCs, TOP services, alcohol and drug services and secondary and tertiary providers of 
maternity, obstetric, mental health and maternal mental health services should improve their systems, guidelines 
and professional development to ensure that they are responsive to the identified increased risk for Māori 
women. (Eleventh Annual Report, 2017) 
Where Māori women exhibit symptoms suggesting serious mental illness or distress, an urgent mental health 
assessment, including consultant psychiatrist review and consultation with perinatal mental health services, on 
the same day these symptoms are first noted should be undertaken. (Eleventh Annual Report, 2017) 
Comprehensive assessment of risk factors for all Māori women, including those seeking a TOP, should be 
undertaken at diagnosis of pregnancy and/or on first presentation for antenatal care. (Eleventh Annual Report, 
2017) 
Māori women who have a history of serious mental illness and are currently well should be referred to specialist 
mental health services for a mental health birth plan, and monitored closely by their maternity care provider +/- 
mental health services. Where such a woman has a miscarriage, the GP should be notified immediately and an 
explicit process for early follow up that includes a review of mental health status agreed with GP. (Eleventh 
Annual Report, 2017) 
The referring doctor of women who undergo a TOP is expected to provide a free post-TOP follow up consultation 
10‒14 days after the procedure. The referring doctor should actively follow up Māori women referred for TOP to 
ensure this consultation is completed and review mental health status during this consultation (Eleventh Annual 
Report, 2017) 
Clinicans are reminded that mental illness can deteriorate very rapidly in pregnancy and the postnatal period, 
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Appendix F: PMMRC recommendations for researchers 2007‒2019 
The table below is a subset of recommendations yet to be implemented made by the PMMRC since its first report in 2007. These 
recommendations are aimed towards researchers. The reports referenced in the third column are all available on the Health Quality & Safety 
Commission’s website at: www.hqsc.govt.nz/our-programmes/mrc/pmmrc/publications-and-resources. 
 
While there has been significant work towards implementing recommendations, further priority must be given to them because a number of 
preventable deaths continue to occur. 
 
This table is one of five (see also Appendices A‒E), each directed towards different areas of maternity services and governing bodies. While 
the below recommendations have been made directly to researchers, there are many recommendations included in Appendices B‒E, where 
barriers to implementation could generate valuable research. It is worthwhile viewing the below recommendations alongside the other 
appendices.    
 
Importantly, we must all continue to support the work of our colleagues and organisations in owning these responsibilities. Together, we can 
make the greatest and most valuable impact towards changing the outcomes of women and their babies, families and whānau. 
PMMRC recommendations relating to research 
Collectively, we need to increase our understanding of the reasons for adverse outcomes in certain groups. For example, within Aotearoa/New Zealand 
and internationally, we have an incomplete understanding of what puts women and babies of Indian ethnicity at increased risk. (Thirteenth Annual Report, 
2019) 
Research on the best model of care for teenage pregnant mothers in New Zealand should be undertaken with a view to reducing stillbirth and neonatal 
death. (Fifth Annual Report, 2011) 
Key stakeholders in provision of health and social services to women at risk should work together to identify existing research on: 
• Reasons for barriers to engagement with maternity care 
• Interventions to address barriers to engagement with maternity care. (Fifth Annual Report, 2011) 
 




Possible causes for the increase in perinatal-related death of babies born to Pacific women, Māori women, women under the age of 20 and over the age of 
40, and women who live in areas of high socioeconomic deprivation should be researched. This information is necessary in order to develop appropriate 
strategies to reduce these possibly preventable deaths. (Fourth Annual Report, 2010) 
Strategies to improve awareness of antenatal care services and increase access among women who are isolated for social, economic, cultural or language 
reasons should be developed. (Third Annual Report, 2009) 
